BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 828662 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H21N3O/c1-21(2)12-16-18(17(25)13-21)20(23-15-6-4-3-5-7-15)19(24-16)14-8-10-22-11-9-14/h3-11,23-24H,12-13H2,1-2H3 IKBVGWGZKPEKHN-UHFFFAOYSA-N 414900 6,6-dimethyl-3-(phenylamino)-2-(pyridin-4- yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.25 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414900&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607263 433914947 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828663 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1Cl InChI=1S/C21H20ClN3O/c1-21(2)10-16-18(17(26)11-21)20(24-13-6-4-3-5-7-13)19(25-16)14-8-9-23-12-15(14)22/h3-9,12,24-25H,10-11H2,1-2H3 OTJFKXAUUSJJHZ-UHFFFAOYSA-N 414901 Preparation of 2-(3-chloropyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.98 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414901&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607003 433914948 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828664 Cc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C22H23N3O/c1-14-5-4-6-16(11-14)24-21-19-17(12-22(2,3)13-18(19)26)25-20(21)15-7-9-23-10-8-15/h4-11,24-25H,12-13H2,1-3H3 WOMLFFOXZOGYHF-UHFFFAOYSA-N 414904 Preparation of 6,6-dimethyl-3-[(3-methylphenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 37.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414904&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607047 433914951 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828665 CC1(C)Cc2[nH]c(c(Nc3cccc(Cl)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20ClN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-4-14(22)10-15)19(25-16)13-6-8-23-9-7-13/h3-10,24-25H,11-12H2,1-2H3 SGVGBNGUJFWEDG-UHFFFAOYSA-N 414905 Preparation of 6,6-dimethyl-3-[(3-chlorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414905&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607155 433914952 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828666 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncn1 InChI=1S/C20H20N4O/c1-20(2)10-15-17(16(25)11-20)19(23-13-6-4-3-5-7-13)18(24-15)14-8-9-21-12-22-14/h3-9,12,23-24H,10-11H2,1-2H3 MHSRDFHWMHNGGJ-UHFFFAOYSA-N 414906 Preparation of 6,6-dimethyl-3-(phenylamino)-2-(pyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 5 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 25.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414906&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606828 433914953 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828667 CC1(C)Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20FN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-4-14(22)10-15)19(25-16)13-6-8-23-9-7-13/h3-10,24-25H,11-12H2,1-2H3 VBEFHVKVBNTPHV-UHFFFAOYSA-N 414907 Preparation of 2-(3-fluoropyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414907&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606829 433914954 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828668 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414909 Preparation of 3-(phenylamino)-6-(propan-2-yl)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 17::US10428044, Example 18::US10428044, Example 7 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.57 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414909&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606783 433914956 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828669 O=C1CC(Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1)c1ccccc1 414910 Preparation of 6-Phenyl-3-phenylamino-2-(pyridin-4-yl)-1,5,6,7-tetrahydroindol-4-one::US10428044, Example 8 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 22.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414910&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606784 433914957 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828670 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C19H17N3O/c23-16-8-4-7-15-17(16)19(21-14-5-2-1-3-6-14)18(22-15)13-9-11-20-12-10-13/h1-3,5-6,9-12,21-22H,4,7-8H2 DPMOETSXJIEJIE-UHFFFAOYSA-N 414911 Preparation of 3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 9 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414911&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607335 433914958 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828671 CC1(C)Cc2[nH]c(c(Nc3ccc(Cl)cc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20ClN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-14(22)4-6-15)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 CQOYAXAOLZABAT-UHFFFAOYSA-N 414912 Preparation of 3-[(4-chlorophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 10 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414912&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607312 433914959 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828672 CC1(C)Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20FN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-14(22)4-6-15)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 AYGYXZDDLABDLE-UHFFFAOYSA-N 414913 Preparation of 3-[(4-fluorophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 11 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414913&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607308 433914960 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828673 CC1(C)Cc2[nH]c(c(Nc3cccc(Br)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20BrN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-4-14(22)10-15)19(25-16)13-6-8-23-9-7-13/h3-10,24-25H,11-12H2,1-2H3 OMGPPBODKVESMK-UHFFFAOYSA-N 414914 Preparation of 3-[(3-bromophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 12 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414914&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606672 433914961 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828674 O=C1CC2(CCC2)Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C22H21N3O/c26-18-14-22(9-4-10-22)13-17-19(18)21(24-16-5-2-1-3-6-16)20(25-17)15-7-11-23-12-8-15/h1-3,5-8,11-12,24-25H,4,9-10,13-14H2 SBGHAZAHMGYLSE-UHFFFAOYSA-N 414915 Preparation of 3′-(phenylamino)-2′-(pyridin-4-yl)-1′,7′-dihydrospiro[cyclobutane-1,6′-indol]-4′(5′H)-one::US10428044, Example 13 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.55 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414915&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606835 433914962 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828675 Cc1cc(F)cc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C22H22FN3O/c1-13-8-15(23)10-16(9-13)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-4-6-24-7-5-14/h4-10,25-26H,11-12H2,1-3H3 GGDOAXQGEVYICE-UHFFFAOYSA-N 414916 Preparation of 3-[(3-fluoro-5-methylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 14 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414916&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607234 433914963 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828676 CCc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H25N3O/c1-4-15-6-5-7-17(12-15)25-22-20-18(13-23(2,3)14-19(20)27)26-21(22)16-8-10-24-11-9-16/h5-12,25-26H,4,13-14H2,1-3H3 RMDQXTHWIVCXRH-UHFFFAOYSA-N 414917 Preparation of 3-[(3-ethylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 15 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414917&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606683 433914964 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828677 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)[N+]([O-])=O)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20N4O3/c1-21(2)11-16-18(17(26)12-21)20(19(24-16)13-6-8-22-9-7-13)23-14-4-3-5-15(10-14)25(27)28/h3-10,23-24H,11-12H2,1-2H3 KGOMSRFPIKEQCU-UHFFFAOYSA-N 414918 Preparation of 6,6-dimethyl-3-[(3-nitrophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 16 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 27.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414918&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606738 433914965 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828678 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414909 Preparation of 3-(phenylamino)-6-(propan-2-yl)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 17::US10428044, Example 18::US10428044, Example 7 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.04 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414909&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606783 433914956 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828679 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414909 Preparation of 3-(phenylamino)-6-(propan-2-yl)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 17::US10428044, Example 18::US10428044, Example 7 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.09 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414909&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606783 433914956 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828680 CC1(C)Cc2[nH]c(c(Nc3cc(F)cc(Cl)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19ClFN3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-3-5-24-6-4-12)25-15-8-13(22)7-14(23)9-15/h3-9,25-26H,10-11H2,1-2H3 BGUNCYAUJUQMNO-UHFFFAOYSA-N 414921 Preparation of 3-[(3-chloro-5-fluorophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 19 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414921&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606895 433914966 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828681 FC(F)(F)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414922 Preparation of 3-(phenylamino)-2-(pyridin-4-yl)-6-(trifluoromethyl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 20 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.33 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414922&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607196 433914967 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828682 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19F2N3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-5-7-24-8-6-12)25-13-3-4-14(22)15(23)9-13/h3-9,25-26H,10-11H2,1-2H3 LZKLCQKQRNHWAH-UHFFFAOYSA-N 414923 Preparation of 3-[(3,4-difluorophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 21 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414923&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607190 433914968 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828683 CC1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414924 Preparation of 6-methyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 22 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414924&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606962 433914969 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828684 CC1(C)Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(F)c1 InChI=1S/C21H19F2N3O/c1-21(2)10-15-18(16(27)11-21)20(25-14-5-3-4-13(22)9-14)19(26-15)12-6-7-24-17(23)8-12/h3-9,25-26H,10-11H2,1-2H3 HPWZKCSSMVCCMT-UHFFFAOYSA-N 414925 Preparation of 3-[(3-fluorophenyl)amino]-2-(2-fluoropyridin-4-yl)-6,6-dimethyl-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 24 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414925&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607278 433914970 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828685 CC1(C)Cc2[nH]c(c(Nc3ccccn3)c2C(=O)C1)-c1ccncc1 InChI=1S/C20H20N4O/c1-20(2)11-14-17(15(25)12-20)19(24-16-5-3-4-8-22-16)18(23-14)13-6-9-21-10-7-13/h3-10,23H,11-12H2,1-2H3,(H,22,24) WQWBQHFHHBUQKU-UHFFFAOYSA-N 414926 Preparation of 6,6-dimethyl-2-(pyridin-4-yl)-3-(pyridin-2-ylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 25 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414926&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606834 433914971 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828686 CC1(C)Cc2[nH]c(c(Nc3ccc4ccoc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H21N3O2/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)15-5-8-24-9-6-15)25-16-4-3-14-7-10-28-19(14)11-16/h3-11,25-26H,12-13H2,1-2H3 DMVGNTIASNCYEF-UHFFFAOYSA-N 414927 Preparation of 3-(1-benzofuran-6-ylamino)-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 26 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 32.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414927&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607204 433914972 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828687 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc2[nH]ccc12 InChI=1S/C23H22N4O/c1-23(2)12-17-19(18(28)13-23)21(26-14-6-4-3-5-7-14)20(27-17)15-8-10-24-22-16(15)9-11-25-22/h3-11,26-27H,12-13H2,1-2H3,(H,24,25) PDVSSSBRBFCJLG-UHFFFAOYSA-N 414928 Preparation of 6,6-dimethyl-3-(phenylamino)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 27 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 43.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414928&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607194 433914973 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828688 CCC1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414929 Preparation of 6-ethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 28 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.93 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414929&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606853 433914974 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828689 CC(C)CC1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 414930 Preparation of 6-(2-methylpropyl)-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 29 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.17 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414930&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606924 433914975 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828690 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1F InChI=1S/C21H20FN3O/c1-21(2)10-16-18(17(26)11-21)20(24-13-6-4-3-5-7-13)19(25-16)14-8-9-23-12-15(14)22/h3-9,12,24-25H,10-11H2,1-2H3 IPYRKMHTTDKCTL-UHFFFAOYSA-N 414931 Preparation of 2-(3-fluoropyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 30 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.69 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414931&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607208 433914976 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828691 CC1(C)Cc2[nH]c(c(Nc3cc(F)cc(F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19F2N3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-3-5-24-6-4-12)25-15-8-13(22)7-14(23)9-15/h3-9,25-26H,10-11H2,1-2H3 NRFXEKOYUYGCRP-UHFFFAOYSA-N 414932 Preparation of 3-[(3,5-difluorophenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 31 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.55 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414932&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607019 433914977 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828692 CC1(C)Cc2[nH]c(c(Nc3cc(F)c(F)c(F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H18F3N3O/c1-21(2)9-15-17(16(28)10-21)20(19(27-15)11-3-5-25-6-4-11)26-12-7-13(22)18(24)14(23)8-12/h3-8,26-27H,9-10H2,1-2H3 YLRZYUOUZJGEFZ-UHFFFAOYSA-N 414933 6,6-dimethyl-2-(pyridin-4-yl)-3-[(3,4,5-trifluorophenyl)amino]-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 32 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414933&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607304 433914978 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828693 Clc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C19H16ClN3O/c20-14-11-21-10-9-13(14)18-19(22-12-5-2-1-3-6-12)17-15(23-18)7-4-8-16(17)24/h1-3,5-6,9-11,22-23H,4,7-8H2 KUONBVUMFVVYFR-UHFFFAOYSA-N 414934 Preparation of 6 2-(3-chloropyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 33 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414934&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606694 433914979 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828694 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc2[nH]ncc12 InChI=1S/C22H21N5O/c1-22(2)10-16-18(17(28)11-22)20(25-13-6-4-3-5-7-13)19(26-16)14-8-9-23-21-15(14)12-24-27-21/h3-9,12,25-26H,10-11H2,1-2H3,(H,23,24,27) GBGWKQYMNBTOQM-UHFFFAOYSA-N 414936 Preparation of 6,6-dimethyl-3-(phenylamino)-2-(1H-pyrazolo[3,4-b]pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 34 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 31.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414936&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606822 433914981 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828695 CCC(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C24H26N4O2/c1-4-20(30)28-19-12-15(10-11-25-19)22-23(26-16-8-6-5-7-9-16)21-17(27-22)13-24(2,3)14-18(21)29/h5-12,26-27H,4,13-14H2,1-3H3,(H,25,28,30) VHIXOPYASCTCJF-UHFFFAOYSA-N 414937 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 35 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414937&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606883 433914982 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828696 CC(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C23H24N4O2/c1-14(28)25-19-11-15(9-10-24-19)21-22(26-16-7-5-4-6-8-16)20-17(27-21)12-23(2,3)13-18(20)29/h4-11,26-27H,12-13H2,1-3H3,(H,24,25,28) QYMLBODCNCPTDG-UHFFFAOYSA-N 414938 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 36 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414938&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606965 433914983 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828697 O=C1CC2(CC2)Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C21H19N3O/c25-17-13-21(8-9-21)12-16-18(17)20(23-15-4-2-1-3-5-15)19(24-16)14-6-10-22-11-7-14/h1-7,10-11,23-24H,8-9,12-13H2 GQBUNOODBIVKLD-UHFFFAOYSA-N 414939 Preparation of 3′-(phenylamino)-2′-(pyridin-4-yl)-1′,7′-dihydrospiro[cyclopropane-1,6′-indol]-4′(5′H)-one::US10428044, Example 37 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.50 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414939&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607069 433914984 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828698 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccncc2)cc1F InChI=1S/C19H15F2N3O/c20-13-5-4-12(10-14(13)21)23-19-17-15(2-1-3-16(17)25)24-18(19)11-6-8-22-9-7-11/h4-10,23-24H,1-3H2 BYUHPGMPUKSJNA-UHFFFAOYSA-N 414940 3-[(3,4-difluorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 134::US10428044, Example 38 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.97 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414940&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607094 433914985 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828699 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H20N4O2/c1-13(26)23-18-12-14(10-11-22-18)20-21(24-15-6-3-2-4-7-15)19-16(25-20)8-5-9-17(19)27/h2-4,6-7,10-12,24-25H,5,8-9H2,1H3,(H,22,23,26) NUWLCKNRFZWKEF-UHFFFAOYSA-N 414941 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 39 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414941&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606740 433914986 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828700 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1cccc(F)c1 InChI=1S/C21H19FN4O2/c1-12(27)24-18-10-13(8-9-23-18)20-21(25-15-5-2-4-14(22)11-15)19-16(26-20)6-3-7-17(19)28/h2,4-5,8-11,25-26H,3,6-7H2,1H3,(H,23,24,27) ZLGHAVDGSFLJNQ-UHFFFAOYSA-N 414942 Preparation of N-(4-{3-[(3-fluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)acetamide::US10428044, Example 40 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414942&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606864 433914987 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828701 Fc1cccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccncc2)c1 InChI=1S/C19H16FN3O/c20-13-3-1-4-14(11-13)22-19-17-15(5-2-6-16(17)24)23-18(19)12-7-9-21-10-8-12/h1,3-4,7-11,22-23H,2,5-6H2 XXIKPTKZAKAOQJ-UHFFFAOYSA-N 414943 Preparation of 3-[(3-fluorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 41 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414943&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606899 433914988 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828702 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccncc2)cc1 InChI=1S/C19H16FN3O/c20-13-4-6-14(7-5-13)22-19-17-15(2-1-3-16(17)24)23-18(19)12-8-10-21-11-9-12/h4-11,22-23H,1-3H2 SJBCDTNIAGZAPV-UHFFFAOYSA-N 414945 Preparation of 3-[(4-fluorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 42 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414945&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606898 433914990 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828703 Fc1cccc(Nc2c([nH]c3CC(CC(=O)c23)C(F)(F)F)-c2ccncc2)c1 414946 Preparation of 3-[(3-fluorophenyl)amino]-2-(pyridin-4-yl)-6-(trifluoromethyl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 43 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.60 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414946&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606900 433914991 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828704 Fc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C19H16FN3O/c20-16-11-12(9-10-21-16)18-19(22-13-5-2-1-3-6-13)17-14(23-18)7-4-8-15(17)24/h1-3,5-6,9-11,22-23H,4,7-8H2 PGAVENDGQQTVGY-UHFFFAOYSA-N 414947 Preparation of 2-(2-fluoropyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 44 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414947&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607300 433914992 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828705 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)-c3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O/c1-27(2)16-22-24(23(31)17-27)26(25(30-22)19-11-13-28-14-12-19)29-21-10-6-9-20(15-21)18-7-4-3-5-8-18/h3-15,29-30H,16-17H2,1-2H3 PVKVDADSZIAOJE-UHFFFAOYSA-N 414948 Preparation of 3-(biphenyl-3-ylamino)-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 45 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414948&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606798 433914993 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828706 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)C#N InChI=1S/C22H20N4O/c1-22(2)11-17-19(18(27)12-22)21(25-15-6-4-3-5-7-15)20(26-17)14-8-9-24-16(10-14)13-23/h3-10,25-26H,11-12H2,1-2H3 YVGRCFZSSYUOGA-UHFFFAOYSA-N 414949 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridine-2-carbonitrile::US10428044, Example 46 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414949&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606771 433914994 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828707 Fc1cccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccnc(NC(=O)C3CC3)c2)c1 InChI=1S/C23H21FN4O2/c24-15-3-1-4-16(12-15)26-22-20-17(5-2-6-18(20)29)27-21(22)14-9-10-25-19(11-14)28-23(30)13-7-8-13/h1,3-4,9-13,26-27H,2,5-8H2,(H,25,28,30) XCRNBURJGZRGJH-UHFFFAOYSA-N 414950 Preparation of N-(4-{3-[(3-fluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)cyclopropanecarboxamide::US10428044, Example 47 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414950&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607092 433914995 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828708 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1CC1 InChI=1S/C23H22N4O2/c28-18-8-4-7-17-20(18)22(25-16-5-2-1-3-6-16)21(26-17)15-11-12-24-19(13-15)27-23(29)14-9-10-14/h1-3,5-6,11-14,25-26H,4,7-10H2,(H,24,27,29) XITQKXHVXHDVMM-UHFFFAOYSA-N 414951 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 48 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414951&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606734 433914996 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828709 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(N)c1 414952 Preparation of 2-(2-aminopyridin-4-yl)-3-(phenylamino)-6-(propan-2-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 49 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414952&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607105 433914997 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828710 CC(C)C1Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(N)c1 414953 Preparation of 2-(2-aminopyridin-4-yl)-3-[(3-fluorophenyl)amino]-6-(propan-2-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 50 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 36.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414953&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607109 433914998 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828711 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C(F)(F)F)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H20F3N3O/c1-21(2)11-16-18(17(29)12-21)20(19(28-16)13-6-8-26-9-7-13)27-15-5-3-4-14(10-15)22(23,24)25/h3-10,27-28H,11-12H2,1-2H3 RBOTWGMDSXBWIY-UHFFFAOYSA-N 414954 6,6-dimethyl-2-(pyridin-4-yl)-3-{[3- (trifluoromethyl)phenyl]amino}-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 51 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 136 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414954&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606952 433914999 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828712 COc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C22H23N3O2/c1-22(2)12-17-19(18(26)13-22)21(20(25-17)14-7-9-23-10-8-14)24-15-5-4-6-16(11-15)27-3/h4-11,24-25H,12-13H2,1-3H3 VEEFZSOQACUYLZ-UHFFFAOYSA-N 414955 3-[(3-methoxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 52 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 99.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414955&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606705 433915000 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828713 Cc1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C22H23N3O/c1-14-6-4-5-7-16(14)24-21-19-17(12-22(2,3)13-18(19)26)25-20(21)15-8-10-23-11-9-15/h4-11,24-25H,12-13H2,1-3H3 YARKURFPZLKEJU-UHFFFAOYSA-N 414956 6,6-dimethyl-3-[(2-methylphenyl)amino]-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 53 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 82.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414956&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607330 433915001 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828714 Cc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1 InChI=1S/C22H23N3O/c1-14-4-6-16(7-5-14)24-21-19-17(12-22(2,3)13-18(19)26)25-20(21)15-8-10-23-11-9-15/h4-11,24-25H,12-13H2,1-3H3 JHHLVGWQDXNXPD-UHFFFAOYSA-N 414957 6,6-dimethyl-3-[(4-methylphenyl)amino]-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 54 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 148 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414957&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607218 433915002 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828715 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnnc1 InChI=1S/C20H20N4O/c1-20(2)10-15-17(16(25)11-20)19(23-14-6-4-3-5-7-14)18(24-15)13-8-9-21-22-12-13/h3-9,12,23-24H,10-11H2,1-2H3 WBKJPWALTGDNFK-UHFFFAOYSA-N 414958 6,6-dimethyl-3-(phenylamino)-2-(pyridazin-4- yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 55 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 449 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414958&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606792 433915003 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828716 COc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1OC InChI=1S/C23H25N3O3/c1-23(2)12-16-19(17(27)13-23)21(20(26-16)14-8-10-24-11-9-14)25-15-6-5-7-18(28-3)22(15)29-4/h5-11,25-26H,12-13H2,1-4H3 UFDVOXPANLCKOM-UHFFFAOYSA-N 414959 3-[(2,3-dimethoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 56 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 654 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414959&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606793 433915004 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828717 COc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1OC InChI=1S/C23H25N3O3/c1-23(2)12-16-20(17(27)13-23)22(21(26-16)14-7-9-24-10-8-14)25-15-5-6-18(28-3)19(11-15)29-4/h5-11,25-26H,12-13H2,1-4H3 QQIVACUOFQCWSU-UHFFFAOYSA-N 414960 3-[(3,4-dimethoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 58 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414960&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606951 433915005 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828718 COc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1 InChI=1S/C22H23N3O2/c1-22(2)12-17-19(18(26)13-22)21(20(25-17)14-8-10-23-11-9-14)24-15-4-6-16(27-3)7-5-15/h4-11,24-25H,12-13H2,1-3H3 XFGMJENCLPGLPF-UHFFFAOYSA-N 414961 3-[(4-methoxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 59 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 422 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414961&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607272 433915006 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828719 CC1(C)Cc2[nH]c(c(Nc3ccccc3F)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20FN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-6-4-3-5-14(15)22)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 ZJXVQMNWDWIFQZ-UHFFFAOYSA-N 414962 3-[(2-fluorophenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 60 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 95.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414962&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606892 433915007 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828720 CC1(C)Cc2[nH]c(c(Nc3ccccc3Cl)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20ClN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-6-4-3-5-14(15)22)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 JGWJNMVLMFHRGG-UHFFFAOYSA-N 414963 3-[(2-chlorophenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 61 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 68.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414963&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607299 433915008 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828721 COc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c(OC)c1 InChI=1S/C23H25N3O3/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)14-7-9-24-10-8-14)25-16-6-5-15(28-3)11-19(16)29-4/h5-11,25-26H,12-13H2,1-4H3 XWLJWMWJHFHVGX-UHFFFAOYSA-N 414964 3-[(2,4-dimethoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 62 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 167 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414964&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607336 433915009 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828722 CC1(C)Cc2[nH]c(c(Nc3cccnc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C20H20N4O/c1-20(2)10-15-17(16(25)11-20)19(23-14-4-3-7-22-12-14)18(24-15)13-5-8-21-9-6-13/h3-9,12,23-24H,10-11H2,1-2H3 QTDJFQMPCZCBLU-UHFFFAOYSA-N 414965 6,6-dimethyl-2-(pyridin-4-yl)-3-(pyridin-3- ylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 63 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 196 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414965&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606946 433915010 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828723 CC1(C)Cc2[nH]c(c(Nc3cncc4ccccc34)c2C(=O)C1)-c1ccncc1 InChI=1S/C24H22N4O/c1-24(2)11-18-21(20(29)12-24)23(22(27-18)15-7-9-25-10-8-15)28-19-14-26-13-16-5-3-4-6-17(16)19/h3-10,13-14,27-28H,11-12H2,1-2H3 VHBDJGRJJIPEEA-UHFFFAOYSA-N 414966 3-(isoquinolin-4-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 64 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1820 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414966&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607061 433915011 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828724 CC1(C)Cc2[nH]c(c(Nc3cccc(N)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H22N4O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-4-14(22)10-15)19(25-16)13-6-8-23-9-7-13/h3-10,24-25H,11-12,22H2,1-2H3 AKAOYCDKVOCIKD-UHFFFAOYSA-N 414967 3-[(3-aminophenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 65 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 525 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414967&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606665 433915012 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828725 CC1(C)Cc2[nH]c(c(Nc3cnc4ccccc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C24H22N4O/c1-24(2)12-19-21(20(29)13-24)23(22(28-19)15-7-9-25-10-8-15)27-17-11-16-5-3-4-6-18(16)26-14-17/h3-11,14,27-28H,12-13H2,1-2H3 KPTFTIPVAMKZSH-UHFFFAOYSA-N 414968 6,6-dimethyl-2-(pyridin-4-yl)-3-(quinolin-3- ylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 66 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2260 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414968&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607026 433915013 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828726 CC1(C)Cc2[nH]c(c(Nc3ccc4occc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H21N3O2/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)14-5-8-24-9-6-14)25-16-3-4-19-15(11-16)7-10-28-19/h3-11,25-26H,12-13H2,1-2H3 HIWYTTMSHVUZGW-UHFFFAOYSA-N 414969 3-(1-benzofuran-5-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 67 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 87.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414969&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606945 433915014 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828727 CC1(C)Cc2[nH]c(c(Nc3ccc4cc[nH]c4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H22N4O/c1-23(2)12-18-20(19(28)13-23)22(21(27-18)15-5-8-24-9-6-15)26-16-4-3-14-7-10-25-17(14)11-16/h3-11,25-27H,12-13H2,1-2H3 LTGBMOLWWFWRCN-UHFFFAOYSA-N 414970 3-(1H-indol-6-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 68 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 84.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414970&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606929 433915015 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828728 CC1(C)Cc2[nH]c(c(Nc3ccc4sccc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H21N3OS/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)14-5-8-24-9-6-14)25-16-3-4-19-15(11-16)7-10-28-19/h3-11,25-26H,12-13H2,1-2H3 FIWBLUZFIIQRSQ-UHFFFAOYSA-N 414971 3-(1-benzothiophen-5-ylamino)-6,6-dimethyl- 2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 69 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 76.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414971&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607198 433915016 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828729 CC1(C)Cc2[nH]c(c(Nc3ccc4[nH]ccc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H22N4O/c1-23(2)12-18-20(19(28)13-23)22(21(27-18)14-5-8-24-9-6-14)26-16-3-4-17-15(11-16)7-10-25-17/h3-11,25-27H,12-13H2,1-2H3 SWMGRMZFGRFWIZ-UHFFFAOYSA-N 414972 3-(1H-indol-5-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 70 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 81.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414972&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606724 433915017 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828730 CC1(C)Cc2[nH]c(c(Nc3ccccc3Br)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20BrN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-6-4-3-5-14(15)22)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 ZLHRLKBGXQCBIS-UHFFFAOYSA-N 414973 3-[(2-bromophenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 71 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 49.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414973&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606723 433915018 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828731 CC1(C)Cc2[nH]c(c(Nc3ccc(Br)cc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H20BrN3O/c1-21(2)11-16-18(17(26)12-21)20(24-15-5-3-14(22)4-6-15)19(25-16)13-7-9-23-10-8-13/h3-10,24-25H,11-12H2,1-2H3 DQQIBRGSSLDROT-UHFFFAOYSA-N 414974 3-[(4-bromophenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 72 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 47.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414974&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606722 433915019 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828732 CC1(C)Cc2[nH]c(c(Nc3ccc4nc[nH]c4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H21N5O/c1-22(2)10-17-19(18(28)11-22)21(20(27-17)13-5-7-23-8-6-13)26-14-3-4-15-16(9-14)25-12-24-15/h3-9,12,26-27H,10-11H2,1-2H3,(H,24,25) UQSFDDIMKQKUPC-UHFFFAOYSA-N 414975 3-(1H-benzimidazol-6-ylamino)-6,6-dimethyl- 2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 73 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19900 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414975&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607260 433915020 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828733 CC1(C)Cc2[nH]c(c(Nc3ccc4cn[nH]c4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H21N5O/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-5-7-23-8-6-13)25-15-4-3-14-12-24-27-16(14)9-15/h3-9,12,25-26H,10-11H2,1-2H3,(H,24,27) TUQGWHZVHRMFIU-UHFFFAOYSA-N 414976 3-(1H-indazol-6-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 74 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 82.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414976&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606707 433915021 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828734 CC1(C)Cc2[nH]c(c(Nc3ccnc4ccccc34)c2C(=O)C1)-c1ccncc1 InChI=1S/C24H22N4O/c1-24(2)13-19-21(20(29)14-24)23(22(28-19)15-7-10-25-11-8-15)27-18-9-12-26-17-6-4-3-5-16(17)18/h3-12,28H,13-14H2,1-2H3,(H,26,27) JVOKRLLGFJGDMZ-UHFFFAOYSA-N 414977 6,6-dimethyl-2-(pyridin-4-yl)-3-(quinolin-4- ylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 75 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14100 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414977&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606708 433915022 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828735 COc1ccc(OC)c(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H25N3O3/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)14-7-9-24-10-8-14)25-16-11-15(28-3)5-6-19(16)29-4/h5-11,25-26H,12-13H2,1-4H3 HSLYDKSGTGHZGM-UHFFFAOYSA-N 414978 3-[(2,5-dimethoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 76 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4270 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414978&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607293 433915023 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828736 CC1(C)Cc2[nH]c(c(Nc3cc(Cl)cc(Cl)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19Cl2N3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-3-5-24-6-4-12)25-15-8-13(22)7-14(23)9-15/h3-9,25-26H,10-11H2,1-2H3 JQGHCAVLYJOJBM-UHFFFAOYSA-N 414980 3-[(3,5-dichlorophenyl)amino]-6,6-dimethyl- 2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 77 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1550 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414980&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606969 433915025 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828737 CC1(C)Cc2[nH]c(c(Nc3cc(Cl)ccc3Cl)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19Cl2N3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-5-7-24-8-6-12)25-15-9-13(22)3-4-14(15)23/h3-9,25-26H,10-11H2,1-2H3 DTLWXPIVNYQRKH-UHFFFAOYSA-N 414981 3-[(2,5-dichlorophenyl)amino]-6,6-dimethyl- 2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 78 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6950 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414981&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607306 433915026 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828738 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C#N)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H20N4O/c1-22(2)11-17-19(18(27)12-22)21(20(26-17)15-6-8-24-9-7-15)25-16-5-3-4-14(10-16)13-23/h3-10,25-26H,11-12H2,1-2H3 LRZCKFLGKPJLHP-UHFFFAOYSA-N 414982 3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}benzonitrile::US10428044, Example 79 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 133 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414982&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606824 433915027 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828739 CC1(C)Cc2[nH]c(c(Nc3cccc(OCc4ccccc4)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C28H27N3O2/c1-28(2)16-23-25(24(32)17-28)27(26(31-23)20-11-13-29-14-12-20)30-21-9-6-10-22(15-21)33-18-19-7-4-3-5-8-19/h3-15,30-31H,16-18H2,1-2H3 OZOMCGXNRHGZIW-UHFFFAOYSA-N 414983 3-{[3-(benzyloxy)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 80 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 188 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414983&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606825 433915028 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828740 Cc1cc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)ccc1F InChI=1S/C22H22FN3O/c1-13-10-15(4-5-16(13)23)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-6-8-24-9-7-14/h4-10,25-26H,11-12H2,1-3H3 ZHXLCPAKQKDPJO-UHFFFAOYSA-N 414984 3-[(4-fluoro-3-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 81 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 44.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414984&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607210 433915029 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828741 Cc1ccc(F)c(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C22H22FN3O/c1-13-4-5-15(23)16(10-13)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-6-8-24-9-7-14/h4-10,25-26H,11-12H2,1-3H3 SEYFIIILLGJRAY-UHFFFAOYSA-N 414985 3-[(2-fluoro-5-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 82 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 510 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414985&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607083 433915030 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828742 CCc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1 InChI=1S/C23H25N3O/c1-4-15-5-7-17(8-6-15)25-22-20-18(13-23(2,3)14-19(20)27)26-21(22)16-9-11-24-12-10-16/h5-12,25-26H,4,13-14H2,1-3H3 XCFUWEVKIJMHHA-UHFFFAOYSA-N 414986 3-[(4-ethylphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 83 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 293 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414986&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607108 433915031 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828743 CCc1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C23H25N3O/c1-4-15-7-5-6-8-17(15)25-22-20-18(13-23(2,3)14-19(20)27)26-21(22)16-9-11-24-12-10-16/h5-12,25-26H,4,13-14H2,1-3H3 QMURQQGGMPBLAG-UHFFFAOYSA-N 414987 3-[(2-ethylphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 84 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 127 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414987&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606861 433915032 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828744 CC(C)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C24H27N3O/c1-15(2)17-6-5-7-18(12-17)26-23-21-19(13-24(3,4)14-20(21)28)27-22(23)16-8-10-25-11-9-16/h5-12,15,26-27H,13-14H2,1-4H3 KULFZLWKAGVJHR-UHFFFAOYSA-N 414988 6,6-dimethyl-3-{[3-(propan-2- yl)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 85 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 73.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414988&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606754 433915033 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828745 CC(C)c1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1 InChI=1S/C24H27N3O/c1-15(2)16-5-7-18(8-6-16)26-23-21-19(13-24(3,4)14-20(21)28)27-22(23)17-9-11-25-12-10-17/h5-12,15,26-27H,13-14H2,1-4H3 RDTHPBXFUVJXGP-UHFFFAOYSA-N 414989 6,6-dimethyl-3-{[4-(propan-2- yl)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 86 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5460 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414989&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606885 433915034 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828746 CC1(C)Cc2[nH]c(c(Nc3cc(Cl)ccc3F)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19ClFN3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-5-7-24-8-6-12)25-15-9-13(22)3-4-14(15)23/h3-9,25-26H,10-11H2,1-2H3 YGYPBJXHFHARFI-UHFFFAOYSA-N 414991 3-[(5-chloro-2-fluorophenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 87 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1780 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414991&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606926 433915036 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828747 CC(C)c1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C24H27N3O/c1-15(2)17-7-5-6-8-18(17)26-23-21-19(13-24(3,4)14-20(21)28)27-22(23)16-9-11-25-12-10-16/h5-12,15,26-27H,13-14H2,1-4H3 PDLCVBSZGBRDAU-UHFFFAOYSA-N 414992 6,6-dimethyl-3-{[2-(propan-2- yl)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 88 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2610 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414992&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606715 433915037 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828748 CC1(C)Cc2[nH]c(c(Nc3cccc(O)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H21N3O2/c1-21(2)11-16-18(17(26)12-21)20(23-14-4-3-5-15(25)10-14)19(24-16)13-6-8-22-9-7-13/h3-10,23-25H,11-12H2,1-2H3 GRGOSCZAFBAQKW-UHFFFAOYSA-N 414993 3-[(3-hydroxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 89 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 288 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414993&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606869 433915038 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828749 CC1(C)Cc2[nH]c(c(Nc3ccc(cc3)N([O-])=O)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H21N4O3/c1-21(2)11-16-18(17(26)12-21)20(19(24-16)13-7-9-22-10-8-13)23-14-3-5-15(6-4-14)25(27)28/h3-10,25H,11-12H2,1-2H3,(H2-,22,23,24,26,27,28)/q-1 XYFIWNCEHNQJHR-UHFFFAOYSA-N 414994 6,6-dimethyl-3-[(4-nitrophenyl)amino]-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 90 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 509 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414994&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607192 433915039 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828750 Cc1c(Cl)cccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C22H22ClN3O/c1-13-15(23)5-4-6-16(13)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-7-9-24-10-8-14/h4-10,25-26H,11-12H2,1-3H3 FZFOMIISEJWVEU-UHFFFAOYSA-N 414995 3-[(3-chloro-2-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 91 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 101 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414995&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606769 433915040 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828751 Cc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1Cl InChI=1S/C22H22ClN3O/c1-13-4-5-15(10-16(13)23)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-6-8-24-9-7-14/h4-10,25-26H,11-12H2,1-3H3 OKUBDANTCGDOFA-UHFFFAOYSA-N 414996 3-[(3-chloro-4-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 92 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 296 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414996&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607029 433915041 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828752 Cc1ccc(Cl)cc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C22H22ClN3O/c1-13-4-5-15(23)10-16(13)25-21-19-17(11-22(2,3)12-18(19)27)26-20(21)14-6-8-24-9-7-14/h4-10,25-26H,11-12H2,1-3H3 LRSHESGZWCUQJB-UHFFFAOYSA-N 414997 3-[(5-chloro-2-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 93 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7400 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414997&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607246 433915042 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828753 CC1(C)Cc2[nH]c(c(Nc3cccc(Cl)c3F)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19ClFN3O/c1-21(2)10-15-17(16(27)11-21)20(19(26-15)12-6-8-24-9-7-12)25-14-5-3-4-13(22)18(14)23/h3-9,25-26H,10-11H2,1-2H3 YUBINBPOBCUDFQ-UHFFFAOYSA-N 414998 3-[(3-chloro-2-fluorophenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 94 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 114 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414998&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607298 433915043 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828754 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(Cl)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H19ClFN3O/c1-21(2)10-16-18(17(27)11-21)20(19(26-16)12-5-7-24-8-6-12)25-13-3-4-15(23)14(22)9-13/h3-9,25-26H,10-11H2,1-2H3 WJFXBKCVZXGQPY-UHFFFAOYSA-N 414999 3-[(3-chloro-4-fluorophenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 95 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 43.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414999&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606901 433915044 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828755 Cc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1F InChI=1S/C22H22FN3O/c1-13-5-4-6-15(19(13)23)25-21-18-16(11-22(2,3)12-17(18)27)26-20(21)14-7-9-24-10-8-14/h4-10,25-26H,11-12H2,1-3H3 TVVRTASUBKHANK-UHFFFAOYSA-N 415000 3-[(2-fluoro-3-methylphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 96 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 85.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415000&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607006 433915045 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828756 CC(C)C(=O)Nc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C25H28N4O2/c1-15(2)24(31)28-18-7-5-6-17(12-18)27-23-21-19(13-25(3,4)14-20(21)30)29-22(23)16-8-10-26-11-9-16/h5-12,15,27,29H,13-14H2,1-4H3,(H,28,31) CEUILESSGKRMPW-UHFFFAOYSA-N 415001 N-(3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}phenyl)-2-methylpropanamide::US10428044, Example 97 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2980 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415001&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607223 433915046 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828757 CCC(=O)Nc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C24H26N4O2/c1-4-20(30)26-16-6-5-7-17(12-16)27-23-21-18(13-24(2,3)14-19(21)29)28-22(23)15-8-10-25-11-9-15/h5-12,27-28H,4,13-14H2,1-3H3,(H,26,30) DFTOCTWSGLHIDK-UHFFFAOYSA-N 415002 N-(3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}phenyl)propanamide::US10428044, Example 98 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1540 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415002&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606964 433915047 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828758 CNC(=O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H24N4O2/c1-23(2)12-17-19(18(28)13-23)21(20(27-17)14-7-9-25-10-8-14)26-16-6-4-5-15(11-16)22(29)24-3/h4-11,26-27H,12-13H2,1-3H3,(H,24,29) YYRJHCVJCXEOIO-UHFFFAOYSA-N 415003 3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3-yl]amino}-N- methylbenzamide::US10428044, Example 99 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2210 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415003&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607075 433915048 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828759 CC1(C)Cc2[nH]c(c(Nc3ccc4[nH]ncc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H21N5O/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-5-7-23-8-6-13)25-15-3-4-16-14(9-15)12-24-27-16/h3-9,12,25-26H,10-11H2,1-2H3,(H,24,27) LLDNMRBQJVQQJO-UHFFFAOYSA-N 415004 3-(1H-indazol-5-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 100 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 95.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415004&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607167 433915049 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828760 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C(N)=O)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22N4O2/c1-22(2)11-16-18(17(27)12-22)20(19(26-16)13-6-8-24-9-7-13)25-15-5-3-4-14(10-15)21(23)28/h3-10,25-26H,11-12H2,1-2H3,(H2,23,28) DIEATGYVXFNUBF-UHFFFAOYSA-N 415005 3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}benzamide::US10428044, Example 101 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 507 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415005&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606803 433915050 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828761 CCCC(=O)Nc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C25H28N4O2/c1-4-6-21(31)27-17-7-5-8-18(13-17)28-24-22-19(14-25(2,3)15-20(22)30)29-23(24)16-9-11-26-12-10-16/h5,7-13,28-29H,4,6,14-15H2,1-3H3,(H,27,31) VGWCDHNPHDDQHT-UHFFFAOYSA-N 415006 N-(3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}phenyl)butanamide::US10428044, Example 102 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 954 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415006&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606858 433915051 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828762 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(Cl)c1 InChI=1S/C21H20ClN3O/c1-21(2)11-15-18(16(26)12-21)20(24-14-6-4-3-5-7-14)19(25-15)13-8-9-23-17(22)10-13/h3-10,24-25H,11-12H2,1-2H3 QSADQDUSXGXSJJ-UHFFFAOYSA-N 415007 2-(2-chloropyridin-4-yl)-6,6-dimethyl-3- (phenylamino)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 103 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 53.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415007&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606742 433915052 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828763 CCOc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H25N3O2/c1-4-28-17-7-5-6-16(12-17)25-22-20-18(13-23(2,3)14-19(20)27)26-21(22)15-8-10-24-11-9-15/h5-12,25-26H,4,13-14H2,1-3H3 IHSPEESOSUYMPF-UHFFFAOYSA-N 415008 3-[(3-ethoxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 104 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 524 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415008&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607266 433915053 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828764 CC(C)Oc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C24H27N3O2/c1-15(2)29-18-7-5-6-17(12-18)26-23-21-19(13-24(3,4)14-20(21)28)27-22(23)16-8-10-25-11-9-16/h5-12,15,26-27H,13-14H2,1-4H3 BUUUKPPKCAINEL-UHFFFAOYSA-N 415009 6,6-dimethyl-3-{[3-(propan-2- yloxy)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 105 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1170 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415009&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607267 433915054 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828765 CC1(C)Cc2[nH]c(c(Nc3cccc(OCCO)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H25N3O3/c1-23(2)13-18-20(19(28)14-23)22(21(26-18)15-6-8-24-9-7-15)25-16-4-3-5-17(12-16)29-11-10-27/h3-9,12,25-27H,10-11,13-14H2,1-2H3 XKGSUQVMEDNGNG-UHFFFAOYSA-N 415010 3-{[3-(2-hydroxyethoxy)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 106 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5350 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415010&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606915 433915055 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828766 CC1(C)Cc2[nH]c(c(Nc3cccc(OC(F)(F)F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H20F3N3O2/c1-21(2)11-16-18(17(29)12-21)20(19(28-16)13-6-8-26-9-7-13)27-14-4-3-5-15(10-14)30-22(23,24)25/h3-10,27-28H,11-12H2,1-2H3 HAZBAHVODVPRQU-UHFFFAOYSA-N 415011 6,6-dimethyl-2-(pyridin-4-yl)-3-{[3- (trifluoromethoxy)phenyl]amino}-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 107 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 164 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415011&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607142 433915056 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828767 CCCOc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C24H27N3O2/c1-4-12-29-18-7-5-6-17(13-18)26-23-21-19(14-24(2,3)15-20(21)28)27-22(23)16-8-10-25-11-9-16/h5-11,13,26-27H,4,12,14-15H2,1-3H3 RTYSIOKYZPCTPX-UHFFFAOYSA-N 415012 6,6-dimethyl-3-[(3-propoxyphenyl)amino]-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 108 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 104 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415012&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606806 433915057 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828768 CC(=O)Nc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H24N4O2/c1-14(28)25-16-5-4-6-17(11-16)26-22-20-18(12-23(2,3)13-19(20)29)27-21(22)15-7-9-24-10-8-15/h4-11,26-27H,12-13H2,1-3H3,(H,25,28) ZPDQTUZZIIBIRN-UHFFFAOYSA-N 415013 N-(3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}phenyl)acetamide::US10428044, Example 109 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4560 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415013&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607317 433915058 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828769 COc1cc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)ccc1F InChI=1S/C22H22FN3O2/c1-22(2)11-16-19(17(27)12-22)21(20(26-16)13-6-8-24-9-7-13)25-14-4-5-15(23)18(10-14)28-3/h4-10,25-26H,11-12H2,1-3H3 BYJGQCVCSSEZDU-UHFFFAOYSA-N 415014 3-[(4-fluoro-3-methoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 110 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 235 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415014&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606698 433915059 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828770 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(CO)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22FN3O2/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-5-7-24-8-6-13)25-15-3-4-16(23)14(9-15)12-27/h3-9,25-27H,10-12H2,1-2H3 NPGSFDVSWYOKOJ-UHFFFAOYSA-N 415015 3-{[4-fluoro-3-(hydroxymethyl)phenyl]amino}- 6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 111 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2630 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415015&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606719 433915060 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828771 CC(O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 415016 3-{[3-(1-hydroxyethyl)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 112 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3480 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415016&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606874 433915061 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828772 CC(=O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H23N3O2/c1-14(27)16-5-4-6-17(11-16)25-22-20-18(12-23(2,3)13-19(20)28)26-21(22)15-7-9-24-10-8-15/h4-11,25-26H,12-13H2,1-3H3 XLNRVCFLPKPFBE-UHFFFAOYSA-N 415017 3-[(3-acetylphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 113 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 174 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415017&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606975 433915062 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828773 CC(C)(C)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C25H29N3O/c1-24(2,3)17-7-6-8-18(13-17)27-23-21-19(14-25(4,5)15-20(21)29)28-22(23)16-9-11-26-12-10-16/h6-13,27-28H,14-15H2,1-5H3 MWPQQJVJBSRNBX-UHFFFAOYSA-N 415018 3-[(3-tert-butylphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 114 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8640 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415018&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606904 433915063 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828775 CC1(C)Cc2[nH]c(c(Nc3cccc(OC(F)F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H21F2N3O2/c1-22(2)11-16-18(17(28)12-22)20(19(27-16)13-6-8-25-9-7-13)26-14-4-3-5-15(10-14)29-21(23)24/h3-10,21,26-27H,11-12H2,1-2H3 PTUMPWYPNWNCFF-UHFFFAOYSA-N 415019 3-{[3-(difluoromethoxy)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6.7-tetrahydro- 4H-indol-4-one::US10428044, Example 117 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 175 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415019&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607178 433915064 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828776 CC(C)(C)OC(=O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C26H29N3O3/c1-25(2,3)32-24(31)17-7-6-8-18(13-17)28-23-21-19(14-26(4,5)15-20(21)30)29-22(23)16-9-11-27-12-10-16/h6-13,28-29H,14-15H2,1-5H3 OAPMACRIGQQNED-UHFFFAOYSA-N 415020 US10428044, Example 118::tert-butyl 3-{[6,6-dimethyl-4-oxo-2-(pyridin-4- yl)-4,5,6,7-tetrahydro-1H-indol-3- yl]amino}benzoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 457 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415020&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607136 433915065 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828777 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C3OCCO3)c2C(=O)C1)-c1ccncc1 InChI=1S/C24H25N3O3/c1-24(2)13-18-20(19(28)14-24)22(21(27-18)15-6-8-25-9-7-15)26-17-5-3-4-16(12-17)23-29-10-11-30-23/h3-9,12,23,26-27H,10-11,13-14H2,1-2H3 GKTSDNPULNNBLP-UHFFFAOYSA-N 415021 3-{[3-(1,3-dioxolan-2-yl)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 119 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2340 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415021&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607176 433915066 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828778 COc1cc(F)ccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C22H22FN3O2/c1-22(2)11-16-19(17(27)12-22)21(20(26-16)13-6-8-24-9-7-13)25-15-5-4-14(23)10-18(15)28-3/h4-10,25-26H,11-12H2,1-3H3 JNVVWWXQRNZSSE-UHFFFAOYSA-N 415022 3-[(4-fluoro-2-methoxyphenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 121 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 323 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415022&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607054 433915067 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828779 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(N)c1 InChI=1S/C21H22N4O/c1-21(2)11-15-18(16(26)12-21)20(24-14-6-4-3-5-7-14)19(25-15)13-8-9-23-17(22)10-13/h3-10,24-25H,11-12H2,1-2H3,(H2,22,23) YBIKIRFKPXXTRD-UHFFFAOYSA-N 415023 Preparation of 2-(2-aminopyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 122 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415023&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607162 433915068 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828780 CC1(C)Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(Nc2cccc(F)c2)c1 InChI=1S/C27H24F2N4O/c1-27(2)14-21-24(22(34)15-27)26(32-20-8-4-6-18(29)13-20)25(33-21)16-9-10-30-23(11-16)31-19-7-3-5-17(28)12-19/h3-13,32-33H,14-15H2,1-2H3,(H,30,31) DGHMGVVWEMYEID-UHFFFAOYSA-N 415024 3-[(3-fluorophenyl)amino]-2-{2-[(3- fluorophenyl)amino]pyridin-4-yl}-6,6- dimethyl-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 123 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 497 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415024&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606986 433915069 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828781 COc1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C22H23N3O2/c1-22(2)12-16-19(17(26)13-22)21(20(25-16)14-8-10-23-11-9-14)24-15-6-4-5-7-18(15)27-3/h4-11,24-25H,12-13H2,1-3H3 JNKMEHAIAVCVDD-UHFFFAOYSA-N 415025 3-[(2-methoxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 124 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 154 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415025&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606910 433915070 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828782 CCOc1cc(F)ccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C23H24FN3O2/c1-4-29-19-11-15(24)5-6-16(19)26-22-20-17(12-23(2,3)13-18(20)28)27-21(22)14-7-9-25-10-8-14/h5-11,26-27H,4,12-13H2,1-3H3 SPTDLUWPFTVOJV-UHFFFAOYSA-N 415026 3-[(2-ethoxy-4-fluorophenyl)amino]-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 125 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 454 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415026&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607224 433915071 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828783 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)N1CCCC1 InChI=1S/C25H28N4O/c1-25(2)15-19-22(20(30)16-25)24(27-18-8-4-3-5-9-18)23(28-19)17-10-11-26-21(14-17)29-12-6-7-13-29/h3-5,8-11,14,27-28H,6-7,12-13,15-16H2,1-2H3 HOBUFGUIXKHULJ-UHFFFAOYSA-N 415027 6,6-dimethyl-3-(phenylamino)-2-[2- (pyrrolidin-1-yl)pyridin-4-yl]-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 126 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14500 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415027&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606984 433915072 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828784 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)N1CCOCC1 InChI=1S/C25H28N4O2/c1-25(2)15-19-22(20(30)16-25)24(27-18-6-4-3-5-7-18)23(28-19)17-8-9-26-21(14-17)29-10-12-31-13-11-29/h3-9,14,27-28H,10-13,15-16H2,1-2H3 STLJPVHSDFAPEX-UHFFFAOYSA-N 415028 6,6-dimethyl-2-[2-(morpholin-4-yl)pyridin-4- yl]-3-(phenylamino)-1,5,6,7-tetrahydro-4H- indol-4-one::US10428044, Example 127 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7750 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415028&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606991 433915073 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828785 CCOc1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C23H25N3O2/c1-4-28-19-8-6-5-7-16(19)25-22-20-17(13-23(2,3)14-18(20)27)26-21(22)15-9-11-24-12-10-15/h5-12,25-26H,4,13-14H2,1-3H3 YXAOHVLBYBMGSV-UHFFFAOYSA-N 415029 3-[(2-ethoxyphenyl)amino]-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 128 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 576 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415029&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606941 433915074 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828786 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(c3)C(F)(F)F)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H19F4N3O/c1-21(2)10-16-18(17(30)11-21)20(19(29-16)12-5-7-27-8-6-12)28-13-3-4-15(23)14(9-13)22(24,25)26/h3-9,28-29H,10-11H2,1-2H3 OJDVMNXKKPCMAU-UHFFFAOYSA-N 415030 3-{[4-fluoro-3-(trifluoromethyl)phenyl]amino}- 6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 129 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 447 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415030&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606940 433915075 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828787 CC1(C)Cc2[nH]c(c(Nc3ccc4ccsc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H21N3OS/c1-23(2)12-17-20(18(27)13-23)22(21(26-17)15-5-8-24-9-6-15)25-16-4-3-14-7-10-28-19(14)11-16/h3-11,25-26H,12-13H2,1-2H3 SGUVPXAANJTDEY-UHFFFAOYSA-N 415031 3-(1-benzothiophen-6-ylamino)-6,6-dimethyl- 2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 130 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415031&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607197 433915076 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828788 Cc1cnccc1-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N3O/c1-14-13-23-10-9-16(14)20-21(24-15-7-5-4-6-8-15)19-17(25-20)11-22(2,3)12-18(19)26/h4-10,13,24-25H,11-12H2,1-3H3 TUGAYGKCXNMQRM-UHFFFAOYSA-N 415032 6,6-dimethyl-2-(3-methylpyridin-4-yl)-3- (phenylamino)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 131 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 51.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415032&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607239 433915077 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828789 CC(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C25H28N4O2/c1-15(2)24(31)29-20-12-16(10-11-26-20)22-23(27-17-8-6-5-7-9-17)21-18(28-22)13-25(3,4)14-19(21)30/h5-12,15,27-28H,13-14H2,1-4H3,(H,26,29,31) GALNVTMMTPGHHF-UHFFFAOYSA-N 415033 N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)- 4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}- 2-methylpropanamide::US10428044, Example 132 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 50.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415033&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606935 433915078 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828790 CC(=O)N(C(C)=O)c1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C25H26N4O3/c1-15(30)29(16(2)31)21-12-17(10-11-26-21)23-24(27-18-8-6-5-7-9-18)22-19(28-23)13-25(3,4)14-20(22)32/h5-12,27-28H,13-14H2,1-4H3 JGBLAKCYJLPGKS-UHFFFAOYSA-N 415034 N-acetyl-N-{4-[6,6-dimethyl-4-oxo-3- (phenylamino)-4,5,6,7-tetrahydro-1H-indol-2 yl]pyridin-2-yl}acetamide::US10428044, Example 133 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 49.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415034&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607201 433915079 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828791 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccncc2)cc1F InChI=1S/C19H15F2N3O/c20-13-5-4-12(10-14(13)21)23-19-17-15(2-1-3-16(17)25)24-18(19)11-6-8-22-9-7-11/h4-10,23-24H,1-3H2 BYUHPGMPUKSJNA-UHFFFAOYSA-N 414940 3-[(3,4-difluorophenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 134::US10428044, Example 38 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 49.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=414940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=414940&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607094 433914985 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828792 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1c(F)cncc1F InChI=1S/C21H19F2N3O/c1-21(2)8-15-18(16(27)9-21)20(25-12-6-4-3-5-7-12)19(26-15)17-13(22)10-24-11-14(17)23/h3-7,10-11,25-26H,8-9H2,1-2H3 PUGULZQHQUODEJ-UHFFFAOYSA-N 415036 2-(3,5-difluoropyridin-4-yl)-6,6-dimethyl-3- (phenylamino)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 135 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 188 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415036&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607095 433915080 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828793 Fc1cccc(Nc2c([nH]c3CCCC(=O)c23)-c2c(F)cncc2F)c1 InChI=1S/C19H14F3N3O/c20-10-3-1-4-11(7-10)24-19-17-14(5-2-6-15(17)26)25-18(19)16-12(21)8-23-9-13(16)22/h1,3-4,7-9,24-25H,2,5-6H2 UTQDNUKTJAASGX-UHFFFAOYSA-N 415037 2-(3,5-difluoropyridin-4-yl)-3-[(3- fluorophenyl)amino]-1,5,6,7-tetrahydro-4H- indol-4-one::US10428044, Example 136 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 924 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415037&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607262 433915081 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828794 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(Br)c1 InChI=1S/C21H20BrN3O/c1-21(2)11-15-18(16(26)12-21)20(24-14-6-4-3-5-7-14)19(25-15)13-8-9-23-17(22)10-13/h3-10,24-25H,11-12H2,1-2H3 JYHMXCVSFMBUCK-UHFFFAOYSA-N 415038 2-(2-bromopyridin-4-yl)-6,6-dimethyl-3- (phenylamino)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 137 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 99.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415038&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606697 433915082 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828795 Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1cccc(F)c1 InChI=1S/C19H17FN4O/c20-12-3-1-4-13(10-12)23-19-17-14(5-2-6-15(17)25)24-18(19)11-7-8-22-16(21)9-11/h1,3-4,7-10,23-24H,2,5-6H2,(H2,21,22) NIBMFVULTFNHHJ-UHFFFAOYSA-N 415039 Preparation of 2-(2-aminopyridin-4-yl)-3-[(3-fluorophenyl)amino]-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 138 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 92.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415039&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607385 433915083 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828796 Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C19H18N4O/c20-16-11-12(9-10-21-16)18-19(22-13-5-2-1-3-6-13)17-14(23-18)7-4-8-15(17)24/h1-3,5-6,9-11,22-23H,4,7-8H2,(H2,20,21) NWUNDUOAQAPYSC-UHFFFAOYSA-N 415041 Preparation of 2-(2-aminopyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 139 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 113 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415041&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606893 433915085 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828798 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccncc2Cl)cc1 InChI=1S/C19H15ClFN3O/c20-14-10-22-9-8-13(14)18-19(23-12-6-4-11(21)5-7-12)17-15(24-18)2-1-3-16(17)25/h4-10,23-24H,1-3H2 PVCPMLPOKNBSAV-UHFFFAOYSA-N 415042 2-(3-chloropyridin-4-yl)-3-[(4- fluorophenyl)amino]-1,5,6,7-tetrahydro-4H- indol-4-one::US10428044, Example 142 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 68.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415042&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606916 433915086 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828799 Cc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N3O/c1-13-12-14(10-11-21-13)19-20(22-15-6-3-2-4-7-15)18-16(23-19)8-5-9-17(18)24/h2-4,6-7,10-12,22-23H,5,8-9H2,1H3 DSALMILIFRRDON-UHFFFAOYSA-N 415045 2-(2-methylpyridin-4-yl)-3-(phenylamino)- 1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 143 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 558 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415045&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606760 433915089 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828800 CCNC(=O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C24H26N4O2/c1-4-26-23(30)16-6-5-7-17(12-16)27-22-20-18(13-24(2,3)14-19(20)29)28-21(22)15-8-10-25-11-9-15/h5-12,27-28H,4,13-14H2,1-3H3,(H,26,30) ZSSYSXDIRNDNKS-UHFFFAOYSA-N 415046 3-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3-yl]amino}-N- ethylbenzamide::US10428044, Example 144 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1720 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415046&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607011 433915090 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828801 CNc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H24N4O/c1-22(2)12-16-19(17(27)13-22)21(25-15-7-5-4-6-8-15)20(26-16)14-9-10-24-18(11-14)23-3/h4-11,25-26H,12-13H2,1-3H3,(H,23,24) YDQOFEYTROYQAC-UHFFFAOYSA-N 415048 6,6-dimethyl-2-[2-(methylamino)pyridin-4-yl]- 3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol- 4-one::US10428044, Example 145 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 148 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415048&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606865 433915092 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828802 CC1(C)Cc2[nH]c(c(Nc3ccccc3C#N)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H20N4O/c1-22(2)11-17-19(18(27)12-22)21(20(26-17)14-7-9-24-10-8-14)25-16-6-4-3-5-15(16)13-23/h3-10,25-26H,11-12H2,1-2H3 KDBQNTUBOYSIAF-UHFFFAOYSA-N 415049 2-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3- yl]amino}benzonitrile::US10428044, Example 146 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 48.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415049&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607280 433915093 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828803 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(c3)C#N)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H19FN4O/c1-22(2)10-17-19(18(28)11-22)21(20(27-17)13-5-7-25-8-6-13)26-15-3-4-16(23)14(9-15)12-24/h3-9,26-27H,10-11H2,1-2H3 WXKVTOBDQBYPRW-UHFFFAOYSA-N 415050 5-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)- 4,5,6,7-tetrahydro-1H-indol-3-yl]amino}-2- fluorobenzonitrile::US10428044, Example 147 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 258 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415050&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606775 433915094 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828804 CC1(C)Cc2[nH]c(c(Nc3ccc(F)c(OC(F)(F)F)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H19F4N3O2/c1-21(2)10-15-18(16(30)11-21)20(19(29-15)12-5-7-27-8-6-12)28-13-3-4-14(23)17(9-13)31-22(24,25)26/h3-9,28-29H,10-11H2,1-2H3 STTXYMYZBCCXGC-UHFFFAOYSA-N 415051 3-{[4-fluoro-3- (trifluoromethoxy)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 148 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 479 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415051&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607160 433915095 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828805 Cc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N3O/c1-14-11-15(9-10-23-14)20-21(24-16-7-5-4-6-8-16)19-17(25-20)12-22(2,3)13-18(19)26/h4-11,24-25H,12-13H2,1-3H3 BTXVFMPVZPHUCZ-UHFFFAOYSA-N 415052 6,6-dimethyl-2-(2-methylpyridin-4-yl)-3- (phenylamino)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 149 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 94.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415052&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606974 433915096 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828806 COc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N3O2/c1-25-17-12-13(10-11-21-17)19-20(22-14-6-3-2-4-7-14)18-15(23-19)8-5-9-16(18)24/h2-4,6-7,10-12,22-23H,5,8-9H2,1H3 NRXLYDMCAGXEKK-UHFFFAOYSA-N 415053 2-(2-methoxypyridin-4-yl)-3-(phenylamino)- 1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 150 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1890 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415053&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607193 433915097 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828808 Brc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C19H16BrN3O/c20-16-11-12(9-10-21-16)18-19(22-13-5-2-1-3-6-13)17-14(23-18)7-4-8-15(17)24/h1-3,5-6,9-11,22-23H,4,7-8H2 IIWKAGGNJDOKKT-UHFFFAOYSA-N 415054 2-(2-bromopyridin-4-yl)-3-(phenylamino)- 1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 152 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 239 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415054&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607338 433915098 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828809 CC1(OCCO1)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C25H27N3O3/c1-24(2)14-19-21(20(29)15-24)23(22(28-19)16-7-9-26-10-8-16)27-18-6-4-5-17(13-18)25(3)30-11-12-31-25/h4-10,13,27-28H,11-12,14-15H2,1-3H3 KQTDAGIUYPIVGI-UHFFFAOYSA-N 415055 6,6-dimethyl-3-{[3-(2-methyl-1,3-dioxolan-2- yl)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 153 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11500 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415055&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607333 433915099 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828810 CCC(O)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 415056 3-{[3-(1-hydroxypropyl)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 154 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415056&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606985 433915100 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828811 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C(O)C(F)(F)F)c2C(=O)C1)-c1ccncc1 415057 6,6-dimethyl-2-(pyridin-4-yl)-3-{[3-(2,2,2- trifluoro-1-hydroxyethyl)phenyl]amino}- 1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 155 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1710 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415057&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606995 433915101 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828812 COC(C)c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 415058 3-{[3-(1-methoxyethyl)phenyl]amino}-6,6- dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro- 4H-indol-4-one::US10428044, Example 156 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 743 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415058&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607153 433915102 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828813 CC1(C)Cc2[nH]c(c(Nc3cccc4ccccc34)c2C(=O)C1)-c1ccncc1 InChI=1S/C25H23N3O/c1-25(2)14-20-22(21(29)15-25)24(23(28-20)17-10-12-26-13-11-17)27-19-9-5-7-16-6-3-4-8-18(16)19/h3-13,27-28H,14-15H2,1-2H3 SPVFXYCILLJWGO-UHFFFAOYSA-N 415059 6,6-dimethyl-3-(naphthalen-1-ylamino)-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 157 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 764 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415059&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606766 433915103 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828814 CC1(C)Cc2[nH]c(c(Nc3ccc4ccccc4c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C25H23N3O/c1-25(2)14-20-22(21(29)15-25)24(23(28-20)17-9-11-26-12-10-17)27-19-8-7-16-5-3-4-6-18(16)13-19/h3-13,27-28H,14-15H2,1-2H3 LWGBSURUUXQCDK-UHFFFAOYSA-N 415060 6,6-dimethyl-3-(naphthalen-2-ylamino)-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 158 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 95.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415060&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606767 433915104 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828815 CC1(C)Cc2[nH]c(c(Nc3ccccc3Oc3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O2/c1-27(2)16-21-24(22(31)17-27)26(25(30-21)18-12-14-28-15-13-18)29-20-10-6-7-11-23(20)32-19-8-4-3-5-9-19/h3-15,29-30H,16-17H2,1-2H3 ZYYFFXWACQGYPV-UHFFFAOYSA-N 415061 6,6-dimethyl-3-[(2-phenoxyphenyl)amino]-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 159 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1060 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415061&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606768 433915105 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828816 CC1(C)Cc2[nH]c(c(Nc3ccccc3-c3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O/c1-27(2)16-22-24(23(31)17-27)26(25(30-22)19-12-14-28-15-13-19)29-21-11-7-6-10-20(21)18-8-4-3-5-9-18/h3-15,29-30H,16-17H2,1-2H3 QBGYPPCUFDPGOO-UHFFFAOYSA-N 415062 3-(biphenyl-2-ylamino)-6,6-dimethyl-2- (pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4- one::US10428044, Example 160 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 204 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415062&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607398 433915106 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828817 Fc1cccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccnc(c2)N(C(=O)C2CC2)C(=O)C2CC2)c1 InChI=1S/C27H25FN4O3/c28-18-3-1-4-19(14-18)30-25-23-20(5-2-6-21(23)33)31-24(25)17-11-12-29-22(13-17)32(26(34)15-7-8-15)27(35)16-9-10-16/h1,3-4,11-16,30-31H,2,5-10H2 YVNDLMYJQMQZOL-UHFFFAOYSA-N 415063 N-(cyclopropylcarbonyl)-N-(4-{3-[(3- fluorophenyl)amino]-4-oxo-4,5,6,7- tetrahydro-1H-indol-2-yl}pyridin-2- yl)cyclopropanecarboxamide::US10428044, Example 162 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 85.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415063&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607358 433915107 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828818 O=C(C1CC1)N(C(=O)C1CC1)c1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H26N4O3/c32-21-8-4-7-20-23(21)25(29-19-5-2-1-3-6-19)24(30-20)18-13-14-28-22(15-18)31(26(33)16-9-10-16)27(34)17-11-12-17/h1-3,5-6,13-17,29-30H,4,7-12H2 IJHWRHPDMKPARS-UHFFFAOYSA-N 415064 N-(cyclopropylcarbonyl)-N-{4-[4-oxo-3- (phenylamino)-4,5,6,7-tetrahydro-1H-indol-2- yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 163 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 126 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415064&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606730 433915108 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828820 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NS(C)(=O)=O)c1 InChI=1S/C22H24N4O3S/c1-22(2)12-16-19(17(27)13-22)21(24-15-7-5-4-6-8-15)20(25-16)14-9-10-23-18(11-14)26-30(3,28)29/h4-11,24-25H,12-13H2,1-3H3,(H,23,26) DHJWZQCKWMQVNV-UHFFFAOYSA-N 415065 N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)- 4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2- yl}methanesulfonamide::US10428044, Example 165 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 733 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415065&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606816 433915109 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828821 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)C(F)F)c1 InChI=1S/C23H22F2N4O2/c1-23(2)11-15-18(16(30)12-23)20(27-14-6-4-3-5-7-14)19(28-15)13-8-9-26-17(10-13)29-22(31)21(24)25/h3-10,21,27-28H,11-12H2,1-2H3,(H,26,29,31) KJJWEIUYRVUIOE-UHFFFAOYSA-N 415066 N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)- 4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}- 2,2-difluoroacetamide::US10428044, Example 166 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1690 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415066&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607038 433915110 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828822 CC(C)[C@@H]1Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccnc(N)c1 415067 2-(2-aminopyridin-4-yl)-3-[(4- fluorophenyl)amino]-6-(propan-2-yl)-1,5,6,7- tetrahydro-4H-indol-4-one::US10428044, Example 167 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 53.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415067&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613420 433915111 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828823 CS(=O)(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H20N4O3S/c1-28(26,27)24-17-12-13(10-11-21-17)19-20(22-14-6-3-2-4-7-14)18-15(23-19)8-5-9-16(18)25/h2-4,6-7,10-12,22-23H,5,8-9H2,1H3,(H,21,24) RJFWRTOMAPLBCE-UHFFFAOYSA-N 415068 N-{4-[4-oxo-3-(phenylamino)-4,5,6,7- tetrahydro-1H-indol-2-yl]pyridin-2- yl}methanesulfonamide::US10428044, Example 168 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6660 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415068&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607091 433915112 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828824 Cn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C20H19N3O/c1-23-16-8-5-9-17(24)18(16)19(22-15-6-3-2-4-7-15)20(23)14-10-12-21-13-11-14/h2-4,6-7,10-13,22H,5,8-9H2,1H3 KWEWROHALKJDAH-UHFFFAOYSA-N 415069 Preparation of 1-methyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 169 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 125 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415069&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607363 433915113 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828825 CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C21H21N3O/c1-2-24-17-9-6-10-18(25)19(17)20(23-16-7-4-3-5-8-16)21(24)15-11-13-22-14-12-15/h3-5,7-8,11-14,23H,2,6,9-10H2,1H3 MCCCTLYAUNADCH-UHFFFAOYSA-N 415070 Preparation of 1-ethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 170 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415070&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606831 433915114 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828826 CCCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H23N3O/c1-2-15-25-18-9-6-10-19(26)20(18)21(24-17-7-4-3-5-8-17)22(25)16-11-13-23-14-12-16/h3-5,7-8,11-14,24H,2,6,9-10,15H2,1H3 YCKDTQWCSMGQDS-UHFFFAOYSA-N 415071 Preparation of 3-(phenylamino)-1-propyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 171 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415071&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606963 433915115 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828827 COC(=O)CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C23H23N3O3/c1-29-20(28)12-15-26-18-8-5-9-19(27)21(18)22(25-17-6-3-2-4-7-17)23(26)16-10-13-24-14-11-16/h2-4,6-7,10-11,13-14,25H,5,8-9,12,15H2,1H3 NLJABTMGXOSCPD-UHFFFAOYSA-N 415072 Preparation of methyl 3-[4-oxo-3-(phenylamino)-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-1-yl]propanoate::US10428044, Example 172 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1050 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415072&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606796 433915116 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828828 OC(=O)CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H21N3O3/c26-18-8-4-7-17-20(18)21(24-16-5-2-1-3-6-16)22(15-9-12-23-13-10-15)25(17)14-11-19(27)28/h1-3,5-6,9-10,12-13,24H,4,7-8,11,14H2,(H,27,28) VHNIIHXCCRRXGN-UHFFFAOYSA-N 415073 Preparation of 3-[4-oxo-3-(phenylamino)-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-1-yl]propanoic acid::US10428044, Example 173 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 474 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415073&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607081 433915117 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828829 NC(=O)CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H22N4O2/c23-19(28)11-14-26-17-7-4-8-18(27)20(17)21(25-16-5-2-1-3-6-16)22(26)15-9-12-24-13-10-15/h1-3,5-6,9-10,12-13,25H,4,7-8,11,14H2,(H2,23,28) GCWKKCVFEPGTLJ-UHFFFAOYSA-N 415074 Preparation 3-[4-oxo-3-(phenylamino)-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-1-yl]propanamide::US10428044, Example 174 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 220 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415074&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607016 433915118 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828830 OCCCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H23N3O2/c26-15-5-14-25-18-8-4-9-19(27)20(18)21(24-17-6-2-1-3-7-17)22(25)16-10-12-23-13-11-16/h1-3,6-7,10-13,24,26H,4-5,8-9,14-15H2 JRALXWUFCHGAPE-UHFFFAOYSA-N 415075 Preparation 1-(3-hydroxypropyl)-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 175 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 217 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415075&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606701 433915119 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828831 CS(=O)(=O)CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H23N3O3S/c1-29(27,28)15-14-25-18-8-5-9-19(26)20(18)21(24-17-6-3-2-4-7-17)22(25)16-10-12-23-13-11-16/h2-4,6-7,10-13,24H,5,8-9,14-15H2,1H3 SMFHZUHKSRWTJW-UHFFFAOYSA-N 415076 Preparation 1-[2-(methylsulfonyl)ethyl]-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 176 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2040 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415076&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607125 433915120 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828832 CCn1c2CCCC(=O)c2c(Nc2ccccc2)c1-c1ccncc1Cl InChI=1S/C21H20ClN3O/c1-2-25-17-9-6-10-18(26)19(17)20(24-14-7-4-3-5-8-14)21(25)15-11-12-23-13-16(15)22/h3-5,7-8,11-13,24H,2,6,9-10H2,1H3 IYZXSJMHBWFXOH-UHFFFAOYSA-N 415077 Preparation of 2-(3-chloropyridin-4-yl)-1-ethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 177 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5670 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415077&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606788 433915121 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828833 CC1Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2C)C(=O)C1 InChI=1S/C21H21N3O/c1-14-12-17-19(18(25)13-14)20(23-16-6-4-3-5-7-16)21(24(17)2)15-8-10-22-11-9-15/h3-11,14,23H,12-13H2,1-2H3 VUBRBNBAUFISJB-UHFFFAOYSA-N 415078 Preparation of 1,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 178 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 99.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415078&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613418 433915122 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828834 Cn1c2CC(C)(C)CC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C22H23N3O/c1-22(2)13-17-19(18(26)14-22)20(24-16-7-5-4-6-8-16)21(25(17)3)15-9-11-23-12-10-15/h4-12,24H,13-14H2,1-3H3 FYPXVRCSLBMMNF-UHFFFAOYSA-N 415079 Preparation of 1,6,6-trimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 179 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 162 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415079&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613204 433915123 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828835 CC1(C)Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2CC(F)(F)F)C(=O)C1 InChI=1S/C23H22F3N3O/c1-22(2)12-17-19(18(30)13-22)20(28-16-6-4-3-5-7-16)21(15-8-10-27-11-9-15)29(17)14-23(24,25)26/h3-11,28H,12-14H2,1-2H3 SJVDLSVRZWZUEK-UHFFFAOYSA-N 415080 Preparation of 6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1-(2,2,2-trifluoroethyl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 180 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 199 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415080&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606971 433915124 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828836 CCn1c2CC(C)(C)CC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C23H25N3O/c1-4-26-18-14-23(2,3)15-19(27)20(18)21(25-17-8-6-5-7-9-17)22(26)16-10-12-24-13-11-16/h5-13,25H,4,14-15H2,1-3H3 IJSZOBPGZJTZKJ-UHFFFAOYSA-N 415081 Preparation of 1-ethyl-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 181 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 32.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415081&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607326 433915125 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828837 CCCn1c2CC(C)(C)CC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C24H27N3O/c1-4-14-27-19-15-24(2,3)16-20(28)21(19)22(26-18-8-6-5-7-9-18)23(27)17-10-12-25-13-11-17/h5-13,26H,4,14-16H2,1-3H3 QVCAWLJSGFECAG-UHFFFAOYSA-N 415082 Preparation of 6,6-dimethyl-3-(phenylamino)-1-propyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 182 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 68.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415082&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613425 433915126 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828838 CC(C)(C)[Si](C)(C)OCCn1c2CC(C)(C)CC(=O)c2c(Nc2ccccc2)c1-c1ccncc1 InChI=1S/C29H39N3O2Si/c1-28(2,3)35(6,7)34-18-17-32-23-19-29(4,5)20-24(33)25(23)26(31-22-11-9-8-10-12-22)27(32)21-13-15-30-16-14-21/h8-16,31H,17-20H2,1-7H3 ZNVXMRZSSNXENQ-UHFFFAOYSA-N 415083 Preparation of 3-anilino-2-(pyridin-4-yl)-1-[2-(tetrahydro-2H-pyran-2-yloxy)ethyl]-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 183 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7090 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415083&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 141479601 433915127 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828839 CC1(C)Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2CCO)C(=O)C1 InChI=1S/C23H25N3O2/c1-23(2)14-18-20(19(28)15-23)21(25-17-6-4-3-5-7-17)22(26(18)12-13-27)16-8-10-24-11-9-16/h3-11,25,27H,12-15H2,1-2H3 PATAXIXTOSGLDK-UHFFFAOYSA-N 415084 Preparation of 1-(2-hydroxyethyl)-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 184 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 200 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415084&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607013 433915128 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828840 CC1(C)Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2CC(N)=O)C(=O)C1 InChI=1S/C23H24N4O2/c1-23(2)12-17-20(18(28)13-23)21(26-16-6-4-3-5-7-16)22(27(17)14-19(24)29)15-8-10-25-11-9-15/h3-11,26H,12-14H2,1-2H3,(H2,24,29) GDBNAGMAEGPKTH-UHFFFAOYSA-N 415085 Preparation of 2-[3-anilino-6,6-dimethyl-4-oxo-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-1-yl]acetamide formic acid salt::US10428044, Example 185 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1300 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415085&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606838 433915129 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828841 CC1(C)Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2Cc2ccccc2)C(=O)C1 InChI=1S/C28H27N3O/c1-28(2)17-23-25(24(32)18-28)26(30-22-11-7-4-8-12-22)27(21-13-15-29-16-14-21)31(23)19-20-9-5-3-6-10-20/h3-16,30H,17-19H2,1-2H3 UJURLVPJQKSZTG-UHFFFAOYSA-N 415086 Preparation of 1-benzyl-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 186 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2940 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415086&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606956 433915130 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828842 CCn1c2CC(C)(C)CC(=O)c2c(Nc2ccccc2)c1-c1ccnc(NC(C)=O)c1 InChI=1S/C25H28N4O2/c1-5-29-19-14-25(3,4)15-20(31)22(19)23(28-18-9-7-6-8-10-18)24(29)17-11-12-26-21(13-17)27-16(2)30/h6-13,28H,5,14-15H2,1-4H3,(H,26,27,30) NNVRIKXRXBPFKK-UHFFFAOYSA-N 415087 Preparation of N-{4-[1-ethyl-6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 187 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 52.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415087&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606943 433915131 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828843 CC1(C)Cc2c(c(Nc3ccccc3)c(-c3ccncc3)n2CC(F)F)C(=O)C1 InChI=1S/C23H23F2N3O/c1-23(2)12-17-20(18(29)13-23)21(27-16-6-4-3-5-7-16)22(28(17)14-19(24)25)15-8-10-26-11-9-15/h3-11,19,27H,12-14H2,1-2H3 JRURJYNRAJNWPO-UHFFFAOYSA-N 415088 Preparation of 1-(2,2-difluoroethyl)-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 188 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 50.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415088&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607313 433915132 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828844 CC(C)[n+]1ccc(cc1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C24H27N3O/c1-16(2)27-12-10-17(11-13-27)22-23(25-18-8-6-5-7-9-18)21-19(26-22)14-24(3,4)15-20(21)28/h5-13,16H,14-15H2,1-4H3,(H,25,26,28)/p+1 RIJXZROCAFLIIH-UHFFFAOYSA-O 415089 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]-1-(propan-2-yl)pyridinium iodide::US10428044, Example 189 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 259 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415089&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607118 433915133 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828845 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc[n+](CC(F)(F)F)cc1 InChI=1S/C23H22F3N3O/c1-22(2)12-17-19(18(30)13-22)21(27-16-6-4-3-5-7-16)20(28-17)15-8-10-29(11-9-15)14-23(24,25)26/h3-11H,12-14H2,1-2H3,(H,27,28,30)/p+1 GOGUMEULHAOOHH-UHFFFAOYSA-O 415090 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]-1-(2,2,2-trifluoroethyl)pyridinium trifluoromethanesulfonate::US10428044, Example 190 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 475 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415090&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607185 433915134 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828846 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc[n+](CCCO)cc1 InChI=1S/C24H27N3O2/c1-24(2)15-19-21(20(29)16-24)23(25-18-7-4-3-5-8-18)22(26-19)17-9-12-27(13-10-17)11-6-14-28/h3-5,7-10,12-13,28H,6,11,14-16H2,1-2H3,(H,25,26,29)/p+1 MBAIKLISIWSXOY-UHFFFAOYSA-O 415091 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]-1-(3-hydroxypropyl)pyridinium iodide::US10428044, Example 191 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 326 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415091&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606757 433915135 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828847 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc[n+](CC(F)F)cc1 InChI=1S/C23H23F2N3O/c1-23(2)12-17-20(18(29)13-23)22(26-16-6-4-3-5-7-16)21(27-17)15-8-10-28(11-9-15)14-19(24)25/h3-11,19H,12-14H2,1-2H3,(H,26,27,29)/p+1 HZERJSVSXSPPOJ-UHFFFAOYSA-O 415092 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]-1-(2,2-difluoroethyl)pyridinium trifluoromethanesulfonate::US10428044, Example 192 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1280 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415092&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607123 433915136 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828848 COC(=O)C[n+]1ccc(cc1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C24H25N3O3/c1-24(2)13-18-21(19(28)14-24)23(25-17-7-5-4-6-8-17)22(26-18)16-9-11-27(12-10-16)15-20(29)30-3/h4-12H,13-15H2,1-3H3,(H,25,26,28)/p+1 QBXCXQWWQYSSOU-UHFFFAOYSA-O 415093 Preparation of 4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]-1-(2-methoxy-2-oxoethyl)pyridinium bromide::US10428044, Example 193 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 921 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415093&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606920 433915137 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828849 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2\C(C1)=N\O)-c1ccncc1 InChI=1S/C21H22N4O/c1-21(2)12-16-18(17(13-21)25-26)20(23-15-6-4-3-5-7-15)19(24-16)14-8-10-22-11-9-14/h3-11,23-24,26H,12-13H2,1-2H3/b25-17+ VNKGZHXHKULDKM-KOEQRZSOSA-N 415094 Preparation of 4-(hydroxyimino)-6,6-dimethyl-N-phenyl-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-3-amine::US10428044, Example 194 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 42.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415094&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136992997 433915138 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828850 CC(=O)O\N=C1/CC(C)(C)Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C23H24N4O2/c1-15(28)29-27-19-14-23(2,3)13-18-20(19)22(25-17-7-5-4-6-8-17)21(26-18)16-9-11-24-12-10-16/h4-12,25-26H,13-14H2,1-3H3/b27-19+ GANRGINWBNQINN-ZXVVBBHZSA-N 415095 Preparation of 1-({(E)-[6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-ylidene]amino}oxy)ethanone::US10428044, Example 195 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 102 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415095&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 141479605 433915139 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828851 Brc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C19H16BrN3O/c20-14-11-21-10-9-13(14)18-19(22-12-5-2-1-3-6-12)17-15(23-18)7-4-8-16(17)24/h1-3,5-6,9-11,22-23H,4,7-8H2 LJXUMYRVOIDCMJ-UHFFFAOYSA-N 415096 Intermediate 1-2-29::US10428044, Example 196 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 36.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415096&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606731 433915140 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828852 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1C#N InChI=1S/C20H16N4O/c21-11-13-12-22-10-9-15(13)19-20(23-14-5-2-1-3-6-14)18-16(24-19)7-4-8-17(18)25/h1-3,5-6,9-10,12,23-24H,4,7-8H2 XVLCNLZPUPJHLS-UHFFFAOYSA-N 415097 Preparation of 4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridine-3-carbonitrile::US10428044, Example 197 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415097&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607211 433915141 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828853 CC(C)(C)OC(=O)n1ccc2c1CC(C)(C)CC2=O InChI=1S/C15H21NO3/c1-14(2,3)19-13(18)16-7-6-10-11(16)8-15(4,5)9-12(10)17/h6-7H,8-9H2,1-5H3 JSXZJZQRQVGUSV-UHFFFAOYSA-N 415098 Preparation of 4-{3-[(3-fluorophenyl)amino]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridine-3-carbonitrile::US10428044, Example 198 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10900 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415098&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607334 433915142 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828854 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1Br InChI=1S/C21H20BrN3O/c1-21(2)10-16-18(17(26)11-21)20(24-13-6-4-3-5-7-13)19(25-16)14-8-9-23-12-15(14)22/h3-9,12,24-25H,10-11H2,1-2H3 GDLJEFQEZPFOPC-UHFFFAOYSA-N 415099 Intermediate 1-2-30::US10428044, Example 199 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415099&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607035 433915143 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828855 CSc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N3OS/c1-22(2)12-16-19(17(26)13-22)21(24-15-7-5-4-6-8-15)20(25-16)14-9-10-23-18(11-14)27-3/h4-11,24-25H,12-13H2,1-3H3 KDPCOWNBNRWMPF-UHFFFAOYSA-N 415100 Intermediate 1-2-31::US10428044, Example 200 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 610 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415100&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607036 433915144 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828856 CSc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)CC(C)(C)C1 InChI=1S/C22H25N3OS2/c1-22(2)11-17(24-13-15-9-10-23-14-19(15)28-3)20(18(26)12-22)21(27)25-16-7-5-4-6-8-16/h4-10,14,24H,11-13H2,1-3H3,(H,25,27) HMYZIJZCBKAGDP-UHFFFAOYSA-N 415101 Intermediate 1-2-32::US10428044, Example 201 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 47.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415101&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613346 433915145 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828857 CS(=O)c1cnccc1-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 415102 Preparation of {4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-3-yl}(methyl)sulfoniumolate::US10428044, Example 202 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1990 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415102&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607063 433915146 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828858 CC1(C)CC(=O)C(C(=S)Nc2cccc(Br)c2)=C(C1)NCc1ccnc(N)c1 InChI=1S/C21H23BrN4OS/c1-21(2)10-16(25-12-13-6-7-24-18(23)8-13)19(17(27)11-21)20(28)26-15-5-3-4-14(22)9-15/h3-9,25H,10-12H2,1-2H3,(H2,23,24)(H,26,28) SIDARPQHEYRRGZ-UHFFFAOYSA-N 415103 Intermediate 1-2-33::US10428044, Example 203 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 115 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415103&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613428 433915147 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828859 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(Nc2cnn(Cc3ccccc3)c2)c1 InChI=1S/C31H30N6O/c1-31(2)16-25-28(26(38)17-31)30(35-23-11-7-4-8-12-23)29(36-25)22-13-14-32-27(15-22)34-24-18-33-37(20-24)19-21-9-5-3-6-10-21/h3-15,18,20,35-36H,16-17,19H2,1-2H3,(H,32,34) XKQMUXKUBYRKRX-UHFFFAOYSA-N 415104 Intermediate 1-10-1::US10428044, Example 204 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 42.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415104&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606950 433915148 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828860 Cn1cc(Nc2cc(ccn2)-c2[nH]c3CC(C)(C)CC(=O)c3c2Nc2ccccc2)cn1 InChI=1S/C25H26N6O/c1-25(2)12-19-22(20(32)13-25)24(29-17-7-5-4-6-8-17)23(30-19)16-9-10-26-21(11-16)28-18-14-27-31(3)15-18/h4-11,14-15,29-30H,12-13H2,1-3H3,(H,26,28) PEDAETJPRCNYMH-UHFFFAOYSA-N 415105 Intermediate 1-10-2::US10428044, Example 205 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 22.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415105&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606884 433915149 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828861 Nc1cc(ccn1)-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1 InChI=1S/C21H20N4O/c22-17-10-13(6-9-23-17)19-20(24-14-4-2-1-3-5-14)18-15(25-19)11-21(7-8-21)12-16(18)26/h1-6,9-10,24-25H,7-8,11-12H2,(H2,22,23) IICLLZBQLYOLJQ-UHFFFAOYSA-N 415106 Intermediate 1-2-36::US10428044, Example 206 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.73 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415106&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606849 433915150 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828862 Fc1cc(ccn1)-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1 InChI=1S/C21H18FN3O/c22-17-10-13(6-9-23-17)19-20(24-14-4-2-1-3-5-14)18-15(25-19)11-21(7-8-21)12-16(18)26/h1-6,9-10,24-25H,7-8,11-12H2 OEUQDGHIMWZUDA-UHFFFAOYSA-N 415107 Intermediate 1-2-37::US10428044, Example 207 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.32 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415107&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606729 433915151 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828863 Fc1cnccc1-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1 InChI=1S/C21H18FN3O/c22-15-12-23-9-6-14(15)19-20(24-13-4-2-1-3-5-13)18-16(25-19)10-21(7-8-21)11-17(18)26/h1-6,9,12,24-25H,7-8,10-11H2 BLTIOYPDMYXIPV-UHFFFAOYSA-N 415108 Preparation of 2′-(3-fluoropyridin-4-yl)-3′-(phenylamino)-1′,7′-dihydrospiro[cyclopropane-1,6′-indol]-4′(5′H)-one::US10428044, Example 208 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.39 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415108&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606852 433915152 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828864 Cc1cc(cc(C)n1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N3O/c1-14-10-16(11-15(2)24-14)21-22(25-17-8-6-5-7-9-17)20-18(26-21)12-23(3,4)13-19(20)27/h5-11,25-26H,12-13H2,1-4H3 STWRPZGORJPWPS-UHFFFAOYSA-N 415109 Intermediate 1-2-39::US10428044, Example 209 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3120 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415109&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613436 433915153 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828865 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc2OCCOc12 InChI=1S/C23H23N3O3/c1-23(2)12-16-18(17(27)13-23)20(25-14-6-4-3-5-7-14)19(26-16)15-8-9-24-22-21(15)28-10-11-29-22/h3-9,25-26H,10-13H2,1-2H3 YLECPGJGFXLSCZ-UHFFFAOYSA-N 415110 Intermediate 1-11-3::US10428044, Example 210 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 130 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415110&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606994 433915154 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828866 Nc1cc(CNC2=C(C(=S)Nc3ccc(F)cc3)C(=O)CCC2)ccn1 InChI=1S/C19H19FN4OS/c20-13-4-6-14(7-5-13)24-19(26)18-15(2-1-3-16(18)25)23-11-12-8-9-22-17(21)10-12/h4-10,23H,1-3,11H2,(H2,21,22)(H,24,26) XNRSUOCDVAWTIP-UHFFFAOYSA-N 415111 Intermediate 1-2-41::US10428044, Example 211 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 114 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415111&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613350 433915155 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828867 Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccc(F)c(F)c1 InChI=1S/C19H16F2N4O/c20-12-5-4-11(9-13(12)21)24-19-17-14(2-1-3-15(17)26)25-18(19)10-6-7-23-16(22)8-10/h4-9,24-25H,1-3H2,(H2,22,23) XPIGYZHJYNVJNW-UHFFFAOYSA-N 415112 Intermediate 1-2-42::US10428044, Example 212 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 220 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415112&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607342 433915156 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828868 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(F)c1 InChI=1S/C21H20FN3O/c1-21(2)11-15-18(16(26)12-21)20(24-14-6-4-3-5-7-14)19(25-15)13-8-9-23-17(22)10-13/h3-10,24-25H,11-12H2,1-2H3 MTPFRTAOMXQPMY-UHFFFAOYSA-N 415113 Intermediate 1-2-43::US10428044, Example 213 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415113&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607341 433915157 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828869 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1ccnc(Cl)c1Cl InChI=1S/C21H21Cl2N3OS/c1-21(2)10-15(25-12-13-8-9-24-19(23)18(13)22)17(16(27)11-21)20(28)26-14-6-4-3-5-7-14/h3-9,25H,10-12H2,1-2H3,(H,26,28) DRFRRBXCYVUWCY-UHFFFAOYSA-N 415114 Intermediate 1-2-44::US10428044, Example 214 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 67.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415114&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613244 433915158 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828870 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc(Cl)ncc1Cl InChI=1S/C21H19Cl2N3O/c1-21(2)9-15-18(16(27)10-21)20(25-12-6-4-3-5-7-12)19(26-15)13-8-17(23)24-11-14(13)22/h3-8,11,25-26H,9-10H2,1-2H3 XBUOUVZQLXIUKI-UHFFFAOYSA-N 415115 Preparation of 2-(2,5-dichloropyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 215 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9680 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415115&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606850 433915159 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828871 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc(Cl)nc(Cl)c1 InChI=1S/C21H19Cl2N3O/c1-21(2)10-14-18(15(27)11-21)20(24-13-6-4-3-5-7-13)19(25-14)12-8-16(22)26-17(23)9-12/h3-9,24-25H,10-11H2,1-2H3 CSJKLHWIAHTLRC-UHFFFAOYSA-N 415116 Intermediate 1-2-45::US10428044, Example 216 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415116&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606758 433915160 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828872 Clc1cc(CNC2=C(C(=S)Nc3ccccc3)C(=O)CCC2)cc(Cl)n1 InChI=1S/C19H17Cl2N3OS/c20-16-9-12(10-17(21)24-16)11-22-14-7-4-8-15(25)18(14)19(26)23-13-5-2-1-3-6-13/h1-3,5-6,9-10,22H,4,7-8,11H2,(H,23,26) ALVYFYUCHJYKBI-UHFFFAOYSA-N 415117 Intermediate 1-2-46::US10428044, Example 217 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415117&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613443 433915161 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828873 Fc1cc(-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)c(F)cn1 InChI=1S/C19H15F2N3O/c20-13-10-22-16(21)9-12(13)18-19(23-11-5-2-1-3-6-11)17-14(24-18)7-4-8-15(17)25/h1-3,5-6,9-10,23-24H,4,7-8H2 PWTDVIJHXGHTIX-UHFFFAOYSA-N 415118 Intermediate 1-2-47::US10428044, Example 218 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 906 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415118&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607144 433915162 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828874 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1ccnc(Cl)c1F InChI=1S/C21H21ClFN3OS/c1-21(2)10-15(25-12-13-8-9-24-19(22)18(13)23)17(16(27)11-21)20(28)26-14-6-4-3-5-7-14/h3-9,25H,10-12H2,1-2H3,(H,26,28) RFSUMPJHGSQGGY-UHFFFAOYSA-N 415119 Intermediate 1-2-48::US10428044, Example 219 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415119&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613399 433915163 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828875 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1cc(Cl)ncc1F InChI=1S/C21H21ClFN3OS/c1-21(2)9-16(24-11-13-8-18(22)25-12-15(13)23)19(17(27)10-21)20(28)26-14-6-4-3-5-7-14/h3-8,12,24H,9-11H2,1-2H3,(H,26,28) YNBKNFDZYLPGOY-UHFFFAOYSA-N 415120 Intermediate 1-2-49::US10428044, Example 220 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1400 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415120&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613400 433915164 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828876 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc2[nH]cnc12 InChI=1S/C22H21N5O/c1-22(2)10-15-17(16(28)11-22)20(26-13-6-4-3-5-7-13)18(27-15)14-8-9-23-21-19(14)24-12-25-21/h3-9,12,26-27H,10-11H2,1-2H3,(H,23,24,25) DIUPGLCCYDOENN-UHFFFAOYSA-N 415121 Intermediate 1-2-50::US10428044, Example 221 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415121&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606977 433915165 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828877 CC(C)C1Cc2[nH]c(c(Nc3ccc(F)c(F)c3)c2C(=O)C1)-c1ccnc(N)c1 415122 Intermediate 1-2-51::US10428044, Example 222 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415122&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607070 433915166 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828878 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(N)n1 InChI=1S/C20H21N5O/c1-20(2)10-14-16(15(26)11-20)18(23-12-6-4-3-5-7-12)17(24-14)13-8-9-22-19(21)25-13/h3-9,23-24H,10-11H2,1-2H3,(H2,21,22,25) TXQZFLQXDNHFAG-UHFFFAOYSA-N 415123 Intermediate 1-11-4::US10428044, Example 223 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415123&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607062 433915167 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828879 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1cc(N)ncn1 InChI=1S/C20H21N5O/c1-20(2)9-14-17(15(26)10-20)19(24-12-6-4-3-5-7-12)18(25-14)13-8-16(21)23-11-22-13/h3-8,11,24-25H,9-10H2,1-2H3,(H2,21,22,23) BVRBFQPSAHHGEE-UHFFFAOYSA-N 415124 Intermediate 1-2-53::US10428044, Example 224 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 248 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415124&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606790 433915168 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828880 CCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22N4O2/c1-2-19(28)26-18-13-14(11-12-23-18)21-22(24-15-7-4-3-5-8-15)20-16(25-21)9-6-10-17(20)27/h3-5,7-8,11-13,24-25H,2,6,9-10H2,1H3,(H,23,26,28) XGQQBZJMPJEXOX-UHFFFAOYSA-N 415125 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 225 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415125&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607225 433915169 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828881 CCCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H24N4O2/c1-2-7-20(29)27-19-14-15(12-13-24-19)22-23(25-16-8-4-3-5-9-16)21-17(26-22)10-6-11-18(21)28/h3-5,8-9,12-14,25-26H,2,6-7,10-11H2,1H3,(H,24,27,29) DBWCFAMXCMDHOH-UHFFFAOYSA-N 415126 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}butanamide::US10428044, Example 226 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415126&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606917 433915170 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828882 CC(C)(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H26N4O2/c1-24(2,3)23(30)28-19-14-15(12-13-25-19)21-22(26-16-8-5-4-6-9-16)20-17(27-21)10-7-11-18(20)29/h4-6,8-9,12-14,26-27H,7,10-11H2,1-3H3,(H,25,28,30) RPXCCSZIHBOLLZ-UHFFFAOYSA-N 415127 Preparation of 2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 227 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 260 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415127&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607320 433915171 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828883 CC1(CC1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H24N4O2/c1-24(11-12-24)23(30)28-19-14-15(10-13-25-19)21-22(26-16-6-3-2-4-7-16)20-17(27-21)8-5-9-18(20)29/h2-4,6-7,10,13-14,26-27H,5,8-9,11-12H2,1H3,(H,25,28,30) ODFKYHVCNOERME-UHFFFAOYSA-N 415128 Preparation of 1-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 228 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 56.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415128&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606998 433915172 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828884 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1CCC1 InChI=1S/C24H24N4O2/c29-19-11-5-10-18-21(19)23(26-17-8-2-1-3-9-17)22(27-18)16-12-13-25-20(14-16)28-24(30)15-6-4-7-15/h1-3,8-9,12-15,26-27H,4-7,10-11H2,(H,25,28,30) ZCYXNZMSHZJMFN-UHFFFAOYSA-N 415129 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclobutanecarboxamide::US10428044, Example 229 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415129&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606813 433915173 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828885 CC(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H24N4O2/c1-14(2)23(29)27-19-13-15(11-12-24-19)21-22(25-16-7-4-3-5-8-16)20-17(26-21)9-6-10-18(20)28/h3-5,7-8,11-14,25-26H,6,9-10H2,1-2H3,(H,24,27,29) NTICJTHCAFRRMQ-UHFFFAOYSA-N 415130 Preparation of 2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 230 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415130&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607258 433915174 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828886 O=C(CC1CC1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H24N4O2/c29-19-8-4-7-18-22(19)24(26-17-5-2-1-3-6-17)23(27-18)16-11-12-25-20(14-16)28-21(30)13-15-9-10-15/h1-3,5-6,11-12,14-15,26-27H,4,7-10,13H2,(H,25,28,30) OSBWRWMLXGIEGW-UHFFFAOYSA-N 415131 Preparation of 2-cyclopropyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 231 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415131&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607303 433915175 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828887 CC1(C)CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415132 Preparation of 2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 232 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 34.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415132&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606840 433915176 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828888 O=C(Cc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H24N4O2/c32-22-13-7-12-21-25(22)27(29-20-10-5-2-6-11-20)26(30-21)19-14-15-28-23(17-19)31-24(33)16-18-8-3-1-4-9-18/h1-6,8-11,14-15,17,29-30H,7,12-13,16H2,(H,28,31,33) KKDCHEPSLGIEOY-UHFFFAOYSA-N 415133 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-phenylacetamide::US10428044, Example 233 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 43.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415133&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606797 433915177 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828889 O=C(CCc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C28H26N4O2/c33-23-13-7-12-22-26(23)28(30-21-10-5-2-6-11-21)27(31-22)20-16-17-29-24(18-20)32-25(34)15-14-19-8-3-1-4-9-19/h1-6,8-11,16-18,30-31H,7,12-15H2,(H,29,32,34) YWQHRLLUOKYYLJ-UHFFFAOYSA-N 415134 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}but-3-ynamide::US10428044, Example 234::US10428044, Example 235 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1940 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415134&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607248 433915178 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828890 O=C(CCc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C28H26N4O2/c33-23-13-7-12-22-26(23)28(30-21-10-5-2-6-11-21)27(31-22)20-16-17-29-24(18-20)32-25(34)15-14-19-8-3-1-4-9-19/h1-6,8-11,16-18,30-31H,7,12-15H2,(H,29,32,34) YWQHRLLUOKYYLJ-UHFFFAOYSA-N 415134 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}but-3-ynamide::US10428044, Example 234::US10428044, Example 235 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 61.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415134&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607248 433915178 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828891 O=C(CCCc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C29H28N4O2/c34-24-15-8-14-23-27(24)29(31-22-12-5-2-6-13-22)28(32-23)21-17-18-30-25(19-21)33-26(35)16-7-11-20-9-3-1-4-10-20/h1-6,9-10,12-13,17-19,31-32H,7-8,11,14-16H2,(H,30,33,35) CQQRCYYRWXGWCD-UHFFFAOYSA-N 415136 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-4-phenylbutanamide::US10428044, Example 236 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.26 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415136&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606714 433915179 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828892 CC1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415137 Preparation of 2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 237 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415137&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607055 433915180 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828893 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccccc1 InChI=1S/C26H22N4O2/c31-21-13-7-12-20-23(21)25(28-19-10-5-2-6-11-19)24(29-20)18-14-15-27-22(16-18)30-26(32)17-8-3-1-4-9-17/h1-6,8-11,14-16,28-29H,7,12-13H2,(H,27,30,32) RIKBIWQIHAZOAR-UHFFFAOYSA-N 415138 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 238 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415138&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606685 433915181 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828894 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1CC1c1ccccc1 415139 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-phenylcyclopropanecarboxamide::US10428044, Example 239 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 45.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415139&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606780 433915182 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828895 CN(C(C)=O)c1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22N4O2/c1-14(27)26(2)19-13-15(11-12-23-19)21-22(24-16-7-4-3-5-8-16)20-17(25-21)9-6-10-18(20)28/h3-5,7-8,11-13,24-25H,6,9-10H2,1-2H3 WHFCACZPDVDEEC-UHFFFAOYSA-N 415140 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-N-methylacetamide::US10428044, Example 240 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6740 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415140&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613382 433915183 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828896 CC(F)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415141 Preparation of 2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 241 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415141&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607103 433915184 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828897 CC(C)(F)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H23FN4O2/c1-23(2,24)22(30)28-18-13-14(11-12-25-18)20-21(26-15-7-4-3-5-8-15)19-16(27-20)9-6-10-17(19)29/h3-5,7-8,11-13,26-27H,6,9-10H2,1-2H3,(H,25,28,30) TXGRSBYVRHZVBE-UHFFFAOYSA-N 415142 Preparation of 2-fluoro-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 242 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 182 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415142&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607090 433915185 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828898 CC(C)(CO)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H26N4O3/c1-24(2,14-29)23(31)28-19-13-15(11-12-25-19)21-22(26-16-7-4-3-5-8-16)20-17(27-21)9-6-10-18(20)30/h3-5,7-8,11-13,26-27,29H,6,9-10,14H2,1-2H3,(H,25,28,31) LZEAGDDIMRZQNI-UHFFFAOYSA-N 415143 Preparation of 3-hydroxy-2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 243 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 255 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415143&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607240 433915186 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828899 CSCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22N4O2S/c1-29-13-19(28)26-18-12-14(10-11-23-18)21-22(24-15-6-3-2-4-7-15)20-16(25-21)8-5-9-17(20)27/h2-4,6-7,10-12,24-25H,5,8-9,13H2,1H3,(H,23,26,28) XCVZSPYNHCQFJM-UHFFFAOYSA-N 415144 Preparation of 2-(methylsulfanyl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 244 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 31.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415144&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606753 433915187 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828900 CC(C)(C#N)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H23N5O2/c1-24(2,14-25)23(31)29-19-13-15(11-12-26-19)21-22(27-16-7-4-3-5-8-16)20-17(28-21)9-6-10-18(20)30/h3-5,7-8,11-13,27-28H,6,9-10H2,1-2H3,(H,26,29,31) ZSJMUTFXRGDWHL-UHFFFAOYSA-N 415145 Preparation of 2-cyano-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 245 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 84.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415145&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607071 433915188 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828901 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1(CC1)C#N InChI=1S/C24H21N5O2/c25-14-24(10-11-24)23(31)29-19-13-15(9-12-26-19)21-22(27-16-5-2-1-3-6-16)20-17(28-21)7-4-8-18(20)30/h1-3,5-6,9,12-13,27-28H,4,7-8,10-11H2,(H,26,29,31) CVIDSLGCCQRPMF-UHFFFAOYSA-N 415146 Preparation of 1-cyano-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 246 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 60.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415146&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607056 433915189 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828902 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C(F)(F)F 415147 Preparation of 3,3,3-trifluoro-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 247 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 81.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415147&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607116 433915190 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828903 CS(=O)(=O)CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22N4O4S/c1-31(29,30)13-19(28)26-18-12-14(10-11-23-18)21-22(24-15-6-3-2-4-7-15)20-16(25-21)8-5-9-17(20)27/h2-4,6-7,10-12,24-25H,5,8-9,13H2,1H3,(H,23,26,28) SHGDPIKWFPDFKO-UHFFFAOYSA-N 415148 Preparation of 2-(methylsulfonyl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 248 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415148&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606866 433915191 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828904 F[C@H]1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415149 Preparation of rel-(R,S/S,R)-2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 249 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415149&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 129029842 433915192 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828905 F[C@H]1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415149 Preparation of rel-(R,S/S,R)-2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 249 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.55 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415149&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 129029842 433915192 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828908 F[C@@H]1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415150 Preparation of rel-(S,S/R,R)-2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 252::US10428044, Example 253 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415150&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 129030177 433915193 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828909 F[C@@H]1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415150 Preparation of rel-(S,S/R,R)-2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 252::US10428044, Example 253 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415150&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 129030177 433915193 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828910 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)[C@@H]2C[C@H]2F)c1 415152 Preparation of (S,R)—N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-fluorocyclopropanecarboxamide::US10428044, Example 254 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.34 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415152&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607397 433915194 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828913 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 415153 Preparation of (R,R)—N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-fluorocyclopropanecarboxamide::US10428044, Example 257::US10428044, Example 259 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 59.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415153&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613219 433915195 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828915 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 415153 Preparation of (R,R)—N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-fluorocyclopropanecarboxamide::US10428044, Example 257::US10428044, Example 259 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415153&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613219 433915195 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828916 FC1(F)CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415155 Preparation of 2,2-difluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 260 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415155&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607175 433915196 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828917 FC1(CC1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H21FN4O2/c24-23(10-11-23)22(30)28-18-13-14(9-12-25-18)20-21(26-15-5-2-1-3-6-15)19-16(27-20)7-4-8-17(19)29/h1-3,5-6,9,12-13,26-27H,4,7-8,10-11H2,(H,25,28,30) OIUBFAVJWNIROQ-UHFFFAOYSA-N 415156 Preparation of 1-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 261 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 41.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415156&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607097 433915197 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828918 FC(F)(F)C1CC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415157 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(trifluoromethyl)cyclopropanecarboxamide::US10428044, Example 262 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 32.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415157&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607139 433915198 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828919 CC(C)(CF)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H25FN4O2/c1-24(2,14-25)23(31)29-19-13-15(11-12-26-19)21-22(27-16-7-4-3-5-8-16)20-17(28-21)9-6-10-18(20)30/h3-5,7-8,11-13,27-28H,6,9-10,14H2,1-2H3,(H,26,29,31) IYRSFUHCOZYZOE-UHFFFAOYSA-N 415158 Preparation of 3-fluoro-2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 263 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 140 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415158&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606889 433915199 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828920 Fc1ccccc1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H21FN4O2/c27-19-10-5-4-9-18(19)26(33)31-22-15-16(13-14-28-22)24-25(29-17-7-2-1-3-8-17)23-20(30-24)11-6-12-21(23)32/h1-5,7-10,13-15,29-30H,6,11-12H2,(H,28,31,33) QIUKGFMRWIGJFV-UHFFFAOYSA-N 415159 Preparation of 2-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 264 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415159&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607080 433915200 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828921 Fc1cccc(c1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H21FN4O2/c27-18-7-4-6-17(14-18)26(33)31-22-15-16(12-13-28-22)24-25(29-19-8-2-1-3-9-19)23-20(30-24)10-5-11-21(23)32/h1-4,6-9,12-15,29-30H,5,10-11H2,(H,28,31,33) IHDBJAHABYUUDC-UHFFFAOYSA-N 415160 Preparation of 3-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 265 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415160&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607243 433915201 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828922 Fc1ccc(cc1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H21FN4O2/c27-18-11-9-16(10-12-18)26(33)31-22-15-17(13-14-28-22)24-25(29-19-5-2-1-3-6-19)23-20(30-24)7-4-8-21(23)32/h1-3,5-6,9-15,29-30H,4,7-8H2,(H,28,31,33) IENKRMMKPHTJPN-UHFFFAOYSA-N 415161 Preparation of 4-fluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 266 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415161&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606937 433915202 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828923 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)15-21-24(22(34)16-28)26(31-20-6-4-3-5-7-20)25(32-21)18-12-13-30-23(14-18)33-27(35)17-8-10-19(29)11-9-17/h3-14,31-32H,15-16H2,1-2H3,(H,30,33,35) RBJHOGJLUWXCLE-UHFFFAOYSA-N 415162 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-4-fluorobenzamide::US10428044, Example 267 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.55 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415162&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606918 433915203 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828924 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccncc1 InChI=1S/C25H21N5O2/c31-20-8-4-7-19-22(20)24(28-18-5-2-1-3-6-18)23(29-19)17-11-14-27-21(15-17)30-25(32)16-9-12-26-13-10-16/h1-3,5-6,9-15,28-29H,4,7-8H2,(H,27,30,32) SVBXFDSDHBFZIK-UHFFFAOYSA-N 415163 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}pyridine-4-carboxamide::US10428044, Example 268 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 22.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415163&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606805 433915204 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828925 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccccn1 InChI=1S/C25H21N5O2/c31-20-11-6-10-18-22(20)24(28-17-7-2-1-3-8-17)23(29-18)16-12-14-27-21(15-16)30-25(32)19-9-4-5-13-26-19/h1-5,7-9,12-15,28-29H,6,10-11H2,(H,27,30,32) ZQHKTSFPUSELIG-UHFFFAOYSA-N 415164 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}pyridine-2-carboxamide::US10428044, Example 269 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415164&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606944 433915205 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828926 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1nccs1 InChI=1S/C23H19N5O2S/c29-17-8-4-7-16-19(17)21(26-15-5-2-1-3-6-15)20(27-16)14-9-10-24-18(13-14)28-22(30)23-25-11-12-31-23/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,24,28,30) RGYCJKOJBOWIBP-UHFFFAOYSA-N 415165 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-2-carboxamide::US10428044, Example 270 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415165&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607307 433915206 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828927 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cscn1 InChI=1S/C23H19N5O2S/c29-18-8-4-7-16-20(18)22(26-15-5-2-1-3-6-15)21(27-16)14-9-10-24-19(11-14)28-23(30)17-12-31-13-25-17/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,24,28,30) JTAVCSPCKRRXNO-UHFFFAOYSA-N 415166 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-4-carboxamide::US10428044, Example 271 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.64 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415166&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607261 433915207 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828928 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2cscn2)c1 InChI=1S/C25H23N5O2S/c1-25(2)11-17-21(19(31)12-25)23(28-16-6-4-3-5-7-16)22(29-17)15-8-9-26-20(10-15)30-24(32)18-13-33-14-27-18/h3-10,13-14,28-29H,11-12H2,1-2H3,(H,26,30,32) KZDXHUBHTCNNGT-UHFFFAOYSA-N 415167 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-4-carboxamide::US10428044, Example 272 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.63 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415167&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613220 433915208 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828929 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cncs1 InChI=1S/C23H19N5O2S/c29-17-8-4-7-16-20(17)22(26-15-5-2-1-3-6-15)21(27-16)14-9-10-25-19(11-14)28-23(30)18-12-24-13-31-18/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,25,28,30) CSKWPSJMCMELCX-UHFFFAOYSA-N 415168 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-5-carboxamide::US10428044, Example 273 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.66 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415168&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606817 433915209 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828930 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ncc[nH]1 InChI=1S/C23H20N6O2/c30-17-8-4-7-16-19(17)21(27-15-5-2-1-3-6-15)20(28-16)14-9-10-24-18(13-14)29-23(31)22-25-11-12-26-22/h1-3,5-6,9-13,27-28H,4,7-8H2,(H,25,26)(H,24,29,31) RZVJBBKXZQYFPZ-UHFFFAOYSA-N 415169 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-imidazole-2-carboxamide::US10428044, Example 274 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 48.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415169&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607321 433915210 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828931 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccn[nH]1 InChI=1S/C23H20N6O2/c30-18-8-4-7-16-20(18)22(26-15-5-2-1-3-6-15)21(27-16)14-9-11-24-19(13-14)28-23(31)17-10-12-25-29-17/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,25,29)(H,24,28,31) JWIBSFGGKXRNJO-UHFFFAOYSA-N 415170 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-5-carboxamide::US10428044, Example 275 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415170&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607400 433915211 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828932 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccsn1 InChI=1S/C23H19N5O2S/c29-18-8-4-7-16-20(18)22(25-15-5-2-1-3-6-15)21(26-16)14-9-11-24-19(13-14)27-23(30)17-10-12-31-28-17/h1-3,5-6,9-13,25-26H,4,7-8H2,(H,24,27,30) KMIDWBCGAXUVNS-UHFFFAOYSA-N 415171 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,2-thiazole-3-carboxamide::US10428044, Example 276::US10428044, Example 277 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415171&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607104 433915212 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828933 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccsn1 InChI=1S/C23H19N5O2S/c29-18-8-4-7-16-20(18)22(25-15-5-2-1-3-6-15)21(26-16)14-9-11-24-19(13-14)27-23(30)17-10-12-31-28-17/h1-3,5-6,9-13,25-26H,4,7-8H2,(H,24,27,30) KMIDWBCGAXUVNS-UHFFFAOYSA-N 415171 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,2-thiazole-3-carboxamide::US10428044, Example 276::US10428044, Example 277 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.52 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415171&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607104 433915212 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828934 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cocn1 InChI=1S/C23H19N5O3/c29-18-8-4-7-16-20(18)22(26-15-5-2-1-3-6-15)21(27-16)14-9-10-24-19(11-14)28-23(30)17-12-31-13-25-17/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,24,28,30) FANVPGPRYNHCNJ-UHFFFAOYSA-N 415173 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-oxazole-4-carboxamide::US10428044, Example 278 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415173&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606710 433915213 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828935 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cccnc1 InChI=1S/C25H21N5O2/c31-20-10-4-9-19-22(20)24(28-18-7-2-1-3-8-18)23(29-19)16-11-13-27-21(14-16)30-25(32)17-6-5-12-26-15-17/h1-3,5-8,11-15,28-29H,4,9-10H2,(H,27,30,32) SDGJXHIVKHTDFY-UHFFFAOYSA-N 415174 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}pyridine-3-carboxamide::US10428044, Example 279 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415174&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606913 433915214 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828936 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1ccns1 InChI=1S/C23H19N5O2S/c29-17-8-4-7-16-20(17)22(26-15-5-2-1-3-6-15)21(27-16)14-9-11-24-19(13-14)28-23(30)18-10-12-25-31-18/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,24,28,30) AOLKHIDOHYBADZ-UHFFFAOYSA-N 415175 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,2-thiazole-5-carboxamide::US10428044, Example 280 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415175&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606882 433915215 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828937 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cnn[nH]1 InChI=1S/C22H19N7O2/c30-17-8-4-7-15-19(17)21(25-14-5-2-1-3-6-14)20(26-15)13-9-10-23-18(11-13)27-22(31)16-12-24-29-28-16/h1-3,5-6,9-12,25-26H,4,7-8H2,(H,23,27,31)(H,24,28,29) QCMQZZYIKUFLTA-UHFFFAOYSA-N 415176 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-1,2,3-triazole-5-carboxamide::US10428044, Example 281 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415176&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606958 433915216 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828938 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cnco1 InChI=1S/C23H19N5O3/c29-17-8-4-7-16-20(17)22(26-15-5-2-1-3-6-15)21(27-16)14-9-10-25-19(11-14)28-23(30)18-12-24-13-31-18/h1-3,5-6,9-13,26-27H,4,7-8H2,(H,25,28,30) XAZRBBLQMVORAO-UHFFFAOYSA-N 415177 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-oxazole-5-carboxamide::US10428044, Example 282 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.72 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415177&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606833 433915217 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828939 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1nnn[nH]1 InChI=1S/C21H18N8O2/c30-15-8-4-7-14-17(15)19(23-13-5-2-1-3-6-13)18(24-14)12-9-10-22-16(11-12)25-21(31)20-26-28-29-27-20/h1-3,5-6,9-11,23-24H,4,7-8H2,(H,22,25,31)(H,26,27,28,29) SCIZHTZAXGFJBV-UHFFFAOYSA-N 415178 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-tetrazole-5-carboxamide::US10428044, Example 283 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415178&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606856 433915218 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828940 O=C(Cc1ccc[nH]1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H23N5O2/c31-20-10-4-9-19-23(20)25(28-17-6-2-1-3-7-17)24(29-19)16-11-13-27-21(14-16)30-22(32)15-18-8-5-12-26-18/h1-3,5-8,11-14,26,28-29H,4,9-10,15H2,(H,27,30,32) ZDFOVZSVYFRBEX-UHFFFAOYSA-N 415179 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(1H-pyrrol-2-yl)acetamide::US10428044, Example 284 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415179&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607180 433915219 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828941 O=C(Cc1nccs1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H21N5O2S/c30-18-8-4-7-17-22(18)24(27-16-5-2-1-3-6-16)23(28-17)15-9-10-25-19(13-15)29-20(31)14-21-26-11-12-32-21/h1-3,5-6,9-13,27-28H,4,7-8,14H2,(H,25,29,31) WWTQNYHSZHZNDS-UHFFFAOYSA-N 415180 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(1,3-thiazol-2-yl)acetamide::US10428044, Example 285 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 30.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415180&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607112 433915220 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828942 O=C(Cc1cc[nH]c1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H23N5O2/c31-20-8-4-7-19-23(20)25(28-18-5-2-1-3-6-18)24(29-19)17-10-12-27-21(14-17)30-22(32)13-16-9-11-26-15-16/h1-3,5-6,9-12,14-15,26,28-29H,4,7-8,13H2,(H,27,30,32) NLGQIDQPMVYWBE-UHFFFAOYSA-N 415181 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(1H-pyrrol-3-yl)acetamide::US10428044, Example 286 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 21.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415181&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607404 433915221 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828943 O=C(Cc1cscn1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H21N5O2S/c30-19-8-4-7-18-22(19)24(27-16-5-2-1-3-6-16)23(28-18)15-9-10-25-20(11-15)29-21(31)12-17-13-32-14-26-17/h1-3,5-6,9-11,13-14,27-28H,4,7-8,12H2,(H,25,29,31) OQLJFUVKIMWSLG-UHFFFAOYSA-N 415182 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(1,3-thiazol-4-yl)acetamide::US10428044, Example 287 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 48.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415182&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607253 433915222 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828944 O=C(Cc1ccco1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N4O3/c30-20-10-4-9-19-23(20)25(27-17-6-2-1-3-7-17)24(28-19)16-11-12-26-21(14-16)29-22(31)15-18-8-5-13-32-18/h1-3,5-8,11-14,27-28H,4,9-10,15H2,(H,26,29,31) APXGIBSHQOZMAW-UHFFFAOYSA-N 415183 Preparation of 2-(furan-2-yl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 288 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415183&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607110 433915223 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828945 Cc1cc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)on1 InChI=1S/C25H23N5O3/c1-15-12-18(33-30-15)14-22(32)29-21-13-16(10-11-26-21)24-25(27-17-6-3-2-4-7-17)23-19(28-24)8-5-9-20(23)31/h2-4,6-7,10-13,27-28H,5,8-9,14H2,1H3,(H,26,29,32) NJIGFPIYPHBFNJ-UHFFFAOYSA-N 415184 Preparation of 2-(3-methyl-1,2-oxazol-5-yl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 289 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415184&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607025 433915224 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828946 O=C(Cc1cccs1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N4O2S/c30-20-10-4-9-19-23(20)25(27-17-6-2-1-3-7-17)24(28-19)16-11-12-26-21(14-16)29-22(31)15-18-8-5-13-32-18/h1-3,5-8,11-14,27-28H,4,9-10,15H2,(H,26,29,31) LTMYXFSNOYWZSN-UHFFFAOYSA-N 415185 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(thiophen-2-yl)acetamide::US10428044, Example 290::US10428044, Example 291 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415185&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607370 433915225 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828947 O=C(Cc1cccs1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N4O2S/c30-20-10-4-9-19-23(20)25(27-17-6-2-1-3-7-17)24(28-19)16-11-12-26-21(14-16)29-22(31)15-18-8-5-13-32-18/h1-3,5-8,11-14,27-28H,4,9-10,15H2,(H,26,29,31) LTMYXFSNOYWZSN-UHFFFAOYSA-N 415185 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(thiophen-2-yl)acetamide::US10428044, Example 290::US10428044, Example 291 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415185&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607370 433915225 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828948 Cn1nccc1CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H24N6O2/c1-31-18(11-13-27-31)15-22(33)30-21-14-16(10-12-26-21)24-25(28-17-6-3-2-4-7-17)23-19(29-24)8-5-9-20(23)32/h2-4,6-7,10-14,28-29H,5,8-9,15H2,1H3,(H,26,30,33) BUCQKVGLIWWXMS-UHFFFAOYSA-N 415187 Preparation of 2-(1-methyl-1H-pyrazol-5-yl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 292 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 340 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415187&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607086 433915226 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828949 CC(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1 InChI=1S/C23H22N4O2/c1-14(28)25-19-11-15(7-10-24-19)21-22(26-16-5-3-2-4-6-16)20-17(27-21)12-23(8-9-23)13-18(20)29/h2-7,10-11,26-27H,8-9,12-13H2,1H3,(H,24,25,28) XDSBRJFLPBEYLV-UHFFFAOYSA-N 415188 Preparation of N-{4-[4′-oxo-3′-(phenylamino)-1′,4′,5′,7′-tetrahydrospiro[cyclopropane-1,6′-indol]-2′-yl]pyridin-2-yl}acetamide::US10428044, Example 293 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415188&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606972 433915227 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828950 O=C(Nc1cc(ccn1)-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1)C1CC1 InChI=1S/C25H24N4O2/c30-19-14-25(9-10-25)13-18-21(19)23(27-17-4-2-1-3-5-17)22(28-18)16-8-11-26-20(12-16)29-24(31)15-6-7-15/h1-5,8,11-12,15,27-28H,6-7,9-10,13-14H2,(H,26,29,31) OYAOCYGJGYNVTI-UHFFFAOYSA-N 415189 Preparation of N-{4-[4′-oxo-3′-(phenylamino)-1′,4′,5′,7′-tetrahydrospiro[cyclopropane-1,6′-indol]-2′-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 294 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.17 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415189&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606876 433915228 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828951 CC(C)(C)OC(=O)N1CC(C1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C28H31N5O4/c1-28(2,3)37-27(36)33-15-18(16-33)26(35)32-22-14-17(12-13-29-22)24-25(30-19-8-5-4-6-9-19)23-20(31-24)10-7-11-21(23)34/h4-6,8-9,12-14,18,30-31H,7,10-11,15-16H2,1-3H3,(H,29,32,35) STPAKPUSLBRZAY-UHFFFAOYSA-N 415190 Preparation of tert-butyl 3-({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}carbamoyl)azetidine-1-carboxylate::US10428044, Example 295 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415190&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606922 433915229 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828952 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1CNC1 InChI=1S/C23H23N5O2/c29-18-8-4-7-17-20(18)22(26-16-5-2-1-3-6-16)21(27-17)14-9-10-25-19(11-14)28-23(30)15-12-24-13-15/h1-3,5-6,9-11,15,24,26-27H,4,7-8,12-13H2,(H,25,28,30) KWSAVHPPLHGNGL-UHFFFAOYSA-N 415191 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}azetidine-3-carboxamide::US10428044, Example 296 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3450 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415191&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606843 433915230 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828953 CN(CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C(=O)OC(C)(C)C InChI=1S/C27H31N5O4/c1-27(2,3)36-26(35)32(4)16-22(34)31-21-15-17(13-14-28-21)24-25(29-18-9-6-5-7-10-18)23-19(30-24)11-8-12-20(23)33/h5-7,9-10,13-15,29-30H,8,11-12,16H2,1-4H3,(H,28,31,34) POEFQBQXFLENHB-UHFFFAOYSA-N 415192 Preparation of tert-butyl methyl[2-oxo-2-({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}amino)ethyl]carbamate::US10428044, Example 297 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 271 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415192&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607183 433915231 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828954 CN(CCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C(=O)OC(C)(C)C InChI=1S/C28H33N5O4/c1-28(2,3)37-27(36)33(4)16-14-23(35)32-22-17-18(13-15-29-22)25-26(30-19-9-6-5-7-10-19)24-20(31-25)11-8-12-21(24)34/h5-7,9-10,13,15,17,30-31H,8,11-12,14,16H2,1-4H3,(H,29,32,35) SJSCDQQAFVXHBY-UHFFFAOYSA-N 415193 Preparation of tert-butyl methyl[3-oxo-3-({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}amino)propyl]carbamate::US10428044, Example 299 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 74.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415193&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606938 433915232 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828955 CNCCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5O2/c1-24-12-11-20(30)28-19-14-15(10-13-25-19)22-23(26-16-6-3-2-4-7-16)21-17(27-22)8-5-9-18(21)29/h2-4,6-7,10,13-14,24,26-27H,5,8-9,11-12H2,1H3,(H,25,28,30) CJWYGHKWPURGAH-UHFFFAOYSA-N 415194 Preparation of N2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-beta-alaninamide::US10428044, Example 300 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 475 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415194&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606999 433915233 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828956 C[C@@H](N(C)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415195 Preparation of tert-butyl methyl[(2R)-1-oxo-1-({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}amino)propan-2-yl]carbamate::US10428044, Example 301 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 738 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415195&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606839 433915234 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828957 CN[C@H](C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415196 Preparation of N2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-D-alaninamide::US10428044, Example 302 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 480 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415196&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607251 433915235 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828958 C[C@H](N(C)C(=O)OC(C)(C)C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415197 Preparation of tert-butyl methyl[(2S)-1-oxo-1-({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}amino)propan-2-yl]carbamate::US10428044, Example 303 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1410 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415197&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606741 433915236 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828959 CN[C@@H](C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415198 Preparation of N2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-L-alaninamide::US10428044, Example 304 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 174 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415198&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607164 433915237 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828960 CNC(C)(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H27N5O2/c1-24(2,25-3)23(31)29-19-14-15(12-13-26-19)21-22(27-16-8-5-4-6-9-16)20-17(28-21)10-7-11-18(20)30/h4-6,8-9,12-14,25,27-28H,7,10-11H2,1-3H3,(H,26,29,31) LTWZAADQKJFUPV-UHFFFAOYSA-N 415199 Preparation of N2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}alaninamide::US10428044, Example 306 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3990 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415199&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613251 433915238 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828961 CN(C)CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5O2/c1-28(2)14-20(30)27-19-13-15(11-12-24-19)22-23(25-16-7-4-3-5-8-16)21-17(26-22)9-6-10-18(21)29/h3-5,7-8,11-13,25-26H,6,9-10,14H2,1-2H3,(H,24,27,30) VSHVHPARKKSQCU-UHFFFAOYSA-N 415200 Preparation of N2,N2;-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}glycinamide::US10428044, Example 307 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 208 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415200&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613391 433915239 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828962 O=C(CN1CCCC1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H27N5O2/c31-20-10-6-9-19-23(20)25(27-18-7-2-1-3-8-18)24(28-19)17-11-12-26-21(15-17)29-22(32)16-30-13-4-5-14-30/h1-3,7-8,11-12,15,27-28H,4-6,9-10,13-14,16H2,(H,26,29,32) FHMDYLBLCMPPAK-UHFFFAOYSA-N 415201 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(pyrrolidin-1-yl)acetamide::US10428044, Example 308 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 234 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415201&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607382 433915240 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828963 CN1CCCC1C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415202 Preparation of 1-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-prolinamide::US10428044, Example 309 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 238 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415202&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613275 433915241 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828964 CN1C(CCC1=O)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415203 Preparation of 1-methyl-5-oxo-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-prolinamide::US10428044, Example 310 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 127 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415203&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613222 433915242 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828965 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)C1CCC(=O)N1 415204 Preparation of 5-oxo-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-prolinamide::US10428044, Example 311 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415204&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613406 433915243 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828966 COC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1cccc(F)c1 InChI=1S/C21H19FN4O3/c1-29-21(28)26-17-10-12(8-9-23-17)19-20(24-14-5-2-4-13(22)11-14)18-15(25-19)6-3-7-16(18)27/h2,4-5,8-11,24-25H,3,6-7H2,1H3,(H,23,26,28) SSUSLLFTNLUUHV-UHFFFAOYSA-N 415205 Preparation of methyl (4-{3-[(3-fluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)carbamate::US10428044, Example 312 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415205&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613457 433915244 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828967 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccc(F)cc1 InChI=1S/C21H19FN4O2/c1-12(27)24-18-11-13(9-10-23-18)20-21(25-15-7-5-14(22)6-8-15)19-16(26-20)3-2-4-17(19)28/h5-11,25-26H,2-4H2,1H3,(H,23,24,27) HNQPXQJOGKFBLV-UHFFFAOYSA-N 415206 Preparation of methyl N-(4-{3-[(4-fluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)acetamide::US10428044, Example 313 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415206&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606903 433915245 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828968 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccnc(NC(=O)C3CC3)c2)cc1 InChI=1S/C23H21FN4O2/c24-15-6-8-16(9-7-15)26-22-20-17(2-1-3-18(20)29)27-21(22)14-10-11-25-19(12-14)28-23(30)13-4-5-13/h6-13,26-27H,1-5H2,(H,25,28,30) IHGWFULERXRIIM-UHFFFAOYSA-N 415207 Preparation of N-(4-{3-[(4-fluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)cyclopropanecarboxamide::US10428044, Example 314 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 47.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415207&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607032 433915246 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828969 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccc(F)c(F)c1 InChI=1S/C21H18F2N4O2/c1-11(28)25-18-9-12(7-8-24-18)20-21(19-16(27-20)3-2-4-17(19)29)26-13-5-6-14(22)15(23)10-13/h5-10,26-27H,2-4H2,1H3,(H,24,25,28) SPRDMCZPCYPONY-UHFFFAOYSA-N 415208 Preparation of N-(4-{3-[(3,4-difluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)acetamide::US10428044, Example 315 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 101 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415208&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606932 433915247 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828970 Fc1ccc(Nc2c([nH]c3CCCC(=O)c23)-c2ccnc(NC(=O)C3CC3)c2)cc1F InChI=1S/C23H20F2N4O2/c24-15-7-6-14(11-16(15)25)27-22-20-17(2-1-3-18(20)30)28-21(22)13-8-9-26-19(10-13)29-23(31)12-4-5-12/h6-12,27-28H,1-5H2,(H,26,29,31) KJEXDOARFTZEIZ-UHFFFAOYSA-N 415209 Preparation of N-(4-{3-[(3,4-difluorophenyl)amino]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}pyridin-2-yl)cyclopropanecarboxamide::US10428044, Example 316 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 82.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415209&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607229 433915248 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828971 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(C)=O)c1 415210 Preparation of N-{4-[4-oxo-3-(phenylamino)-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 317 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415210&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606815 433915249 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828972 CC(C)C1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)C2CC2)c1 415211 Preparation of N-{4-[4-oxo-3-(phenylamino)-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 318 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.71 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415211&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606727 433915250 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828973 CC(C)C1Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(NC(C)=O)c1 415212 Preparation of N-{4-[3-[(3-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 319 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.69 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415212&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606808 433915251 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828974 CC(C)C1Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(NC(=O)C2CC2)c1 415213 Preparation of N-{4-[3-[(3-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 320 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.04 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415213&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606959 433915252 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828975 CC(C)C1Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccnc(NC(C)=O)c1 415214 Preparation of N-{4-[3-[(4-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 321::US10428044, Example 323::US10428044, Example 324 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415214&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607121 433915253 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828976 CC(C)C1Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccnc(NC(=O)C2CC2)c1 415215 Preparation of N-{4-[3-[(4-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 322 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415215&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606761 433915254 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828977 CC(C)C1Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccnc(NC(C)=O)c1 415214 Preparation of N-{4-[3-[(4-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 321::US10428044, Example 323::US10428044, Example 324 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 21.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415214&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607121 433915253 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828978 CC(C)C1Cc2[nH]c(c(Nc3ccc(F)cc3)c2C(=O)C1)-c1ccnc(NC(C)=O)c1 415214 Preparation of N-{4-[3-[(4-fluorophenyl)amino]-4-oxo-6-(propan-2-yl)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 321::US10428044, Example 323::US10428044, Example 324 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415214&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607121 433915253 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828979 COCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22N4O3/c1-29-13-19(28)26-18-12-14(10-11-23-18)21-22(24-15-6-3-2-4-7-15)20-16(25-21)8-5-9-17(20)27/h2-4,6-7,10-12,24-25H,5,8-9,13H2,1H3,(H,23,26,28) KCFZWRJBGRNQBT-UHFFFAOYSA-N 415218 Preparation of 2-methoxy-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 325 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415218&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607214 433915255 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828980 COC(C)(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H26N4O3/c1-24(2,31-3)23(30)28-19-14-15(12-13-25-19)21-22(26-16-8-5-4-6-9-16)20-17(27-21)10-7-11-18(20)29/h4-6,8-9,12-14,26-27H,7,10-11H2,1-3H3,(H,25,28,30) XYBAPCSUQDBVGQ-UHFFFAOYSA-N 415219 Preparation of 2-methoxy-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 326 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 608 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415219&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607130 433915256 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828981 CC(C)(O)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H24N4O3/c1-23(2,30)22(29)27-18-13-14(11-12-24-18)20-21(25-15-7-4-3-5-8-15)19-16(26-20)9-6-10-17(19)28/h3-5,7-8,11-13,25-26,30H,6,9-10H2,1-2H3,(H,24,27,29) ADKUMUMMIAEKCN-UHFFFAOYSA-N 415220 Preparation of 2-hydroxy-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 327 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 280 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415220&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606927 433915257 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828982 CCOC(C)(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H28N4O3/c1-4-32-25(2,3)24(31)29-20-15-16(13-14-26-20)22-23(27-17-9-6-5-7-10-17)21-18(28-22)11-8-12-19(21)30/h5-7,9-10,13-15,27-28H,4,8,11-12H2,1-3H3,(H,26,29,31) HHGQHWLAFTWNAU-UHFFFAOYSA-N 415221 Preparation of (2-ethoxy-2-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 328 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 524 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415221&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607127 433915258 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828983 COC(C)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415222 Preparation of (2-methoxy-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}propanamide::US10428044, Example 329 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 65.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415222&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606908 433915259 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828984 CCCOCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H26N4O3/c1-2-13-31-15-21(30)28-20-14-16(11-12-25-20)23-24(26-17-7-4-3-5-8-17)22-18(27-23)9-6-10-19(22)29/h3-5,7-8,11-12,14,26-27H,2,6,9-10,13,15H2,1H3,(H,25,28,30) VTXDJSDOADKCKE-UHFFFAOYSA-N 415223 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-propoxyacetamide::US10428044, Example 330 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.83 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415223&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606764 433915260 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828985 CC(C)COCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H28N4O3/c1-16(2)14-32-15-22(31)29-21-13-17(11-12-26-21)24-25(27-18-7-4-3-5-8-18)23-19(28-24)9-6-10-20(23)30/h3-5,7-8,11-13,16,27-28H,6,9-10,14-15H2,1-2H3,(H,26,29,31) MVLJLUVDKCICIH-UHFFFAOYSA-N 415224 Preparation of 2-(2-methylpropoxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 331 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415224&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606846 433915261 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828986 FC(F)(F)C(F)(F)COCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H21F5N4O3/c25-23(26,24(27,28)29)13-36-12-19(35)33-18-11-14(9-10-30-18)21-22(31-15-5-2-1-3-6-15)20-16(32-21)7-4-8-17(20)34/h1-3,5-6,9-11,31-32H,4,7-8,12-13H2,(H,30,33,35) AKOMUVHGRZKMPI-UHFFFAOYSA-N 415225 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(2,2,3,3-tetrafluoropropoxy)acetamide::US10428044, Example 332 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415225&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613458 433915262 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828987 CCCCOCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H28N4O3/c1-2-3-14-32-16-22(31)29-21-15-17(12-13-26-21)24-25(27-18-8-5-4-6-9-18)23-19(28-24)10-7-11-20(23)30/h4-6,8-9,12-13,15,27-28H,2-3,7,10-11,14,16H2,1H3,(H,26,29,31) UANSSOYQZHPVGF-UHFFFAOYSA-N 415226 Preparation of 2-butoxy-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 333 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.33 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415226&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606911 433915263 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828988 CCOCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H24N4O3/c1-2-30-14-20(29)27-19-13-15(11-12-24-19)22-23(25-16-7-4-3-5-8-16)21-17(26-22)9-6-10-18(21)28/h3-5,7-8,11-13,25-26H,2,6,9-10,14H2,1H3,(H,24,27,29) GHYDUYRCTDRWCH-UHFFFAOYSA-N 415227 Preparation of 2-ethoxy-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 334 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.36 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415227&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607031 433915264 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828989 C=CCOCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H24N4O3/c1-2-13-31-15-21(30)28-20-14-16(11-12-25-20)23-24(26-17-7-4-3-5-8-17)22-18(27-23)9-6-10-19(22)29/h2-5,7-8,11-12,14,26-27H,1,6,9-10,13,15H2,(H,25,28,30) UYEMNXGEQKFCRD-UHFFFAOYSA-N 415228 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(prop-2-en-1-yloxy)acetamide::US10428044, Example 335 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.90 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415228&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606752 433915265 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828990 O=C(COCC#C)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H22N4O3/c1-2-13-31-15-21(30)28-20-14-16(11-12-25-20)23-24(26-17-7-4-3-5-8-17)22-18(27-23)9-6-10-19(22)29/h1,3-5,7-8,11-12,14,26-27H,6,9-10,13,15H2,(H,25,28,30) CXAQWUXYJHVALP-UHFFFAOYSA-N 415229 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(prop-2-yn-1-yloxy)acetamide::US10428044, Example 336 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.53 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415229&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607316 433915266 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828991 O=C(COc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H24N4O3/c32-22-13-7-12-21-25(22)27(29-19-8-3-1-4-9-19)26(30-21)18-14-15-28-23(16-18)31-24(33)17-34-20-10-5-2-6-11-20/h1-6,8-11,14-16,29-30H,7,12-13,17H2,(H,28,31,33) VVMLVCZGIXWNMB-UHFFFAOYSA-N 415230 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-phenoxyacetamide::US10428044, Example 337 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 22.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415230&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606735 433915267 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828992 Fc1cccc(OCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)c1 InChI=1S/C27H23FN4O3/c28-18-6-4-9-20(15-18)35-16-24(34)32-23-14-17(12-13-29-23)26-27(30-19-7-2-1-3-8-19)25-21(31-26)10-5-11-22(25)33/h1-4,6-9,12-15,30-31H,5,10-11,16H2,(H,29,32,34) PPAQJPMUYDSZES-UHFFFAOYSA-N 415231 Preparation of 2-(3-fluorophenoxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 338 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 31.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415231&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606859 433915268 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828993 Fc1ccccc1OCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H23FN4O3/c28-19-9-4-5-12-22(19)35-16-24(34)32-23-15-17(13-14-29-23)26-27(30-18-7-2-1-3-8-18)25-20(31-26)10-6-11-21(25)33/h1-5,7-9,12-15,30-31H,6,10-11,16H2,(H,29,32,34) OQQOLQKNLAVJSO-UHFFFAOYSA-N 415232 Preparation of 2-(2-fluorophenoxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 339 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 39.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415232&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606772 433915269 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828994 O=C(COCc1ccccc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C28H26N4O3/c33-23-13-7-12-22-26(23)28(30-21-10-5-2-6-11-21)27(31-22)20-14-15-29-24(16-20)32-25(34)18-35-17-19-8-3-1-4-9-19/h1-6,8-11,14-16,30-31H,7,12-13,17-18H2,(H,29,32,34) ZNXYZMPTTSQSAE-UHFFFAOYSA-N 415233 Preparation of 2-(benzyloxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 340 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.25 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415233&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607126 433915270 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828995 Fc1ccc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C28H25FN4O3/c29-20-11-9-18(10-12-20)16-36-17-25(35)33-24-15-19(13-14-30-24)27-28(31-21-5-2-1-3-6-21)26-22(32-27)7-4-8-23(26)34/h1-3,5-6,9-15,31-32H,4,7-8,16-17H2,(H,30,33,35) RVEZNXWCYAYWJJ-UHFFFAOYSA-N 415234 Preparation of 2-[(4-fluorobenzyl)oxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 341 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.89 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415234&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606990 433915271 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828996 COc1ccc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C29H28N4O4/c1-36-22-12-10-19(11-13-22)17-37-18-26(35)33-25-16-20(14-15-30-25)28-29(31-21-6-3-2-4-7-21)27-23(32-28)8-5-9-24(27)34/h2-4,6-7,10-16,31-32H,5,8-9,17-18H2,1H3,(H,30,33,35) WQKSNBBGJOOZKW-UHFFFAOYSA-N 415235 Preparation of 2-[(4-methoxybenzyl)oxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 342 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.12 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415235&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606830 433915272 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828997 O=C(COCC1CCCCO1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415236 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-[(2S)-tetrahydro-2H-pyran-2-ylmethoxy]acetamide::US10428044, Example 343 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.45 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415236&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606716 433915273 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828998 O=C(COc1ccsc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N4O3S/c30-20-8-4-7-19-23(20)25(27-17-5-2-1-3-6-17)24(28-19)16-9-11-26-21(13-16)29-22(31)14-32-18-10-12-33-15-18/h1-3,5-6,9-13,15,27-28H,4,7-8,14H2,(H,26,29,31) LRUZVJMAFRVMJY-UHFFFAOYSA-N 415237 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(thiophen-3-yloxy)acetamide::US10428044, Example 344 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415237&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606867 433915274 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 828999 Clc1sccc1OCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H21ClN4O3S/c26-25-19(10-12-34-25)33-14-21(32)30-20-13-15(9-11-27-20)23-24(28-16-5-2-1-3-6-16)22-17(29-23)7-4-8-18(22)31/h1-3,5-6,9-13,28-29H,4,7-8,14H2,(H,27,30,32) RVWSNWLZJMPZCP-UHFFFAOYSA-N 415238 Preparation of 2-[(2-chlorothiophen-3-yl)oxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 345 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 72.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415238&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606677 433915275 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829000 Cc1cc(OCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)no1 InChI=1S/C25H23N5O4/c1-15-12-22(30-34-15)33-14-21(32)29-20-13-16(10-11-26-20)24-25(27-17-6-3-2-4-7-17)23-18(28-24)8-5-9-19(23)31/h2-4,6-7,10-13,27-28H,5,8-9,14H2,1H3,(H,26,29,32) YRHREYIRUMPWBN-UHFFFAOYSA-N 415239 Preparation of 2-[(5-methyl-1,2-oxazol-3-yl)oxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 346 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.88 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415239&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607151 433915276 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829001 O=C(COc1ccccn1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H23N5O3/c32-20-10-6-9-19-24(20)26(29-18-7-2-1-3-8-18)25(30-19)17-12-14-27-21(15-17)31-22(33)16-34-23-11-4-5-13-28-23/h1-5,7-8,11-15,29-30H,6,9-10,16H2,(H,27,31,33) WWDAFIPJAFGRGW-UHFFFAOYSA-N 415240 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(pyridin-2-yloxy)acetamide::US10428044, Example 347 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 101 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415240&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606979 433915277 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829002 O=C(COc1ccon1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H21N5O4/c30-18-8-4-7-17-22(18)24(26-16-5-2-1-3-6-16)23(27-17)15-9-11-25-19(13-15)28-20(31)14-32-21-10-12-33-29-21/h1-3,5-6,9-13,26-27H,4,7-8,14H2,(H,25,28,31) XJNQKHIQEROYGL-UHFFFAOYSA-N 415241 Preparation of 2-(1,2-oxazol-3-yloxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 348 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415241&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606970 433915278 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829003 Cc1noc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)n1 InChI=1S/C25H24N6O4/c1-15-27-22(35-31-15)14-34-13-21(33)30-20-12-16(10-11-26-20)24-25(28-17-6-3-2-4-7-17)23-18(29-24)8-5-9-19(23)32/h2-4,6-7,10-12,28-29H,5,8-9,13-14H2,1H3,(H,26,30,33) OGMOFDRAYZJTOC-UHFFFAOYSA-N 415242 Preparation of 2-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 349 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.19 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415242&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606931 433915279 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829004 Cc1cc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)on1 InChI=1S/C26H25N5O4/c1-16-12-19(35-31-16)14-34-15-23(33)30-22-13-17(10-11-27-22)25-26(28-18-6-3-2-4-7-18)24-20(29-25)8-5-9-21(24)32/h2-4,6-7,10-13,28-29H,5,8-9,14-15H2,1H3,(H,27,30,33) FUUPLIYAGCJISG-UHFFFAOYSA-N 415243 Preparation of 2-[(3-methyl-1,2-oxazol-5-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 350 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.53 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415243&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606934 433915280 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829005 Cn1nccc1COCC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H26N6O3/c1-32-19(11-13-28-32)15-35-16-23(34)31-22-14-17(10-12-27-22)25-26(29-18-6-3-2-4-7-18)24-20(30-25)8-5-9-21(24)33/h2-4,6-7,10-14,29-30H,5,8-9,15-16H2,1H3,(H,27,31,34) FTDOBKDNPZEJEJ-UHFFFAOYSA-N 415244 Preparation of 2-[(1-methyl-1H-pyrazol-5-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 351 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.22 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415244&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607048 433915281 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829006 O=C(COCc1ccco1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H24N4O4/c31-21-10-4-9-20-24(21)26(28-18-6-2-1-3-7-18)25(29-20)17-11-12-27-22(14-17)30-23(32)16-33-15-19-8-5-13-34-19/h1-3,5-8,11-14,28-29H,4,9-10,15-16H2,(H,27,30,32) RWLNXBWKAKEPKW-UHFFFAOYSA-N 415245 Preparation of 2-(furan-2-ylmethoxy)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 352 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.68 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415245&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606668 433915282 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829007 Cc1nnc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)o1 InChI=1S/C25H24N6O4/c1-15-30-31-22(35-15)14-34-13-21(33)29-20-12-16(10-11-26-20)24-25(27-17-6-3-2-4-7-17)23-18(28-24)8-5-9-19(23)32/h2-4,6-7,10-12,27-28H,5,8-9,13-14H2,1H3,(H,26,29,33) UQGDTJVVVLLHBK-UHFFFAOYSA-N 415246 Preparation of 2-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 353 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415246&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606947 433915283 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829008 Cc1cc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)no1 InChI=1S/C26H25N5O4/c1-16-12-19(31-35-16)14-34-15-23(33)30-22-13-17(10-11-27-22)25-26(28-18-6-3-2-4-7-18)24-20(29-25)8-5-9-21(24)32/h2-4,6-7,10-13,28-29H,5,8-9,14-15H2,1H3,(H,27,30,33) UDEOWUXYVYUTRT-UHFFFAOYSA-N 415247 Preparation of 2-[(5-methyl-1,2-oxazol-3-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 354 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.57 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415247&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606868 433915284 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829009 Cc1cnc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)o1 InChI=1S/C26H25N5O4/c1-16-13-28-23(35-16)15-34-14-22(33)31-21-12-17(10-11-27-21)25-26(29-18-6-3-2-4-7-18)24-19(30-25)8-5-9-20(24)32/h2-4,6-7,10-13,29-30H,5,8-9,14-15H2,1H3,(H,27,31,33) ATWRZQFBQOYDSP-UHFFFAOYSA-N 415248 Preparation of 2-[(5-methyl-1,3-oxazol-2-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 355 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.45 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415248&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606987 433915285 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829010 Cc1nnc(COCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)s1 InChI=1S/C25H24N6O3S/c1-15-30-31-22(35-15)14-34-13-21(33)29-20-12-16(10-11-26-20)24-25(27-17-6-3-2-4-7-17)23-18(28-24)8-5-9-19(23)32/h2-4,6-7,10-12,27-28H,5,8-9,13-14H2,1H3,(H,26,29,33) UFAFHBPXUAKVGC-UHFFFAOYSA-N 415249 Preparation of 2-[(5-methyl-1,3,4-thiadiazol-2-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 356 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.91 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415249&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606841 433915286 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829011 CC(=O)Nc1cc(ncn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N5O2/c1-13(28)25-18-9-15(23-12-24-18)20-21(26-14-7-5-4-6-8-14)19-16(27-20)10-22(2,3)11-17(19)29/h4-9,12,26-27H,10-11H2,1-3H3,(H,23,24,25,28) HTSQRCCYEKYPSC-UHFFFAOYSA-N 415250 Preparation of N-{6-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyrimidin-4-yl}acetamide::US10428044, Example 357 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3080 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415250&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606905 433915287 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829012 CNc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H20N4O/c1-21-17-12-13(10-11-22-17)19-20(23-14-6-3-2-4-7-14)18-15(24-19)8-5-9-16(18)25/h2-4,6-7,10-12,23-24H,5,8-9H2,1H3,(H,21,22) ZDMUFAHYWBPPJS-UHFFFAOYSA-N 415251 Intermediate 1-10-3::US10428044, Example 358 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1130 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415251&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606778 433915288 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829013 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC2CCC2)c1 InChI=1S/C25H28N4O/c1-25(2)14-19-22(20(30)15-25)24(28-18-7-4-3-5-8-18)23(29-19)16-11-12-26-21(13-16)27-17-9-6-10-17/h3-5,7-8,11-13,17,28-29H,6,9-10,14-15H2,1-2H3,(H,26,27) JLNFRLMYOMPAGU-UHFFFAOYSA-N 415252 Intermediate 1-10-4::US10428044, Example 359 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 208 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415252&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606779 433915289 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829014 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)N1CCC1 InChI=1S/C24H26N4O/c1-24(2)14-18-21(19(29)15-24)23(26-17-7-4-3-5-8-17)22(27-18)16-9-10-25-20(13-16)28-11-6-12-28/h3-5,7-10,13,26-27H,6,11-12,14-15H2,1-2H3 OAKTVSLODLACQG-UHFFFAOYSA-N 415253 Intermediate 1-10-5::US10428044, Example 360 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12700 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415253&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606870 433915290 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829015 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCC(F)(F)F)c1 InChI=1S/C23H23F3N4O/c1-22(2)11-16-19(17(31)12-22)21(29-15-6-4-3-5-7-15)20(30-16)14-8-9-27-18(10-14)28-13-23(24,25)26/h3-10,29-30H,11-13H2,1-2H3,(H,27,28) SLVIYXVOWOMNKC-UHFFFAOYSA-N 415254 Intermediate 1-10-6::US10428044, Example 361 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 600 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415254&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607028 433915291 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829016 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCCC(F)(F)F)c1 InChI=1S/C24H25F3N4O/c1-23(2)13-17-20(18(32)14-23)22(30-16-6-4-3-5-7-16)21(31-17)15-8-10-28-19(12-15)29-11-9-24(25,26)27/h3-8,10,12,30-31H,9,11,13-14H2,1-2H3,(H,28,29) CURDBKWZRCAQTN-UHFFFAOYSA-N 415255 Intermediate 1-10-7::US10428044, Example 362 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 392 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415255&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606703 433915292 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829017 CC(Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1)C(F)F 415256 Intermediate 1-10-9::US10428044, Example 363 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 207 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415256&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607140 433915293 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829018 CC(C)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H24N4O/c1-14(2)24-19-13-15(11-12-23-19)21-22(25-16-7-4-3-5-8-16)20-17(26-21)9-6-10-18(20)27/h3-5,7-8,11-14,25-26H,6,9-10H2,1-2H3,(H,23,24) GXGJQRDBQLNCSQ-UHFFFAOYSA-N 415257 Preparation of 3-(phenylamino)-2-[2-(propan-2-ylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 364 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 502 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415257&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607041 433915294 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829019 FC(F)(F)CCNc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H21F3N4O/c23-22(24,25)10-12-27-18-13-14(9-11-26-18)20-21(28-15-5-2-1-3-6-15)19-16(29-20)7-4-8-17(19)30/h1-3,5-6,9,11,13,28-29H,4,7-8,10,12H2,(H,26,27) COMXBRCZYIITGH-UHFFFAOYSA-N 415258 Preparation of 3-(phenylamino)-2-{2-[(3,3,3-trifluoropropyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 365 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 604 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415258&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606978 433915295 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829020 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCc2ccccc2)c1 InChI=1S/C26H24N4O/c31-22-13-7-12-21-24(22)26(29-20-10-5-2-6-11-20)25(30-21)19-14-15-27-23(16-19)28-17-18-8-3-1-4-9-18/h1-6,8-11,14-16,29-30H,7,12-13,17H2,(H,27,28) FYMOGVQBZJRRMP-UHFFFAOYSA-N 415259 Preparation of 2-[2-(benzylamino)pyridin-4-yl]-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 366 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1660 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415259&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606878 433915296 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829021 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCc2ccncc2)c1 InChI=1S/C25H23N5O/c31-21-8-4-7-20-23(21)25(29-19-5-2-1-3-6-19)24(30-20)18-11-14-27-22(15-18)28-16-17-9-12-26-13-10-17/h1-3,5-6,9-15,29-30H,4,7-8,16H2,(H,27,28) RQYMXPSYMXMXGS-UHFFFAOYSA-N 415260 Preparation of 3-(phenylamino)-2-{2-[(pyridin-4-ylmethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 367 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 291 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415260&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613334 433915297 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829022 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCC2CC2)c1 InChI=1S/C23H24N4O/c28-19-8-4-7-18-21(19)23(26-17-5-2-1-3-6-17)22(27-18)16-11-12-24-20(13-16)25-14-15-9-10-15/h1-3,5-6,11-13,15,26-27H,4,7-10,14H2,(H,24,25) SASVETZAHYIPKB-UHFFFAOYSA-N 415261 Preparation of 2-{2-[(cyclopropylmethyl)amino]pyridin-4-yl}-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 368 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 622 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415261&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607277 433915298 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829023 OC(=O)CNc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H20N4O3/c26-16-8-4-7-15-19(16)21(24-14-5-2-1-3-6-14)20(25-15)13-9-10-22-17(11-13)23-12-18(27)28/h1-3,5-6,9-11,24-25H,4,7-8,12H2,(H,22,23)(H,27,28) DYRLOIUZESPUOO-UHFFFAOYSA-N 415262 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}glycine::US10428044, Example 369 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 362 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415262&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606845 433915299 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829024 CC1(C)OC[C@H](CNc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)O1 415263 Preparation of 2-[2-({[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}amino)pyridin-4-yl]-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 370 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1300 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415263&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613465 433915300 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829025 OC[C@@H](O)CNc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415264 Preparation of 2 2-(2-{[(2S)-2,3-dihydroxypropyl]amino}pyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 371 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1010 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415264&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613267 433915301 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829026 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCc2cccnc2)c1 InChI=1S/C25H23N5O/c31-21-10-4-9-20-23(21)25(29-19-7-2-1-3-8-19)24(30-20)18-11-13-27-22(14-18)28-16-17-6-5-12-26-15-17/h1-3,5-8,11-15,29-30H,4,9-10,16H2,(H,27,28) FCFMBAPFLPAWFH-UHFFFAOYSA-N 415265 Preparation of 3-(phenylamino)-2-{2-[(pyridin-3-ylmethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 372 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9530 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415265&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613466 433915302 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829027 CC(C)(C)OC(=O)N1CC(CNc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)C1 InChI=1S/C28H33N5O3/c1-28(2,3)36-27(35)33-16-18(17-33)15-30-23-14-19(12-13-29-23)25-26(31-20-8-5-4-6-9-20)24-21(32-25)10-7-11-22(24)34/h4-6,8-9,12-14,18,31-32H,7,10-11,15-17H2,1-3H3,(H,29,30) UUBOIKGGMIQKQD-UHFFFAOYSA-N 415266 Preparation of tert-butyl 3-[({4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}amino)methyl]azetidine-1-carboxylate::US10428044, Example 373 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 694 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415266&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606759 433915303 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829028 Cn1nnnc1Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H20N8O/c1-29-21(26-27-28-29)25-17-12-13(10-11-22-17)19-20(23-14-6-3-2-4-7-14)18-15(24-19)8-5-9-16(18)30/h2-4,6-7,10-12,23-24H,5,8-9H2,1H3,(H,22,25,26,28) LGKYJJPBWNGOFG-UHFFFAOYSA-N 415267 Preparation of 2-{2-[(1-methyl-1H-tetrazol-5-yl)amino]pyridin-4-yl}-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 374 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415267&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606773 433915304 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829029 Fc1cccc(Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)c1 InChI=1S/C25H21FN4O/c26-17-6-4-9-19(15-17)28-22-14-16(12-13-27-22)24-25(29-18-7-2-1-3-8-18)23-20(30-24)10-5-11-21(23)31/h1-4,6-9,12-15,29-30H,5,10-11H2,(H,27,28) JNMJIROIGJUWFR-UHFFFAOYSA-N 415268 Preparation of 2-{2-[(3-fluorophenyl)amino]pyridin-4-yl}-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 375 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 330 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415268&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606906 433915305 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829030 CC(C)Nc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H24N4O/c1-14(2)24-18-13-23-12-11-16(18)21-22(25-15-7-4-3-5-8-15)20-17(26-21)9-6-10-19(20)27/h3-5,7-8,11-14,24-26H,6,9-10H2,1-2H3 PLTYJOPQZRCVDJ-UHFFFAOYSA-N 415269 Intermediate 1-10-10::US10428044, Example 376 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2510 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415269&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607099 433915306 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829031 CCNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N5O2/c1-2-23-22(29)27-18-13-14(11-12-24-18)20-21(25-15-7-4-3-5-8-15)19-16(26-20)9-6-10-17(19)28/h3-5,7-8,11-13,25-26H,2,6,9-10H2,1H3,(H2,23,24,27,29) YPKSWXUTOBJBSS-UHFFFAOYSA-N 415270 Preparation of 1-ethyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 377 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 30.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415270&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607042 433915307 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829032 CC(C)NC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5O2/c1-14(2)25-23(30)28-19-13-15(11-12-24-19)21-22(26-16-7-4-3-5-8-16)20-17(27-21)9-6-10-18(20)29/h3-5,7-8,11-14,26-27H,6,9-10H2,1-2H3,(H2,24,25,28,30) UHKOXGSPICRTFV-UHFFFAOYSA-N 415271 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-propan-2-ylurea::US10428044, Example 378 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 64.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415271&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607100 433915308 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829033 O=C(NC1CC1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H23N5O2/c29-18-8-4-7-17-20(18)22(25-15-5-2-1-3-6-15)21(27-17)14-11-12-24-19(13-14)28-23(30)26-16-9-10-16/h1-3,5-6,11-13,16,25,27H,4,7-10H2,(H2,24,26,28,30) OJVPFWYIGFTCBT-UHFFFAOYSA-N 415272 Preparation of 1-cyclopropyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 379 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 36.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415272&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607242 433915309 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829034 CC(C)(C)NC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H27N5O2/c1-24(2,3)29-23(31)28-19-14-15(12-13-25-19)21-22(26-16-8-5-4-6-9-16)20-17(27-21)10-7-11-18(20)30/h4-6,8-9,12-14,26-27H,7,10-11H2,1-3H3,(H2,25,28,29,31) ZCVUPKVAVINZFJ-UHFFFAOYSA-N 415273 Preparation of 1-tert-butyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 380 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 437 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415273&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606717 433915310 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829035 CC(C)CNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H27N5O2/c1-15(2)14-26-24(31)29-20-13-16(11-12-25-20)22-23(27-17-7-4-3-5-8-17)21-18(28-22)9-6-10-19(21)30/h3-5,7-8,11-13,15,27-28H,6,9-10,14H2,1-2H3,(H2,25,26,29,31) QTPSTSLYGJVZMY-UHFFFAOYSA-N 415274 Preparation of 1-(2-methylpropyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 381 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 94.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415274&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607310 433915311 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829036 FC(F)(F)CNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H20F3N5O2/c23-22(24,25)12-27-21(32)30-17-11-13(9-10-26-17)19-20(28-14-5-2-1-3-6-14)18-15(29-19)7-4-8-16(18)31/h1-3,5-6,9-11,28-29H,4,7-8,12H2,(H2,26,27,30,32) QYHCXKVGCYPDHP-UHFFFAOYSA-N 415275 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-(2,2,2-trifluoroethyl)urea::US10428044, Example 382 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 84.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415275&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613412 433915312 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829037 COCCNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5O3/c1-31-13-12-25-23(30)28-19-14-15(10-11-24-19)21-22(26-16-6-3-2-4-7-16)20-17(27-21)8-5-9-18(20)29/h2-4,6-7,10-11,14,26-27H,5,8-9,12-13H2,1H3,(H2,24,25,28,30) KGDUBAGVPKGQEN-UHFFFAOYSA-N 415276 Preparation of 1-(2-methoxyethyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 383 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 69.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415276&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606933 433915313 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829038 O=C(NCc1ccco1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H23N5O3/c31-20-10-4-9-19-22(20)24(28-17-6-2-1-3-7-17)23(29-19)16-11-12-26-21(14-16)30-25(32)27-15-18-8-5-13-33-18/h1-3,5-8,11-14,28-29H,4,9-10,15H2,(H2,26,27,30,32) FFCSTYZXYVTAJY-UHFFFAOYSA-N 415277 Preparation of 1-(furan-2-ylmethyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 384 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 113 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415277&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606851 433915314 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829039 O=C(Nc1ccncc1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N6O2/c32-20-8-4-7-19-22(20)24(28-17-5-2-1-3-6-17)23(30-19)16-9-14-27-21(15-16)31-25(33)29-18-10-12-26-13-11-18/h1-3,5-6,9-15,28,30H,4,7-8H2,(H2,26,27,29,31,33) WNAZRUZHXRKXBW-UHFFFAOYSA-N 415278 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-pyridin-4-ylurea::US10428044, Example 385 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415278&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607217 433915315 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829040 O=C(Nc1ccccn1)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H22N6O2/c32-19-10-6-9-18-22(19)24(28-17-7-2-1-3-8-17)23(29-18)16-12-14-27-21(15-16)31-25(33)30-20-11-4-5-13-26-20/h1-5,7-8,11-15,28-29H,6,9-10H2,(H2,26,27,30,31,33) QGIOROOPCLSSTF-UHFFFAOYSA-N 415279 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-pyridin-2-ylurea::US10428044, Example 386 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415279&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607102 433915316 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829041 FC(F)CNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H21F2N5O2/c23-17(24)12-26-22(31)29-18-11-13(9-10-25-18)20-21(27-14-5-2-1-3-6-14)19-15(28-20)7-4-8-16(19)30/h1-3,5-6,9-11,17,27-28H,4,7-8,12H2,(H2,25,26,29,31) BWGQQAPTIIGPPB-UHFFFAOYSA-N 415280 Preparation of 1-(2,2-difluoroethyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 387 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 63.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415280&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606770 433915317 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829042 ClCCNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H22ClN5O2/c23-10-12-25-22(30)28-18-13-14(9-11-24-18)20-21(26-15-5-2-1-3-6-15)19-16(27-20)7-4-8-17(19)29/h1-3,5-6,9,11,13,26-27H,4,7-8,10,12H2,(H2,24,25,28,30) SOQZZABXFDFJKB-UHFFFAOYSA-N 415281 Preparation of 1-(2-chloroethyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 388 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 43.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415281&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607131 433915318 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829043 CSCCNC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5O2S/c1-31-13-12-25-23(30)28-19-14-15(10-11-24-19)21-22(26-16-6-3-2-4-7-16)20-17(27-21)8-5-9-18(20)29/h2-4,6-7,10-11,14,26-27H,5,8-9,12-13H2,1H3,(H2,24,25,28,30) XNMXPHGUBPGCSB-UHFFFAOYSA-N 415282 Preparation of 1-[2-(methylsulfanyl)ethyl]-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 389 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415282&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607257 433915319 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829044 Cn1cc(NC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cn1 InChI=1S/C24H23N7O2/c1-31-14-17(13-26-31)28-24(33)30-20-12-15(10-11-25-20)22-23(27-16-6-3-2-4-7-16)21-18(29-22)8-5-9-19(21)32/h2-4,6-7,10-14,27,29H,5,8-9H2,1H3,(H2,25,28,30,33) LVFPXVNPHLPCBZ-UHFFFAOYSA-N 415283 Preparation of 1-(1-methyl-1H-pyrazol-4-yl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}urea::US10428044, Example 390 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.96 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415283&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606871 433915320 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829045 Cn1cc(NC(=O)Nc2cc(ccn2)-c2[nH]c3CC(C)(C)CC(=O)c3c2Nc2ccccc2)cn1 InChI=1S/C26H27N7O2/c1-26(2)12-19-22(20(34)13-26)24(29-17-7-5-4-6-8-17)23(31-19)16-9-10-27-21(11-16)32-25(35)30-18-14-28-33(3)15-18/h4-11,14-15,29,31H,12-13H2,1-3H3,(H2,27,30,32,35) RRJJDJXLFOFPRS-UHFFFAOYSA-N 415284 Preparation of 1-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-(1-methyl-1H-pyrazol-4-yl)urea::US10428044, Example 391 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.52 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415284&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607077 433915321 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829046 CNC(=S)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H21N5OS/c1-22-21(28)26-17-12-13(10-11-23-17)19-20(24-14-6-3-2-4-7-14)18-15(25-19)8-5-9-16(18)27/h2-4,6-7,10-12,24-25H,5,8-9H2,1H3,(H2,22,23,26,28) FZPNNOPKTGJUTF-UHFFFAOYSA-N 415285 Preparation of 1-methyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 392 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 87.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415285&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607352 433915322 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829047 CCNC(=S)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N5OS/c1-2-23-22(29)27-18-13-14(11-12-24-18)20-21(25-15-7-4-3-5-8-15)19-16(26-20)9-6-10-17(19)28/h3-5,7-8,11-13,25-26H,2,6,9-10H2,1H3,(H2,23,24,27,29) NQWYNQQNWMLVFZ-UHFFFAOYSA-N 415286 Preparation of 1-ethyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 393 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 233 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415286&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607215 433915323 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829048 FC(F)(F)CNC(=S)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H20F3N5OS/c23-22(24,25)12-27-21(32)30-17-11-13(9-10-26-17)19-20(28-14-5-2-1-3-6-14)18-15(29-19)7-4-8-16(18)31/h1-3,5-6,9-11,28-29H,4,7-8,12H2,(H2,26,27,30,32) URVDFLYFHAYJPD-UHFFFAOYSA-N 415287 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-(2,2,2-trifluoroethyl)thiourea::US10428044, Example 394 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1150 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415287&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613403 433915324 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829049 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NC(=S)NC2CC2)c1 InChI=1S/C23H23N5OS/c29-18-8-4-7-17-20(18)22(25-15-5-2-1-3-6-15)21(27-17)14-11-12-24-19(13-14)28-23(30)26-16-9-10-16/h1-3,5-6,11-13,16,25,27H,4,7-10H2,(H2,24,26,28,30) BUBRSNCYFBQGSX-UHFFFAOYSA-N 415288 Preparation of 1-cyclopropyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 395 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 213 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415288&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606794 433915325 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829050 CC(C)(C)NC(=S)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H27N5OS/c1-24(2,3)29-23(31)28-19-14-15(12-13-25-19)21-22(26-16-8-5-4-6-9-16)20-17(27-21)10-7-11-18(20)30/h4-6,8-9,12-14,26-27H,7,10-11H2,1-3H3,(H2,25,28,29,31) GKAYTBIWGRHYJM-UHFFFAOYSA-N 415289 Preparation of 1-tert-butyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 396 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2460 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415289&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607231 433915326 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829051 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NC(=S)NC2CCCC2)c1 InChI=1S/C25H27N5OS/c31-20-12-6-11-19-22(20)24(27-17-7-2-1-3-8-17)23(29-19)16-13-14-26-21(15-16)30-25(32)28-18-9-4-5-10-18/h1-3,7-8,13-15,18,27,29H,4-6,9-12H2,(H2,26,28,30,32) YKGXEOZVXODJIQ-UHFFFAOYSA-N 415290 Preparation of 1-cyclopentyl-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 397 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1050 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415290&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607138 433915327 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829052 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NC(=S)NCC2CC2)c1 InChI=1S/C24H25N5OS/c30-19-8-4-7-18-21(19)23(27-17-5-2-1-3-6-17)22(28-18)16-11-12-25-20(13-16)29-24(31)26-14-15-9-10-15/h1-3,5-6,11-13,15,27-28H,4,7-10,14H2,(H2,25,26,29,31) HEAWSIXVIXWBHY-UHFFFAOYSA-N 415291 Preparation of 1-(cyclopropylmethyl)-3-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}thiourea::US10428044, Example 398 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 552 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415291&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607318 433915328 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829053 CCCNC(=S)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N5OS/c1-2-12-25-23(30)28-19-14-15(11-13-24-19)21-22(26-16-7-4-3-5-8-16)20-17(27-21)9-6-10-18(20)29/h3-5,7-8,11,13-14,26-27H,2,6,9-10,12H2,1H3,(H2,24,25,28,30) XTGHHKDVUYYRNG-UHFFFAOYSA-N 415292 Preparation of 1-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3-propylthiourea::US10428044, Example 399 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 292 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415292&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606942 433915329 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829054 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)C(F)F InChI=1S/C22H21F2N3O/c1-22(2)11-16-18(17(28)12-22)20(26-14-6-4-3-5-7-14)19(27-16)13-8-9-25-15(10-13)21(23)24/h3-10,21,26-27H,11-12H2,1-2H3 CPUOTHRYJGIZIS-UHFFFAOYSA-N 415293 Intermediate 1-11-13::US10428044, Example 400 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 157 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415293&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607020 433915330 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829055 FC(F)c1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H17F2N3O/c21-20(22)15-11-12(9-10-23-15)18-19(24-13-5-2-1-3-6-13)17-14(25-18)7-4-8-16(17)26/h1-3,5-6,9-11,20,24-25H,4,7-8H2 RBVIDRKFSSENTN-UHFFFAOYSA-N 415294 Intermediate 1-2-62::US10428044, Example 401 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 354 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415294&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607051 433915331 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829056 CC1(C)Cc2[nH]c(c(Nc3cccc(F)c3)c2C(=O)C1)-c1ccnc(c1)C(F)F InChI=1S/C22H20F3N3O/c1-22(2)10-16-18(17(29)11-22)20(27-14-5-3-4-13(23)9-14)19(28-16)12-6-7-26-15(8-12)21(24)25/h3-9,21,27-28H,10-11H2,1-2H3 HGJLNIIULJDHKL-UHFFFAOYSA-N 415295 Preparation of 2-[2-(difluoromethyl)pyridin-4-yl]-3-[(3-fluorophenyl)amino]-6,6-dimethyl-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 402 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 312 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415295&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606696 433915332 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829057 COc1cnccc1-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N3O2/c1-22(2)11-16-19(17(26)12-22)21(24-14-7-5-4-6-8-14)20(25-16)15-9-10-23-13-18(15)27-3/h4-10,13,24-25H,11-12H2,1-3H3 VIBSRYCRZLWZSR-UHFFFAOYSA-N 415296 Intermediate 1-10-11::US10428044, Example 403 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.30 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415296&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606887 433915333 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829058 CCOc1cnccc1-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C23H25N3O2/c1-4-28-19-14-24-11-10-16(19)21-22(25-15-8-6-5-7-9-15)20-17(26-21)12-23(2,3)13-18(20)27/h5-11,14,25-26H,4,12-13H2,1-3H3 LVGOFHSREPTWKA-UHFFFAOYSA-N 415297 Intermediate 1-2-64::US10428044, Example 404 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415297&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607133 433915334 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829059 CCCOc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)CC(C)(C)C1 InChI=1S/C24H29N3O2S/c1-4-12-29-21-16-25-11-10-17(21)15-26-19-13-24(2,3)14-20(28)22(19)23(30)27-18-8-6-5-7-9-18/h5-11,16,26H,4,12-15H2,1-3H3,(H,27,30) WCIZZPOBZNECPJ-UHFFFAOYSA-N 415298 Intermediate 1-2-65::US10428044, Example 405 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.40 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415298&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613414 433915335 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829060 CC(C)Oc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)CC(C)(C)C1 InChI=1S/C24H29N3O2S/c1-16(2)29-21-15-25-11-10-17(21)14-26-19-12-24(3,4)13-20(28)22(19)23(30)27-18-8-6-5-7-9-18/h5-11,15-16,26H,12-14H2,1-4H3,(H,27,30) FZGGPGIZRQRLPA-UHFFFAOYSA-N 415299 Intermediate 1-2-66::US10428044, Example 406 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 53.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415299&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613407 433915336 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829061 CC(C)(C)Oc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)CC(C)(C)C1 InChI=1S/C25H31N3O2S/c1-24(2,3)30-21-16-26-12-11-17(21)15-27-19-13-25(4,5)14-20(29)22(19)23(31)28-18-9-7-6-8-10-18/h6-12,16,27H,13-15H2,1-5H3,(H,28,31) ODPQDPDZGLUKTQ-UHFFFAOYSA-N 415300 Intermediate 1-2-67::US10428044, Example 407 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 600 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415300&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613345 433915337 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829062 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1ccncc1OCC(F)F InChI=1S/C23H25F2N3O2S/c1-23(2)10-17(27-12-15-8-9-26-13-19(15)30-14-20(24)25)21(18(29)11-23)22(31)28-16-6-4-3-5-7-16/h3-9,13,20,27H,10-12,14H2,1-2H3,(H,28,31) DBLNOLHZTORWMQ-UHFFFAOYSA-N 415301 Intermediate 1-2-68::US10428044, Example 408 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.42 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415301&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613462 433915338 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829063 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1ccncc1OCCO InChI=1S/C23H27N3O3S/c1-23(2)12-18(25-14-16-8-9-24-15-20(16)29-11-10-27)21(19(28)13-23)22(30)26-17-6-4-3-5-7-17/h3-9,15,25,27H,10-14H2,1-2H3,(H,26,30) XAWJMKJJCRLDPZ-UHFFFAOYSA-N 415302 Intermediate 1-2-68::US10428044, Example 409 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.63 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415302&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613460 433915339 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829064 COCCOc1cnccc1CNC1=C(C(=S)Nc2ccccc2)C(=O)CC(C)(C)C1 InChI=1S/C24H29N3O3S/c1-24(2)13-19(26-15-17-9-10-25-16-21(17)30-12-11-29-3)22(20(28)14-24)23(31)27-18-7-5-4-6-8-18/h4-10,16,26H,11-15H2,1-3H3,(H,27,31) IGJTVSQKJAJCCD-UHFFFAOYSA-N 415303 Intermediate 1-2-69::US10428044, Example 410 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.55 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415303&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613415 433915340 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829065 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1OCC1CC1 InChI=1S/C25H27N3O2/c1-25(2)12-19-22(20(29)13-25)24(27-17-6-4-3-5-7-17)23(28-19)18-10-11-26-14-21(18)30-15-16-8-9-16/h3-7,10-11,14,16,27-28H,8-9,12-13,15H2,1-2H3 YOTDDOJDOAWRFI-UHFFFAOYSA-N 415304 Intermediate 1-2-70::US10428044, Example 411 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.86 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415304&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606961 433915341 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829066 CC1(C)CC(=O)C(C(=S)Nc2ccccc2)=C(C1)NCc1ccncc1OCC(F)(F)F InChI=1S/C23H24F3N3O2S/c1-22(2)10-17(20(18(30)11-22)21(32)29-16-6-4-3-5-7-16)28-12-15-8-9-27-13-19(15)31-14-23(24,25)26/h3-9,13,28H,10-12,14H2,1-2H3,(H,29,32) KKTRCCCUBXUGPL-UHFFFAOYSA-N 415305 Intermediate 1-2-71::US10428044, Example 412 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415305&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613312 433915342 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829067 COc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N3O2/c1-25-17-12-21-11-10-14(17)19-20(22-13-6-3-2-4-7-13)18-15(23-19)8-5-9-16(18)24/h2-4,6-7,10-12,22-23H,5,8-9H2,1H3 SATAGZDDIKOOCD-UHFFFAOYSA-N 415306 Preparation of 2-(3-methoxypyridin-4-yl)-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 413 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 43.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415306&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607384 433915343 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829068 CC1(C)Cc2[nH]c(c(Nc3ccc(cc3)-c3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O/c1-27(2)16-22-24(23(31)17-27)26(25(30-22)20-12-14-28-15-13-20)29-21-10-8-19(9-11-21)18-6-4-3-5-7-18/h3-15,29-30H,16-17H2,1-2H3 LQKXUCADHALFDZ-UHFFFAOYSA-N 415307 Preparation of 3-(biphenyl-4-ylamino)-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 414 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415307&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607202 433915344 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829069 CC1(C)Cc2[nH]c(c(Nc3cccc(Cc4ccccc4)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C28H27N3O/c1-28(2)17-23-25(24(32)18-28)27(26(31-23)21-11-13-29-14-12-21)30-22-10-6-9-20(16-22)15-19-7-4-3-5-8-19/h3-14,16,30-31H,15,17-18H2,1-2H3 OLPVBEGYQZIPPT-UHFFFAOYSA-N 415308 Preparation of 3-[(3-benzylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 415 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 283 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415308&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613477 433915345 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829070 CC1(C)Cc2[nH]c(c(Nc3ccccc3Cc3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C28H27N3O/c1-28(2)17-23-25(24(32)18-28)27(26(31-23)20-12-14-29-15-13-20)30-22-11-7-6-10-21(22)16-19-8-4-3-5-9-19/h3-15,30-31H,16-18H2,1-2H3 WUSVMLGFSQNEJW-UHFFFAOYSA-N 415309 Preparation of 3-[(2-benzylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 416 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 689 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415309&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613395 433915346 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829071 Cn1nccc1-c1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C25H25N5O/c1-25(2)14-19-22(21(31)15-25)24(23(29-19)16-7-10-26-11-8-16)28-18-6-4-5-17(13-18)20-9-12-27-30(20)3/h4-13,28-29H,14-15H2,1-3H3 GNSQTBMHUGNHDX-UHFFFAOYSA-N 415310 Preparation of 6,6-dimethyl-3-{[3-(1-methyl-1H-pyrazol-5-yl)phenyl]amino}-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 417 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 273 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415310&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606880 433915347 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829072 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)-c3ccsc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C25H23N3OS/c1-25(2)13-20-22(21(29)14-25)24(23(28-20)16-6-9-26-10-7-16)27-19-5-3-4-17(12-19)18-8-11-30-15-18/h3-12,15,27-28H,13-14H2,1-2H3 BVLKLRKIVSFYJG-UHFFFAOYSA-N 415311 Preparation of 6,6-dimethyl-2-(pyridin-4-yl)-3-{[3-(thiophen-3-yl)phenyl]amino}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 418 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415311&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606993 433915348 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829073 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)-c3ccco3)c2C(=O)C1)-c1ccncc1 InChI=1S/C25H23N3O2/c1-25(2)14-19-22(20(29)15-25)24(23(28-19)16-8-10-26-11-9-16)27-18-6-3-5-17(13-18)21-7-4-12-30-21/h3-13,27-28H,14-15H2,1-2H3 NFNYGUVPROBGIT-UHFFFAOYSA-N 415312 Preparation of 3-{[3-(furan-2-yl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 419 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415312&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607230 433915349 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829074 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)-c3cccs3)c2C(=O)C1)-c1ccncc1 InChI=1S/C25H23N3OS/c1-25(2)14-19-22(20(29)15-25)24(23(28-19)16-8-10-26-11-9-16)27-18-6-3-5-17(13-18)21-7-4-12-30-21/h3-13,27-28H,14-15H2,1-2H3 BKOPTWASNFKBOY-UHFFFAOYSA-N 415313 Preparation of 6,6-dimethyl-2-(pyridin-4-yl)-3-{[3-(thiophen-2-yl)phenyl]amino}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 420 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 24.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415313&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606762 433915350 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829075 CC1(C)Cc2[nH]c(c(Nc3cccc(Oc4ccccc4)c3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O2/c1-27(2)16-22-24(23(31)17-27)26(25(30-22)18-11-13-28-14-12-18)29-19-7-6-10-21(15-19)32-20-8-4-3-5-9-20/h3-15,29-30H,16-17H2,1-2H3 BWEYMMOANUEALY-UHFFFAOYSA-N 415314 Preparation of 6,6-dimethyl-3-[(3-phenoxyphenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 421 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 200 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415314&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607314 433915351 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829076 CC1(C)Cc2[nH]c(c(Nc3cc(ccn3)-c3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C26H24N4O/c1-26(2)15-20-23(21(31)16-26)25(24(29-20)18-8-11-27-12-9-18)30-22-14-19(10-13-28-22)17-6-4-3-5-7-17/h3-14,29H,15-16H2,1-2H3,(H,28,30) CNFKOZQMTLYAHY-UHFFFAOYSA-N 415315 Preparation of 6,6-dimethyl-3-[(4-phenylpyridin-2-yl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 422 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 330 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415315&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607000 433915352 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829077 CC1(C)Cc2[nH]c(c(Nc3cccc(n3)-c3ccccc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C26H24N4O/c1-26(2)15-20-23(21(31)16-26)25(24(29-20)18-11-13-27-14-12-18)30-22-10-6-9-19(28-22)17-7-4-3-5-8-17/h3-14,29H,15-16H2,1-2H3,(H,28,30) RWBLJHDWPMCHPE-UHFFFAOYSA-N 415316 Preparation of 6,6-dimethyl-3-[(6-phenylpyridin-2-yl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 423 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415316&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606921 433915353 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829078 CC1(C)Cc2[nH]c(c(Nc3ccccc3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H23N3O2/c1-22(2)11-17-19(18(27)12-22)21(20(25-17)14-7-9-23-10-8-14)24-16-6-4-3-5-15(16)13-26/h3-10,24-26H,11-13H2,1-2H3 KRKRDXOBTXQTPY-UHFFFAOYSA-N 415317 Preparation of 3-{[2-(hydroxymethyl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 426 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2.58 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415317&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606750 433915354 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829079 CC1(C)Cc2[nH]c(c(Nc3ccccc3CCO)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H25N3O2/c1-23(2)13-18-20(19(28)14-23)22(21(26-18)16-7-10-24-11-8-16)25-17-6-4-3-5-15(17)9-12-27/h3-8,10-11,25-27H,9,12-14H2,1-2H3 SIQYTWGXUPYKRZ-UHFFFAOYSA-N 415318 Preparation of 3-{[2-(2-hydroxyethyl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 427 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.40 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415318&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606747 433915355 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829080 CC1(C)Cc2[nH]c(c(Nc3cccc(c3)C#C)c2C(=O)C1)-c1ccncc1 InChI=1S/C23H21N3O/c1-4-15-6-5-7-17(12-15)25-22-20-18(13-23(2,3)14-19(20)27)26-21(22)16-8-10-24-11-9-16/h1,5-12,25-26H,13-14H2,2-3H3 XVGPORXFUYEEKW-UHFFFAOYSA-N 415319 Preparation of 3-[(3-ethynylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 428 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 509 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415319&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607233 433915356 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829081 CC1(C)Cc2[nH]c(c(Nc3ccccc3C(N)=O)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22N4O2/c1-22(2)11-16-18(17(27)12-22)20(19(26-16)13-7-9-24-10-8-13)25-15-6-4-3-5-14(15)21(23)28/h3-10,25-26H,11-12H2,1-2H3,(H2,23,28) KEOKNNMAKZYPML-UHFFFAOYSA-N 415320 Preparation of 2-{[6,6-dimethyl-4-oxo-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-3-yl]amino}benzamide::US10428044, Example 429 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 70.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415320&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607074 433915357 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829082 CC1(C)Cc2[nH]c(c(Nc3ccc(cc3)S(N)(=O)=O)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H22N4O3S/c1-21(2)11-16-18(17(26)12-21)20(19(25-16)13-7-9-23-10-8-13)24-14-3-5-15(6-4-14)29(22,27)28/h3-10,24-25H,11-12H2,1-2H3,(H2,22,27,28) ISXJLQDTUWFNCI-UHFFFAOYSA-N 415321 Intermediate 1-1-28::US10428044, Example 432 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2360 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415321&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607252 433915358 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829083 CC1(C)Cc2[nH]c(c(Nc3ccc(cc3)C#N)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H20N4O/c1-22(2)11-17-19(18(27)12-22)21(20(26-17)15-7-9-24-10-8-15)25-16-5-3-14(13-23)4-6-16/h3-10,25-26H,11-12H2,1-2H3 WHAOOXBUSFOIII-UHFFFAOYSA-N 415322 Intermediate 1-1-29::US10428044, Example 433 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2930 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415322&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607017 433915359 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829084 CN(C)c1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)cc1 InChI=1S/C23H26N4O/c1-23(2)13-18-20(19(28)14-23)22(21(26-18)15-9-11-24-12-10-15)25-16-5-7-17(8-6-16)27(3)4/h5-12,25-26H,13-14H2,1-4H3 PJFMROYEPOTHIS-UHFFFAOYSA-N 415323 Intermediate 1-2-78::US10428044, Example 435 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1380 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415323&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606928 433915360 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829085 Fc1cccc(Nc2c([nH]c3CC(CC(=O)c23)C(F)(F)F)-c2ccncc2Cl)c1 415324 Preparation of 2-(3-chloropyridin-4-yl)-3-[(3-fluorophenyl)amino]-6-(trifluoromethyl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 436 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415324&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607124 433915361 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829086 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(CO)c1 InChI=1S/C22H23N3O2/c1-22(2)11-17-19(18(27)12-22)21(24-15-6-4-3-5-7-15)20(25-17)14-8-9-23-16(10-14)13-26/h3-10,24-26H,11-13H2,1-2H3 WQYLKQZEWAPPJT-UHFFFAOYSA-N 415325 Preparation of 2-[2-(hydroxymethyl)pyridin-4-yl]-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 437 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 579 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415325&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607009 433915362 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829087 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1C(F)(F)F InChI=1S/C22H20F3N3O/c1-21(2)10-16-18(17(29)11-21)20(27-13-6-4-3-5-7-13)19(28-16)14-8-9-26-12-15(14)22(23,24)25/h3-9,12,27-28H,10-11H2,1-2H3 JLONDGZWFZYHKR-UHFFFAOYSA-N 415326 Preparation of 6,6-dimethyl-3-(phenylamino)-2-[3-(trifluoromethyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 438 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 345 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415326&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606989 433915363 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829088 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(c1)S(N)(=O)=O InChI=1S/C21H22N4O3S/c1-21(2)11-15-18(16(26)12-21)20(24-14-6-4-3-5-7-14)19(25-15)13-8-9-23-17(10-13)29(22,27)28/h3-10,24-25H,11-12H2,1-2H3,(H2,22,27,28) XGNBJCNPXZSEFC-UHFFFAOYSA-N 415327 Intermediate 1-11-15::US10428044, Example 439 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 649 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415327&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607082 433915364 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829089 FC(F)(F)[C@H]1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 415328 US10428044, Example 440 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415328&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607241 433915365 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829091 FCC1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 415329 Intermediate 1-1-32::US10428044, Example 442 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.97 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415329&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607169 433915366 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829092 ClCC1Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1 415330 Preparation of 6-(chloromethyl)-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 443 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.05 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415330&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606983 433915367 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829093 CC(=O)Nc1cc(ccn1)-c1[nH]c2CC(CCl)CC(=O)c2c1Nc1ccccc1 415331 2-{[(2-aminopyridin-4-yl)methyl]amino}-4-({[tert-butyl(diphenyl)silyl]oxy}methyl)-6-oxo-N-phenylcyclohex-1-ene-1-carbothioamide::US10428044, Example 444 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.61 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415331&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606855 433915368 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829094 CC1(C)CC(=O)c2c(Nc3ccccc3)c([nH]c2C1O)-c1ccncc1 415332 Preparation of 7-hydroxy-6,6-dimethyl-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 445 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415332&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613479 433915369 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829095 OC1CCC(=O)c2c(Nc3ccccc3)c([nH]c12)-c1ccncc1 415333 Preparation of 7-hydroxy-3-(phenylamino)-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 446 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415333&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607390 433915370 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829096 Cn1cc(cn1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H22N6O2/c1-30-14-16(13-26-30)24(32)29-20-12-15(10-11-25-20)22-23(27-17-6-3-2-4-7-17)21-18(28-22)8-5-9-19(21)31/h2-4,6-7,10-14,27-28H,5,8-9H2,1H3,(H,25,29,32) OQDBJRBBSMGURC-UHFFFAOYSA-N 415334 Preparation of 1-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 447 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415334&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607250 433915371 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829097 CC(C)(C)n1cc(cn1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H28N6O2/c1-27(2,3)33-16-18(15-29-33)26(35)32-22-14-17(12-13-28-22)24-25(30-19-8-5-4-6-9-19)23-20(31-24)10-7-11-21(23)34/h4-6,8-9,12-16,30-31H,7,10-11H2,1-3H3,(H,28,32,35) XFVWYOPABLAYCH-UHFFFAOYSA-N 415335 Preparation of 1-tert-butyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 448 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.93 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415335&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606789 433915372 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829098 O=C(Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1)c1cnn(Cc2ccccc2)c1 InChI=1S/C30H26N6O2/c37-25-13-7-12-24-27(25)29(33-23-10-5-2-6-11-23)28(34-24)21-14-15-31-26(16-21)35-30(38)22-17-32-36(19-22)18-20-8-3-1-4-9-20/h1-6,8-11,14-17,19,33-34H,7,12-13,18H2,(H,31,35,38) TUUBMEYEQDRYQG-UHFFFAOYSA-N 415336 Preparation of 1-benzyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 449 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.38 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415336&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607275 433915373 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829099 COc1ccc(Cn2cc(cn2)C(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C31H28N6O3/c1-40-24-12-10-20(11-13-24)18-37-19-22(17-33-37)31(39)36-27-16-21(14-15-32-27)29-30(34-23-6-3-2-4-7-23)28-25(35-29)8-5-9-26(28)38/h2-4,6-7,10-17,19,34-35H,5,8-9,18H2,1H3,(H,32,36,39) SXGFPSVSEQBAQC-UHFFFAOYSA-N 415337 Preparation of 1-(4-methoxybenzyl)-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 450 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.24 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415337&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607199 433915374 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829100 Fc1ccc(cc1F)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H20F2N4O2/c27-18-10-9-16(13-19(18)28)26(34)32-22-14-15(11-12-29-22)24-25(30-17-5-2-1-3-6-17)23-20(31-24)7-4-8-21(23)33/h1-3,5-6,9-14,30-31H,4,7-8H2,(H,29,32,34) YWFGUKHFSFWESD-UHFFFAOYSA-N 415338 Preparation of 3,4-difluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 451 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.82 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415338&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607274 433915375 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829101 Fc1cc(F)cc(c1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C26H20F2N4O2/c27-17-11-16(12-18(28)14-17)26(34)32-22-13-15(9-10-29-22)24-25(30-19-5-2-1-3-6-19)23-20(31-24)7-4-8-21(23)33/h1-3,5-6,9-14,30-31H,4,7-8H2,(H,29,32,34) KPLOFZCBNOBWET-UHFFFAOYSA-N 415339 Preparation of 3,5-difluoro-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 452 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415339&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606748 433915376 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829102 COc1cc(ccc1F)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C27H23FN4O3/c1-35-22-14-17(10-11-19(22)28)27(34)32-23-15-16(12-13-29-23)25-26(30-18-6-3-2-4-7-18)24-20(31-25)8-5-9-21(24)33/h2-4,6-7,10-15,30-31H,5,8-9H2,1H3,(H,29,32,34) VSPGBVOYZWHWFY-UHFFFAOYSA-N 415340 Preparation of 4-fluoro-3-methoxy-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}benzamide::US10428044, Example 453 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415340&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606976 433915377 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829103 Cn1ccc(n1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C24H22N6O2/c1-30-13-11-18(29-30)24(32)28-20-14-15(10-12-25-20)22-23(26-16-6-3-2-4-7-16)21-17(27-22)8-5-9-19(21)31/h2-4,6-7,10-14,26-27H,5,8-9H2,1H3,(H,25,28,32) FVFCQGAVCYFJKZ-UHFFFAOYSA-N 415341 Preparation of 1-methyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-3-carboxamide::US10428044, Example 454 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.33 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415341&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607200 433915378 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829104 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1OCC1CC1 InChI=1S/C23H23N3O2/c27-19-8-4-7-18-21(19)23(25-16-5-2-1-3-6-16)22(26-18)17-11-12-24-13-20(17)28-14-15-9-10-15/h1-3,5-6,11-13,15,25-26H,4,7-10,14H2 JAKIJDIDJSILAF-UHFFFAOYSA-N 415342 Intermediate 1-2-81::US10428044, Example 455 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 24.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415342&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607271 433915379 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829105 CCCOc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C22H23N3O2/c1-2-13-27-19-14-23-12-11-16(19)21-22(24-15-7-4-3-5-8-15)20-17(25-21)9-6-10-18(20)26/h3-5,7-8,11-12,14,24-25H,2,6,9-10,13H2,1H3 IVTONLIUQVCWGY-UHFFFAOYSA-N 415343 Intermediate 1-2-82::US10428044, Example 456 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 73.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415343&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607141 433915380 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829106 FC(F)COc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H19F2N3O2/c22-18(23)12-28-17-11-24-10-9-14(17)20-21(25-13-5-2-1-3-6-13)19-15(26-20)7-4-8-16(19)27/h1-3,5-6,9-11,18,25-26H,4,7-8,12H2 KFTCNBRGHQKQQT-UHFFFAOYSA-N 415344 Preparation of 2-[3-(2,2-difluoroethoxy)pyridin-4-yl]-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 457 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 53.5 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415344&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607008 433915381 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829107 FC(F)(F)COc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H18F3N3O2/c22-21(23,24)12-29-17-11-25-10-9-14(17)19-20(26-13-5-2-1-3-6-13)18-15(27-19)7-4-8-16(18)28/h1-3,5-6,9-11,26-27H,4,7-8,12H2 WZGFVSVWQBJGJT-UHFFFAOYSA-N 415345 Intermediate 1-2-83::US10428044, Example 458 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 78.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415345&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607388 433915382 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829108 OCCOc1cnccc1-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C21H21N3O3/c25-11-12-27-18-13-22-10-9-15(18)20-21(23-14-5-2-1-3-6-14)19-16(24-20)7-4-8-17(19)26/h1-3,5-6,9-10,13,23-25H,4,7-8,11-12H2 ZWCIYOGPFITXSQ-UHFFFAOYSA-N 415346 Intermediate 1-2-84::US10428044, Example 459 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.8 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415346&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607163 433915383 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829109 CC1(C)OC[C@H](O1)C(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 415347 Preparation of (4S)-2,2-dimethyl-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-dioxolane-4-carboxamide::US10428044, Example 460 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415347&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607023 433915384 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829110 CC(=O)Nc1cc(ccn1)-c1[nH]c2CC(CF)CC(=O)c2c1Nc1ccccc1 415348 Preparation of N-{4-[6-(fluoromethyl)-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 461 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.88 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415348&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607049 433915385 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829111 Fc1ccc(OCC(=O)Nc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C27H23FN4O3/c28-18-9-11-20(12-10-18)35-16-24(34)32-23-15-17(13-14-29-23)26-27(30-19-5-2-1-3-6-19)25-21(31-26)7-4-8-22(25)33/h1-3,5-6,9-15,30-31H,4,7-8,16H2,(H,29,32,34) FMHXGFZUANVVTE-UHFFFAOYSA-N 415349 Preparation of N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl)pyridin-2-yl]-2-(4-fluorophenoxy)acetamide::US10428044, Example 462 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415349&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606709 433915386 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829112 Cn1ccnc1CC(=O)Nc1cc(ccn1)-c1[nH]c2CCCC(=O)c2c1Nc1ccccc1 InChI=1S/C25H24N6O2/c1-31-13-12-27-21(31)15-22(33)30-20-14-16(10-11-26-20)24-25(28-17-6-3-2-4-7-17)23-18(29-24)8-5-9-19(23)32/h2-4,6-7,10-14,28-29H,5,8-9,15H2,1H3,(H,26,30,33) HNIBQYGGITWCJX-UHFFFAOYSA-N 415350 Preparation of N-[4-(3-anilino-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl)pyridin-2-yl]-2-(1-methyl-1H-imidazol-2-yl)acetamide::US10428044, Example 463 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 142 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415350&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606720 433915387 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829113 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccncc1O InChI=1S/C21H21N3O2/c1-21(2)10-15-18(16(25)11-21)20(23-13-6-4-3-5-7-13)19(24-15)14-8-9-22-12-17(14)26/h3-9,12,23-24,26H,10-11H2,1-2H3 MFIDQBUYCXTHLI-UHFFFAOYSA-N 415351 Intermediate 1-2-85::US10428044, Example 464 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415351&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606800 433915388 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829114 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2ccn[nH]2)c1 InChI=1S/C25H24N6O2/c1-25(2)13-18-21(19(32)14-25)23(28-16-6-4-3-5-7-16)22(29-18)15-8-10-26-20(12-15)30-24(33)17-9-11-27-31-17/h3-12,28-29H,13-14H2,1-2H3,(H,27,31)(H,26,30,33) FHLIZLGUGCVSJV-UHFFFAOYSA-N 415352 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-3-carboxamide::US10428044, Example 465 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.19 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415352&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607182 433915389 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829115 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)[C@H]2C[C@@H]2F)c1 415353 Preparation of rel-(R,S)-2-fluoro-N-{4-[4′-oxo-3′-(phenylamino)-1′,4′,5′,7′-tetrahydrospiro[cyclopropane-1,6′-indol]-2′-yl]pyridin-2-yl}cyclopropanecarboxamide::US10428044, Example 466 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.03 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415353&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607392 433915390 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829116 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2cc(F)cc(F)c2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)14-21-24(22(35)15-28)26(32-20-6-4-3-5-7-20)25(33-21)16-8-9-31-23(12-16)34-27(36)17-10-18(29)13-19(30)11-17/h3-13,32-33H,14-15H2,1-2H3,(H,31,34,36) ZGCQCLIGPMPLSI-UHFFFAOYSA-N 415354 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3,5-difluorobenzamide::US10428044, Example 467 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415354&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607396 433915391 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829117 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(OCc2ccccc2)c1 InChI=1S/C28H27N3O2/c1-28(2)16-22-25(23(32)17-28)27(30-21-11-7-4-8-12-21)26(31-22)20-13-14-29-24(15-20)33-18-19-9-5-3-6-10-19/h3-15,30-31H,16-18H2,1-2H3 VWZZIDJRQPNNMM-UHFFFAOYSA-N 415355 Intermediate 1-2-86::US10428044, Example 468 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415355&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606814 433915392 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829118 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(O)c1 InChI=1S/C21H21N3O2/c1-21(2)11-15-18(16(25)12-21)20(23-14-6-4-3-5-7-14)19(24-15)13-8-9-22-17(26)10-13/h3-10,23-24H,11-12H2,1-2H3,(H,22,26) XMXQEDDDNDWJOZ-UHFFFAOYSA-N 415356 Preparation of 2-(2-hydroxypyridin-4-yl)-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 469 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2160 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415356&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607220 433915393 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829119 O=C(Nc1cc(ccn1)-c1[nH]c2CC3(CC3)CC(=O)c2c1Nc1ccccc1)c1cocn1 InChI=1S/C25H21N5O3/c31-19-12-25(7-8-25)11-17-21(19)23(28-16-4-2-1-3-5-16)22(29-17)15-6-9-26-20(10-15)30-24(32)18-13-33-14-27-18/h1-6,9-10,13-14,28-29H,7-8,11-12H2,(H,26,30,32) IDBABOSHMWLZOL-UHFFFAOYSA-N 415357 Preparation of N-{4-[4′-oxo-3′-(phenylamino)-1′,4′,5′,7′-tetrahydrospiro[cyclopropane-1,6′-indol]-2′-yl]pyridin-2-yl}-1,3-oxazole-4-carboxamide::US10428044, Example 470 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.49 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415357&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606700 433915394 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829120 CO\N=C1/CC(C)(C)Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C22H24N4O/c1-22(2)13-17-19(18(14-22)26-27-3)21(24-16-7-5-4-6-8-16)20(25-17)15-9-11-23-12-10-15/h4-12,24-25H,13-14H2,1-3H3/b26-18+ WBRALBIZDCBROG-NLRVBDNBSA-N 415358 Preparation of 4-(methoxyimino)-6,6-dimethyl-N-phenyl-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-3-amine::US10428044, Example 471 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4430 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415358&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136992987 433915395 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829121 CC(C)(C)n1cc(cn1)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C29H32N6O2/c1-28(2,3)35-17-19(16-31-35)27(37)34-23-13-18(11-12-30-23)25-26(32-20-9-7-6-8-10-20)24-21(33-25)14-29(4,5)15-22(24)36/h6-13,16-17,32-33H,14-15H2,1-5H3,(H,30,34,37) TYDVWNGSSUYYTN-UHFFFAOYSA-N 415359 Preparation of 1-tert-butyl-N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 472 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.04 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415359&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607084 433915396 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829122 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2ccc(F)c(F)c2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)14-21-24(22(35)15-28)26(32-18-6-4-3-5-7-18)25(33-21)16-10-11-31-23(13-16)34-27(36)17-8-9-19(29)20(30)12-17/h3-13,32-33H,14-15H2,1-2H3,(H,31,34,36) WWUGQPMYVDTXLX-UHFFFAOYSA-N 415360 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-3,4-difluorobenzamide::US10428044, Example 473 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415360&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607177 433915397 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829123 COc1cc(ccc1F)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C29H27FN4O3/c1-29(2)15-21-25(22(35)16-29)27(32-19-7-5-4-6-8-19)26(33-21)17-11-12-31-24(14-17)34-28(36)18-9-10-20(30)23(13-18)37-3/h4-14,32-33H,15-16H2,1-3H3,(H,31,34,36) GDIXRIPHHVPOQO-UHFFFAOYSA-N 415361 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-4-fluoro-3-methoxybenzamide::US10428044, Example 474 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.63 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415361&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613387 433915398 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829124 CC(C)(F)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C25H27FN4O2/c1-24(2)13-17-20(18(31)14-24)22(28-16-8-6-5-7-9-16)21(29-17)15-10-11-27-19(12-15)30-23(32)25(3,4)26/h5-12,28-29H,13-14H2,1-4H3,(H,27,30,32) NZTGUOZQWCWBJM-UHFFFAOYSA-N 415362 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-fluoro-2-methylpropanamide::US10428044, Example 475 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415362&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606953 433915399 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829125 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)COCc2ccccc2)c1 InChI=1S/C30H30N4O3/c1-30(2)16-23-27(24(35)17-30)29(32-22-11-7-4-8-12-22)28(33-23)21-13-14-31-25(15-21)34-26(36)19-37-18-20-9-5-3-6-10-20/h3-15,32-33H,16-19H2,1-2H3,(H,31,34,36) OQYVKHNRBQGKLR-UHFFFAOYSA-N 415363 Preparation of 2-(benzyloxy)-N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 476 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.04 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415363&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607249 433915400 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829126 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)C2CC2(F)F)c1 415364 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2,2-difluorocyclopropanecarboxamide::US10428044, Example 477 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.62 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415364&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606749 433915401 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829127 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2cnn(Cc3ccccc3)c2)c1 InChI=1S/C32H30N6O2/c1-32(2)16-25-28(26(39)17-32)30(35-24-11-7-4-8-12-24)29(36-25)22-13-14-33-27(15-22)37-31(40)23-18-34-38(20-23)19-21-9-5-3-6-10-21/h3-15,18,20,35-36H,16-17,19H2,1-2H3,(H,33,37,40) CZKLNTCZBDRDTE-UHFFFAOYSA-N 415365 Preparation of 1-benzyl-N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1H-pyrazole-4-carboxamide::US10428044, Example 478 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.23 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415365&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607195 433915402 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829128 COc1ccc(Cn2cc(cn2)C(=O)Nc2cc(ccn2)-c2[nH]c3CC(C)(C)CC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C33H32N6O3/c1-33(2)16-26-29(27(40)17-33)31(36-24-7-5-4-6-8-24)30(37-26)22-13-14-34-28(15-22)38-32(41)23-18-35-39(20-23)19-21-9-11-25(42-3)12-10-21/h4-15,18,20,36-37H,16-17,19H2,1-3H3,(H,34,38,41) DNGYUAJEFVWZDC-UHFFFAOYSA-N 415366 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1-(4-methoxybenzyl)-1H-pyrazole-4-carboxamide::US10428044, Example 479 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.09 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415366&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607297 433915403 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829129 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2cncs2)c1 InChI=1S/C25H23N5O2S/c1-25(2)11-17-21(18(31)12-25)23(28-16-6-4-3-5-7-16)22(29-17)15-8-9-27-20(10-15)30-24(32)19-13-26-14-33-19/h3-10,13-14,28-29H,11-12H2,1-2H3,(H,27,30,32) NWMOEFNGJPCJTO-UHFFFAOYSA-N 415367 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-5-carboxamide::US10428044, Example 480 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.30 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415367&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613473 433915404 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829130 Cc1ccc(CO)c(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1 InChI=1S/C23H25N3O2/c1-14-4-5-16(13-27)17(10-14)25-22-20-18(11-23(2,3)12-19(20)28)26-21(22)15-6-8-24-9-7-15/h4-10,25-27H,11-13H2,1-3H3 BJWCHNLCOOLQAS-UHFFFAOYSA-N 415368 Preparation of 3-{[2-(hydroxymethyl)-5-methylphenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 481 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 78.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415368&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606802 433915405 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829131 Cc1ccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c(CO)c1 InChI=1S/C23H25N3O2/c1-14-4-5-17(16(10-14)13-27)25-22-20-18(11-23(2,3)12-19(20)28)26-21(22)15-6-8-24-9-7-15/h4-10,25-27H,11-13H2,1-3H3 ZEDDJORZYGIRAK-UHFFFAOYSA-N 415369 Preparation of 3-{[2-(hydroxymethyl)-4-methylphenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 482 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415369&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607168 433915406 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829132 Cc1cccc(Nc2c([nH]c3CC(C)(C)CC(=O)c23)-c2ccncc2)c1CO InChI=1S/C23H25N3O2/c1-14-5-4-6-17(16(14)13-27)25-22-20-18(11-23(2,3)12-19(20)28)26-21(22)15-7-9-24-10-8-15/h4-10,25-27H,11-13H2,1-3H3 GMIGGFAOTWZKNG-UHFFFAOYSA-N 415370 Preparation of 3-{[2-(hydroxymethyl)-3-methylphenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 483 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.48 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415370&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606732 433915407 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829133 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCCCCc2ccccc2)c1 InChI=1S/C29H30N4O/c34-25-16-9-15-24-27(25)29(32-23-13-5-2-6-14-23)28(33-24)22-17-19-31-26(20-22)30-18-8-7-12-21-10-3-1-4-11-21/h1-6,10-11,13-14,17,19-20,32-33H,7-9,12,15-16,18H2,(H,30,31) OIEOZUAZMANFKC-UHFFFAOYSA-N 415371 Preparation of 3-(phenylamino)-2-{2-[(4-phenylbutyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 484 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 907 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415371&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606755 433915408 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829134 CC1(C)Cc2[nH]c(c(Nc3ccc(F)cc3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22FN3O2/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-5-7-24-8-6-13)25-16-4-3-15(23)9-14(16)12-27/h3-9,25-27H,10-12H2,1-2H3 WGGJNTXYLOUATB-UHFFFAOYSA-N 415372 Preparation of 3-{[4-fluoro-2-(hydroxymethyl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 485 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.84 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415372&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606728 433915409 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829135 CC1(C)Cc2[nH]c(c(Nc3cccc(F)c3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22FN3O2/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-6-8-24-9-7-13)25-16-5-3-4-15(23)14(16)12-27/h3-9,25-27H,10-12H2,1-2H3 UTKCOIPKMKNQTD-UHFFFAOYSA-N 415373 Preparation of 3-{[3-fluoro-2-(hydroxymethyl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 486 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.45 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415373&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606909 433915410 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829136 CC1(C)Cc2[nH]c(c(Nc3cc(F)ccc3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C22H22FN3O2/c1-22(2)10-17-19(18(28)11-22)21(20(26-17)13-5-7-24-8-6-13)25-16-9-15(23)4-3-14(16)12-27/h3-9,25-27H,10-12H2,1-2H3 OTGLGOMMRQMNCQ-UHFFFAOYSA-N 415374 Preparation of 3-{[5-fluoro-2-(hydroxymethyl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 487 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.35 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415374&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606930 433915411 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829137 CC(C)(O)c1ccccc1Nc1c([nH]c2CC(C)(C)CC(=O)c12)-c1ccncc1 InChI=1S/C24H27N3O2/c1-23(2)13-18-20(19(28)14-23)22(21(27-18)15-9-11-25-12-10-15)26-17-8-6-5-7-16(17)24(3,4)29/h5-12,26-27,29H,13-14H2,1-4H3 SUKMEAXYUFEVNX-UHFFFAOYSA-N 415375 Preparation of 3-{[2-(2-hydroxypropan-2-yl)phenyl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 488 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 39.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415375&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606751 433915412 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829138 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCCc2ccccc2)c1 InChI=1S/C27H26N4O/c32-23-13-7-12-22-25(23)27(30-21-10-5-2-6-11-21)26(31-22)20-15-17-29-24(18-20)28-16-14-19-8-3-1-4-9-19/h1-6,8-11,15,17-18,30-31H,7,12-14,16H2,(H,28,29) GEEBFLNMNWFSOG-UHFFFAOYSA-N 415376 Preparation of 3-(phenylamino)-2-{2-[(2-phenylethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 489 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3320 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415376&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613390 433915413 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829139 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCCCc2ccccc2)c1 InChI=1S/C28H28N4O/c33-24-15-7-14-23-26(24)28(31-22-12-5-2-6-13-22)27(32-23)21-16-18-30-25(19-21)29-17-8-11-20-9-3-1-4-10-20/h1-6,9-10,12-13,16,18-19,31-32H,7-8,11,14-15,17H2,(H,29,30) DULJJRFYUPAGDA-UHFFFAOYSA-N 415377 Preparation of 3-(phenylamino)-2-{2-[(3-phenylpropyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 490 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2560 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415377&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607254 433915414 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829140 CCO\N=C1/CC(C)(C)Cc2[nH]c(c(Nc3ccccc3)c12)-c1ccncc1 InChI=1S/C23H26N4O/c1-4-28-27-19-15-23(2,3)14-18-20(19)22(25-17-8-6-5-7-9-17)21(26-18)16-10-12-24-13-11-16/h5-13,25-26H,4,14-15H2,1-3H3/b27-19+ OLSPSWZLVOGYQL-ZXVVBBHZSA-N 415378 Preparation of 4-(ethoxyimino)-6,6-dimethyl-N-phenyl-2-(pyridin-4-yl)-4,5,6,7-tetrahydro-1H-indol-3-amine::US10428044, Example 491 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1240 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415378&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136992974 433915415 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829141 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)COCc2cccnc2)c1 InChI=1S/C29H29N5O3/c1-29(2)14-22-26(23(35)15-29)28(32-21-8-4-3-5-9-21)27(33-22)20-10-12-31-24(13-20)34-25(36)18-37-17-19-7-6-11-30-16-19/h3-13,16,32-33H,14-15,17-18H2,1-2H3,(H,31,34,36) VDFNGPXSVTXDRL-UHFFFAOYSA-N 415379 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(pyridin-3-ylmethoxy)acetamide::US10428044, Example 492 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.28 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415379&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613470 433915416 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829142 Cn1ccnc1COCC(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C28H30N6O3/c1-28(2)14-20-25(21(35)15-28)27(31-19-7-5-4-6-8-19)26(32-20)18-9-10-29-22(13-18)33-24(36)17-37-16-23-30-11-12-34(23)3/h4-13,31-32H,14-17H2,1-3H3,(H,29,33,36) VFENYTSJQSWQOT-UHFFFAOYSA-N 415380 Preparation of 2-[(1-methyl-1H-imidazol-2-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 493 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.63 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415380&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613388 433915417 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829143 Cn1ncnc1COCC(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C27H29N7O3/c1-27(2)12-19-24(20(35)13-27)26(31-18-7-5-4-6-8-18)25(32-19)17-9-10-28-21(11-17)33-23(36)15-37-14-22-29-16-30-34(22)3/h4-11,16,31-32H,12-15H2,1-3H3,(H,28,33,36) CNGXSDADJBQNJC-UHFFFAOYSA-N 415381 Preparation of 2-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 494 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.9 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415381&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613502 433915418 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829144 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)COCc2ccccn2)c1 InChI=1S/C29H29N5O3/c1-29(2)15-22-26(23(35)16-29)28(32-20-8-4-3-5-9-20)27(33-22)19-11-13-31-24(14-19)34-25(36)18-37-17-21-10-6-7-12-30-21/h3-14,32-33H,15-18H2,1-2H3,(H,31,34,36) KJYFFBPOQNUNRH-UHFFFAOYSA-N 415382 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(pyridin-2-ylmethoxy)acetamide::US10428044, Example 495 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.6 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415382&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613353 433915419 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829145 Cc1ncsc1COCC(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C28H29N5O3S/c1-17-22(37-16-30-17)14-36-15-24(35)33-23-11-18(9-10-29-23)26-27(31-19-7-5-4-6-8-19)25-20(32-26)12-28(2,3)13-21(25)34/h4-11,16,31-32H,12-15H2,1-3H3,(H,29,33,35) UPZNRAKQPOECMA-UHFFFAOYSA-N 415383 Preparation of 2-[(4-methyl-1,3-thiazol-5-yl)methoxy]-N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}acetamide::US10428044, Example 496 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.46 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415383&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613475 433915420 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829146 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCCCc2ccccc2)c1 InChI=1S/C30H32N4O/c1-30(2)19-24-27(25(35)20-30)29(33-23-13-7-4-8-14-23)28(34-24)22-15-17-32-26(18-22)31-16-9-12-21-10-5-3-6-11-21/h3-8,10-11,13-15,17-18,33-34H,9,12,16,19-20H2,1-2H3,(H,31,32) BXMKCDQAIMDLIL-UHFFFAOYSA-N 415384 Preparation of 6,6-dimethyl-3-(phenylamino)-2-{2-[(3-phenylpropyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 497 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1440 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415384&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607207 433915421 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829147 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCCc2ccccc2)c1 InChI=1S/C29H30N4O/c1-29(2)18-23-26(24(34)19-29)28(32-22-11-7-4-8-12-22)27(33-23)21-14-16-31-25(17-21)30-15-13-20-9-5-3-6-10-20/h3-12,14,16-17,32-33H,13,15,18-19H2,1-2H3,(H,30,31) JEQPWDKRFAHGPP-UHFFFAOYSA-N 415385 Preparation of 6,6-dimethyl-3-(phenylamino)-2-{2-[(2-phenylethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 498 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1260 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415385&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607355 433915422 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829148 Fc1ccc(CNc2cc(ccn2)-c2[nH]c3CCCC(=O)c3c2Nc2ccccc2)cc1 InChI=1S/C26H23FN4O/c27-19-11-9-17(10-12-19)16-29-23-15-18(13-14-28-23)25-26(30-20-5-2-1-3-6-20)24-21(31-25)7-4-8-22(24)32/h1-3,5-6,9-15,30-31H,4,7-8,16H2,(H,28,29) QLSYRKJDYFLHHK-UHFFFAOYSA-N 415386 Preparation of 2-{2-[(4-fluorobenzyl)amino]pyridin-4-yl}-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 499 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 830 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415386&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607058 433915423 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829149 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCc2cncs2)c1 InChI=1S/C23H21N5OS/c29-19-8-4-7-18-21(19)23(27-16-5-2-1-3-6-16)22(28-18)15-9-10-25-20(11-15)26-13-17-12-24-14-30-17/h1-3,5-6,9-12,14,27-28H,4,7-8,13H2,(H,25,26) WMWHSTKIJIBMAG-UHFFFAOYSA-N 415387 Preparation of 3-(phenylamino)-2-{2-[(1,3-thiazol-5-ylmethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 500 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 356 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415387&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607060 433915424 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829150 O=C1CCCc2[nH]c(c(Nc3ccccc3)c12)-c1ccnc(NCc2cscn2)c1 InChI=1S/C23H21N5OS/c29-19-8-4-7-18-21(19)23(27-16-5-2-1-3-6-16)22(28-18)15-9-10-24-20(11-15)25-12-17-13-30-14-26-17/h1-3,5-6,9-11,13-14,27-28H,4,7-8,12H2,(H,24,25) HLQHXGMHUNLFOE-UHFFFAOYSA-N 415388 Preparation of 3-(phenylamino)-2-{2-[(1,3-thiazol-4-ylmethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 501 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 96.7 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415388&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606968 433915425 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829151 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)COCC(F)(F)F)c1 InChI=1S/C25H25F3N4O3/c1-24(2)11-17-21(18(33)12-24)23(30-16-6-4-3-5-7-16)22(31-17)15-8-9-29-19(10-15)32-20(34)13-35-14-25(26,27)28/h3-10,30-31H,11-14H2,1-2H3,(H,29,32,34) NTGUCOABVMLGHD-UHFFFAOYSA-N 415389 Preparation of N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-2-(2,2,2-trifluoroethoxy)acetamide::US10428044, Example 502 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.4 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415389&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613432 433915426 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829152 O=C1CCCc2[nH]c(c(Nc3ccccn3)c12)-c1ccncc1 InChI=1S/C18H16N4O/c23-14-5-3-4-13-16(14)18(22-15-6-1-2-9-20-15)17(21-13)12-7-10-19-11-8-12/h1-2,6-11,21H,3-5H2,(H,20,22) JOZWVNVADPZBPC-UHFFFAOYSA-N 415390 Intermediate 1-1-33::US10428044, Example 503 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 36.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415390&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606832 433915427 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829153 Cn1ccc(n1)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C26H26N6O2/c1-26(2)14-19-22(20(33)15-26)24(28-17-7-5-4-6-8-17)23(29-19)16-9-11-27-21(13-16)30-25(34)18-10-12-32(3)31-18/h4-13,28-29H,14-15H2,1-3H3,(H,27,30,34) OLXWJFUWWPALCG-UHFFFAOYSA-N 415391 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1-methyl-1H-pyrazole-3-carboxamide::US10428044, Example 504 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.14 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415391&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606948 433915428 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829154 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NC(=O)c2nccs2)c1 InChI=1S/C25H23N5O2S/c1-25(2)13-17-20(18(31)14-25)22(28-16-6-4-3-5-7-16)21(29-17)15-8-9-26-19(12-15)30-23(32)24-27-10-11-33-24/h3-12,28-29H,13-14H2,1-2H3,(H,26,30,32) BKZGNLDHHSZHTH-UHFFFAOYSA-N 415392 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1,3-thiazole-2-carboxamide::US10428044, Example 505 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.1 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415392&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607270 433915429 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829155 Cn1cc(cn1)C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)CC(=O)c2c1Nc1ccccc1 InChI=1S/C26H26N6O2/c1-26(2)12-19-22(20(33)13-26)24(29-18-7-5-4-6-8-18)23(30-19)16-9-10-27-21(11-16)31-25(34)17-14-28-32(3)15-17/h4-11,14-15,29-30H,12-13H2,1-3H3,(H,27,31,34) CLSYLPOGYDXZIE-UHFFFAOYSA-N 415393 Preparation of N-{4-[6,6-dimethyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-indol-2-yl]pyridin-2-yl}-1-methyl-1H-pyrazole-4-carboxamide::US10428044, Example 506 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.77 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415393&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607076 433915430 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829156 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCCCCc2ccccc2)c1 InChI=1S/C31H34N4O/c1-31(2)20-25-28(26(36)21-31)30(34-24-14-7-4-8-15-24)29(35-25)23-16-18-33-27(19-23)32-17-10-9-13-22-11-5-3-6-12-22/h3-8,11-12,14-16,18-19,34-35H,9-10,13,17,20-21H2,1-2H3,(H,32,33) UOPXPZYFQZUAQS-UHFFFAOYSA-N 415394 Preparation of 6,6-dimethyl-3-(phenylamino)-2-{2-[(4-phenylbutyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 507 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 959 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415394&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606795 433915431 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829157 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCc2cncs2)c1 InChI=1S/C25H25N5OS/c1-25(2)11-19-22(20(31)12-25)24(29-17-6-4-3-5-7-17)23(30-19)16-8-9-27-21(10-16)28-14-18-13-26-15-32-18/h3-10,13,15,29-30H,11-12,14H2,1-2H3,(H,27,28) MYBDRTYZGWNMQH-UHFFFAOYSA-N 415395 Preparation of 6,6-dimethyl-3-(phenylamino)-2-{2-[(1,3-thiazol-5-ylmethyl)amino]pyridin-4-yl}-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 508 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 193 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415395&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118613478 433915432 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829158 CC1(C)Cc2[nH]c(c(Nc3ccccc3)c2C(=O)C1)-c1ccnc(NCC2CC2)c1 InChI=1S/C25H28N4O/c1-25(2)13-19-22(20(30)14-25)24(28-18-6-4-3-5-7-18)23(29-19)17-10-11-26-21(12-17)27-15-16-8-9-16/h3-7,10-12,16,28-29H,8-9,13-15H2,1-2H3,(H,26,27) UBGXFSSHBOTVBF-UHFFFAOYSA-N 415396 Preparation of 2-{2-[(cyclopropylmethyl)amino]pyridin-4-yl}-6,6-dimethyl-3-(phenylamino)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 509 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 221 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415396&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607281 433915433 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829159 CC1(C)Cc2[nH]c(c(Nc3cnccc3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H22N4O2/c1-21(2)9-15-18(17(27)10-21)20(19(24-15)13-3-6-22-7-4-13)25-16-11-23-8-5-14(16)12-26/h3-8,11,24-26H,9-10,12H2,1-2H3 UUXYZJQPQVDDHM-UHFFFAOYSA-N 415397 Preparation of 3-{[4-(hydroxymethyl)pyridin-3-yl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 510 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 25.3 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415397&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118607129 433915434 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829160 CC1(C)Cc2[nH]c(c(Nc3ncccc3CO)c2C(=O)C1)-c1ccncc1 InChI=1S/C21H22N4O2/c1-21(2)10-15-17(16(27)11-21)19(18(24-15)13-5-8-22-9-6-13)25-20-14(12-26)4-3-7-23-20/h3-9,24,26H,10-12H2,1-2H3,(H,23,25) WSYLXFZDSRRXCS-UHFFFAOYSA-N 415398 Preparation of 3-{[3-(hydroxymethyl)pyridin-2-yl]amino}-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 511 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 65.2 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415398&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606891 433915435 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829161 CC1(C)Cc2[nH]c(c(Nc3ccc(Cc4ccccc4)cc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C28H27N3O/c1-28(2)17-23-25(24(32)18-28)27(26(31-23)21-12-14-29-15-13-21)30-22-10-8-20(9-11-22)16-19-6-4-3-5-7-19/h3-15,30-31H,16-18H2,1-2H3 USECSCAVVDJWOI-UHFFFAOYSA-N 415399 Preparation of 3-[(4-benzylphenyl)amino]-6,6-dimethyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 513 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415399&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606812 433915436 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 829162 CC1(C)Cc2[nH]c(c(Nc3ccc(Oc4ccccc4)cc3)c2C(=O)C1)-c1ccncc1 InChI=1S/C27H25N3O2/c1-27(2)16-22-24(23(31)17-27)26(25(30-22)18-12-14-28-15-13-18)29-19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h3-15,29-30H,16-17H2,1-2H3 WPHIJNIDDKZOMF-UHFFFAOYSA-N 415400 Preparation of 6,6-dimethyl-3-[(4-phenoxyphenyl)amino]-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-indol-4-one::US10428044, Example 514 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens >20000 US Patent 10.7270/Q2QF8W7J aid1803871 US10428044 Graham, K; Klar, U; Briem, H; Hitchcock, M; Barfacker, L; Eis, K; Schulze, V; Siemeister, G; Bone, W; Schroder, J; Holton, S; Lienau, P; Tempel, R; Sonnenschein, H; Balint, J; Graubaum, H 10/1/2019 8/17/2020 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415400&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 118606811 433915437 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4